id	sid	tid	token	lemma	pos
work_dnaoa4trybfmvfskexkidzt764	1	1	177_04_190802.book(tai10010_fm.fm	177_04_190802.book(tai10010_fm.fm	NNP
work_dnaoa4trybfmvfskexkidzt764	1	2	)	)	-RRB-
work_dnaoa4trybfmvfskexkidzt764	1	3	MJA	MJA	NNP
work_dnaoa4trybfmvfskexkidzt764	1	4	Vol	Vol	NNP
work_dnaoa4trybfmvfskexkidzt764	1	5	177	177	CD
work_dnaoa4trybfmvfskexkidzt764	1	6	19	19	CD
work_dnaoa4trybfmvfskexkidzt764	1	7	August	August	NNP
work_dnaoa4trybfmvfskexkidzt764	1	8	2002	2002	CD
work_dnaoa4trybfmvfskexkidzt764	1	9	193	193	CD
work_dnaoa4trybfmvfskexkidzt764	1	10	NOTABLE	NOTABLE	NNP
work_dnaoa4trybfmvfskexkidzt764	1	11	CASES	case	NNS
work_dnaoa4trybfmvfskexkidzt764	1	12	The	the	DT
work_dnaoa4trybfmvfskexkidzt764	1	13	Medical	Medical	NNP
work_dnaoa4trybfmvfskexkidzt764	1	14	Journal	Journal	NNP
work_dnaoa4trybfmvfskexkidzt764	1	15	of	of	IN
work_dnaoa4trybfmvfskexkidzt764	1	16	Australia	Australia	NNP
work_dnaoa4trybfmvfskexkidzt764	1	17	ISSN	ISSN	NNP
work_dnaoa4trybfmvfskexkidzt764	1	18	:	:	:
work_dnaoa4trybfmvfskexkidzt764	1	19	0025	0025	CD
work_dnaoa4trybfmvfskexkidzt764	1	20	-	-	SYM
work_dnaoa4trybfmvfskexkidzt764	1	21	729X	729x	CD
work_dnaoa4trybfmvfskexkidzt764	1	22	19	19	CD
work_dnaoa4trybfmvfskexkidzt764	1	23	August	August	NNP
work_dnaoa4trybfmvfskexkidzt764	1	24	2002	2002	CD
work_dnaoa4trybfmvfskexkidzt764	1	25	177	177	CD
work_dnaoa4trybfmvfskexkidzt764	1	26	4	4	CD
work_dnaoa4trybfmvfskexkidzt764	1	27	193-	193-	CD
work_dnaoa4trybfmvfskexkidzt764	1	28	195	195	CD
work_dnaoa4trybfmvfskexkidzt764	1	29	©	©	NNP
work_dnaoa4trybfmvfskexkidzt764	1	30	The	the	DT
work_dnaoa4trybfmvfskexkidzt764	1	31	Medical	Medical	NNP
work_dnaoa4trybfmvfskexkidzt764	1	32	Journal	Journal	NNP
work_dnaoa4trybfmvfskexkidzt764	1	33	of	of	IN
work_dnaoa4trybfmvfskexkidzt764	1	34	Australia	Australia	NNP
work_dnaoa4trybfmvfskexkidzt764	1	35	2002	2002	CD
work_dnaoa4trybfmvfskexkidzt764	1	36	www.mja.com.au	www.mja.com.au	:
work_dnaoa4trybfmvfskexkidzt764	1	37	Notable	notable	JJ
work_dnaoa4trybfmvfskexkidzt764	1	38	Cases	case	NNS
work_dnaoa4trybfmvfskexkidzt764	1	39	A	a	DT
work_dnaoa4trybfmvfskexkidzt764	1	40	preterm	preterm	JJ
work_dnaoa4trybfmvfskexkidzt764	1	41	infant	infant	NN
work_dnaoa4trybfmvfskexkidzt764	1	42	born	bear	VBN
work_dnaoa4trybfmvfskexkidzt764	1	43	to	to	IN
work_dnaoa4trybfmvfskexkidzt764	1	44	a	a	DT
work_dnaoa4trybfmvfskexkidzt764	1	45	woman	woman	NN
work_dnaoa4trybfmvfskexkidzt764	1	46	with	with	IN
work_dnaoa4trybfmvfskexkidzt764	1	47	chronic	chronic	JJ
work_dnaoa4trybfmvfskexkidzt764	1	48	lead	lead	NN
work_dnaoa4trybfmvfskexkidzt764	1	49	poisoning	poisoning	NN
work_dnaoa4trybfmvfskexkidzt764	1	50	was	be	VBD
work_dnaoa4trybfmvfskexkidzt764	1	51	found	find	VBN
work_dnaoa4trybfmvfskexkidzt764	1	52	to	to	TO
work_dnaoa4trybfmvfskexkidzt764	1	53	have	have	VB
work_dnaoa4trybfmvfskexkidzt764	1	54	the	the	DT
work_dnaoa4trybfmvfskexkidzt764	1	55	highest	high	JJS
work_dnaoa4trybfmvfskexkidzt764	1	56	blood	blood	NN
work_dnaoa4trybfmvfskexkidzt764	1	57	lead	lead	NN
work_dnaoa4trybfmvfskexkidzt764	1	58	level	level	NN
work_dnaoa4trybfmvfskexkidzt764	1	59	recorded	record	VBN
work_dnaoa4trybfmvfskexkidzt764	1	60	for	for	IN
work_dnaoa4trybfmvfskexkidzt764	1	61	a	a	DT
work_dnaoa4trybfmvfskexkidzt764	1	62	surviving	surviving	NN
work_dnaoa4trybfmvfskexkidzt764	1	63	neonate	neonate	NN
work_dnaoa4trybfmvfskexkidzt764	1	64	.	.	.
work_dnaoa4trybfmvfskexkidzt764	2	1	Parenteral	parenteral	JJ
work_dnaoa4trybfmvfskexkidzt764	2	2	calcium	calcium	NN
work_dnaoa4trybfmvfskexkidzt764	2	3	disodium	disodium	NN
work_dnaoa4trybfmvfskexkidzt764	2	4	edetate	edetate	NN
work_dnaoa4trybfmvfskexkidzt764	2	5	,	,	,
work_dnaoa4trybfmvfskexkidzt764	2	6	but	but	CC
work_dnaoa4trybfmvfskexkidzt764	2	7	not	not	RB
work_dnaoa4trybfmvfskexkidzt764	2	8	oral	oral	JJ
work_dnaoa4trybfmvfskexkidzt764	2	9	succimer	succimer	NN
work_dnaoa4trybfmvfskexkidzt764	2	10	,	,	,
work_dnaoa4trybfmvfskexkidzt764	2	11	was	be	VBD
work_dnaoa4trybfmvfskexkidzt764	2	12	effective	effective	JJ
work_dnaoa4trybfmvfskexkidzt764	2	13	in	in	IN
work_dnaoa4trybfmvfskexkidzt764	2	14	reducing	reduce	VBG
work_dnaoa4trybfmvfskexkidzt764	2	15	the	the	DT
work_dnaoa4trybfmvfskexkidzt764	2	16	infant	infant	NN
work_dnaoa4trybfmvfskexkidzt764	2	17	’s	’s	POS
work_dnaoa4trybfmvfskexkidzt764	2	18	lead	lead	NN
work_dnaoa4trybfmvfskexkidzt764	2	19	burden	burden	NN
work_dnaoa4trybfmvfskexkidzt764	2	20	in	in	IN
work_dnaoa4trybfmvfskexkidzt764	2	21	the	the	DT
work_dnaoa4trybfmvfskexkidzt764	2	22	neonatal	neonatal	JJ
work_dnaoa4trybfmvfskexkidzt764	2	23	period	period	NN
work_dnaoa4trybfmvfskexkidzt764	2	24	.	.	.
work_dnaoa4trybfmvfskexkidzt764	3	1	An	an	DT
work_dnaoa4trybfmvfskexkidzt764	3	2	exposure	exposure	NN
work_dnaoa4trybfmvfskexkidzt764	3	3	assessment	assessment	NN
work_dnaoa4trybfmvfskexkidzt764	3	4	revealed	reveal	VBD
work_dnaoa4trybfmvfskexkidzt764	3	5	the	the	DT
work_dnaoa4trybfmvfskexkidzt764	3	6	mother	mother	NN
work_dnaoa4trybfmvfskexkidzt764	3	7	’s	’s	POS
work_dnaoa4trybfmvfskexkidzt764	3	8	long	long	JJ
work_dnaoa4trybfmvfskexkidzt764	3	9	-	-	HYPH
work_dnaoa4trybfmvfskexkidzt764	3	10	term	term	NN
work_dnaoa4trybfmvfskexkidzt764	3	11	ingestion	ingestion	NN
work_dnaoa4trybfmvfskexkidzt764	3	12	of	of	IN
work_dnaoa4trybfmvfskexkidzt764	3	13	lead	lead	NN
work_dnaoa4trybfmvfskexkidzt764	3	14	-	-	HYPH
work_dnaoa4trybfmvfskexkidzt764	3	15	contaminated	contaminate	VBN
work_dnaoa4trybfmvfskexkidzt764	3	16	herbal	herbal	JJ
work_dnaoa4trybfmvfskexkidzt764	3	17	tablets	tablet	NNS
work_dnaoa4trybfmvfskexkidzt764	3	18	as	as	IN
work_dnaoa4trybfmvfskexkidzt764	3	19	the	the	DT
work_dnaoa4trybfmvfskexkidzt764	3	20	source	source	NN
work_dnaoa4trybfmvfskexkidzt764	3	21	.	.	.
work_dnaoa4trybfmvfskexkidzt764	4	1	(	(	-LRB-
work_dnaoa4trybfmvfskexkidzt764	4	2	MJA	MJA	NNP
work_dnaoa4trybfmvfskexkidzt764	4	3	2002	2002	CD
work_dnaoa4trybfmvfskexkidzt764	4	4	;	;	:
work_dnaoa4trybfmvfskexkidzt764	4	5	177	177	CD
work_dnaoa4trybfmvfskexkidzt764	4	6	:	:	SYM
work_dnaoa4trybfmvfskexkidzt764	4	7	193	193	CD
work_dnaoa4trybfmvfskexkidzt764	4	8	-	-	SYM
work_dnaoa4trybfmvfskexkidzt764	4	9	195	195	CD
work_dnaoa4trybfmvfskexkidzt764	4	10	)	)	-RRB-
work_dnaoa4trybfmvfskexkidzt764	4	11	CHRONIC	CHRONIC	VBZ
work_dnaoa4trybfmvfskexkidzt764	4	12	LEAD	lead	NN
work_dnaoa4trybfmvfskexkidzt764	4	13	POISONING	poisoning	NN
work_dnaoa4trybfmvfskexkidzt764	4	14	may	may	MD
work_dnaoa4trybfmvfskexkidzt764	4	15	manifest	manifest	VB
work_dnaoa4trybfmvfskexkidzt764	4	16	clinically	clinically	RB
work_dnaoa4trybfmvfskexkidzt764	4	17	as	as	IN
work_dnaoa4trybfmvfskexkidzt764	4	18	abdominal	abdominal	JJ
work_dnaoa4trybfmvfskexkidzt764	4	19	pain	pain	NN
work_dnaoa4trybfmvfskexkidzt764	4	20	,	,	,
work_dnaoa4trybfmvfskexkidzt764	4	21	constipation	constipation	NN
work_dnaoa4trybfmvfskexkidzt764	4	22	,	,	,
work_dnaoa4trybfmvfskexkidzt764	4	23	proteinuria	proteinuria	NNP
work_dnaoa4trybfmvfskexkidzt764	4	24	,	,	,
work_dnaoa4trybfmvfskexkidzt764	4	25	haematuria	haematuria	NNP
work_dnaoa4trybfmvfskexkidzt764	4	26	,	,	,
work_dnaoa4trybfmvfskexkidzt764	4	27	peripheral	peripheral	JJ
work_dnaoa4trybfmvfskexkidzt764	4	28	neuropathy	neuropathy	NN
work_dnaoa4trybfmvfskexkidzt764	4	29	and	and	CC
work_dnaoa4trybfmvfskexkidzt764	4	30	muscle	muscle	NN
work_dnaoa4trybfmvfskexkidzt764	4	31	weakness.1	weakness.1	CD
work_dnaoa4trybfmvfskexkidzt764	4	32	With	with	IN
work_dnaoa4trybfmvfskexkidzt764	4	33	more	more	RBR
work_dnaoa4trybfmvfskexkidzt764	4	34	significant	significant	JJ
work_dnaoa4trybfmvfskexkidzt764	4	35	lead	lead	NN
work_dnaoa4trybfmvfskexkidzt764	4	36	poisoning	poisoning	NN
work_dnaoa4trybfmvfskexkidzt764	4	37	,	,	,
work_dnaoa4trybfmvfskexkidzt764	4	38	encephalopathy	encephalopathy	NNP
work_dnaoa4trybfmvfskexkidzt764	4	39	may	may	MD
work_dnaoa4trybfmvfskexkidzt764	4	40	occur.2	occur.2	NNP
work_dnaoa4trybfmvfskexkidzt764	4	41	Sus-	sus-	XX
work_dnaoa4trybfmvfskexkidzt764	4	42	tained	taine	VBN
work_dnaoa4trybfmvfskexkidzt764	4	43	blood	blood	NN
work_dnaoa4trybfmvfskexkidzt764	4	44	lead	lead	NN
work_dnaoa4trybfmvfskexkidzt764	4	45	levels	level	NNS
work_dnaoa4trybfmvfskexkidzt764	4	46	of	of	IN
work_dnaoa4trybfmvfskexkidzt764	4	47	over	over	IN
work_dnaoa4trybfmvfskexkidzt764	4	48	0.5	0.5	CD
work_dnaoa4trybfmvfskexkidzt764	4	49	�	�	NNP
work_dnaoa4trybfmvfskexkidzt764	4	50	mol	mol	NN
work_dnaoa4trybfmvfskexkidzt764	4	51	/	/	SYM
work_dnaoa4trybfmvfskexkidzt764	4	52	L	l	NN
work_dnaoa4trybfmvfskexkidzt764	4	53	in	in	IN
work_dnaoa4trybfmvfskexkidzt764	4	54	early	early	JJ
work_dnaoa4trybfmvfskexkidzt764	4	55	child-	child-	NN
work_dnaoa4trybfmvfskexkidzt764	4	56	hood	hood	NN
work_dnaoa4trybfmvfskexkidzt764	4	57	are	be	VBP
work_dnaoa4trybfmvfskexkidzt764	4	58	likely	likely	JJ
work_dnaoa4trybfmvfskexkidzt764	4	59	to	to	TO
work_dnaoa4trybfmvfskexkidzt764	4	60	be	be	VB
work_dnaoa4trybfmvfskexkidzt764	4	61	associated	associate	VBN
work_dnaoa4trybfmvfskexkidzt764	4	62	with	with	IN
work_dnaoa4trybfmvfskexkidzt764	4	63	intellectual	intellectual	JJ
work_dnaoa4trybfmvfskexkidzt764	4	64	underperformance.3	underperformance.3	CD
work_dnaoa4trybfmvfskexkidzt764	4	65	However	however	RB
work_dnaoa4trybfmvfskexkidzt764	4	66	,	,	,
work_dnaoa4trybfmvfskexkidzt764	4	67	congenital	congenital	JJ
work_dnaoa4trybfmvfskexkidzt764	4	68	lead	lead	NN
work_dnaoa4trybfmvfskexkidzt764	4	69	poisoning	poisoning	NN
work_dnaoa4trybfmvfskexkidzt764	4	70	and	and	CC
work_dnaoa4trybfmvfskexkidzt764	4	71	its	-PRON-	PRP$
work_dnaoa4trybfmvfskexkidzt764	4	72	subsequent	subsequent	JJ
work_dnaoa4trybfmvfskexkidzt764	4	73	management	management	NN
work_dnaoa4trybfmvfskexkidzt764	4	74	has	have	VBZ
work_dnaoa4trybfmvfskexkidzt764	4	75	rarely	rarely	RB
work_dnaoa4trybfmvfskexkidzt764	4	76	been	be	VBN
work_dnaoa4trybfmvfskexkidzt764	4	77	reported	report	VBN
work_dnaoa4trybfmvfskexkidzt764	4	78	in	in	IN
work_dnaoa4trybfmvfskexkidzt764	4	79	preterm	preterm	JJ
work_dnaoa4trybfmvfskexkidzt764	4	80	infants	infant	NNS
work_dnaoa4trybfmvfskexkidzt764	4	81	.	.	.
work_dnaoa4trybfmvfskexkidzt764	5	1	Treatment	treatment	NN
work_dnaoa4trybfmvfskexkidzt764	5	2	is	be	VBZ
work_dnaoa4trybfmvfskexkidzt764	5	3	with	with	IN
work_dnaoa4trybfmvfskexkidzt764	5	4	chelating	chelating	JJ
work_dnaoa4trybfmvfskexkidzt764	5	5	agents	agent	NNS
work_dnaoa4trybfmvfskexkidzt764	5	6	,	,	,
work_dnaoa4trybfmvfskexkidzt764	5	7	which	which	WDT
work_dnaoa4trybfmvfskexkidzt764	5	8	reduce	reduce	VBP
work_dnaoa4trybfmvfskexkidzt764	5	9	lead	lead	JJ
work_dnaoa4trybfmvfskexkidzt764	5	10	concentrations	concentration	NNS
work_dnaoa4trybfmvfskexkidzt764	5	11	in	in	IN
work_dnaoa4trybfmvfskexkidzt764	5	12	the	the	DT
work_dnaoa4trybfmvfskexkidzt764	5	13	blood	blood	NN
work_dnaoa4trybfmvfskexkidzt764	5	14	and	and	CC
work_dnaoa4trybfmvfskexkidzt764	5	15	tissues	tissue	NNS
work_dnaoa4trybfmvfskexkidzt764	5	16	by	by	IN
work_dnaoa4trybfmvfskexkidzt764	5	17	forming	form	VBG
work_dnaoa4trybfmvfskexkidzt764	5	18	water-	water-	JJ
work_dnaoa4trybfmvfskexkidzt764	5	19	soluble	soluble	JJ
work_dnaoa4trybfmvfskexkidzt764	5	20	complexes	complex	NNS
work_dnaoa4trybfmvfskexkidzt764	5	21	that	that	WDT
work_dnaoa4trybfmvfskexkidzt764	5	22	are	be	VBP
work_dnaoa4trybfmvfskexkidzt764	5	23	cleared	clear	VBN
work_dnaoa4trybfmvfskexkidzt764	5	24	by	by	IN
work_dnaoa4trybfmvfskexkidzt764	5	25	the	the	DT
work_dnaoa4trybfmvfskexkidzt764	5	26	kidneys.4	kidneys.4	XX
work_dnaoa4trybfmvfskexkidzt764	5	27	We	-PRON-	PRP
work_dnaoa4trybfmvfskexkidzt764	5	28	report	report	VBP
work_dnaoa4trybfmvfskexkidzt764	5	29	a	a	DT
work_dnaoa4trybfmvfskexkidzt764	5	30	case	case	NN
work_dnaoa4trybfmvfskexkidzt764	5	31	in	in	IN
work_dnaoa4trybfmvfskexkidzt764	5	32	which	which	WDT
work_dnaoa4trybfmvfskexkidzt764	5	33	the	the	DT
work_dnaoa4trybfmvfskexkidzt764	5	34	neonatal	neonatal	JJ
work_dnaoa4trybfmvfskexkidzt764	5	35	blood	blood	NN
work_dnaoa4trybfmvfskexkidzt764	5	36	lead	lead	NN
work_dnaoa4trybfmvfskexkidzt764	5	37	level	level	NN
work_dnaoa4trybfmvfskexkidzt764	5	38	was	be	VBD
work_dnaoa4trybfmvfskexkidzt764	5	39	the	the	DT
work_dnaoa4trybfmvfskexkidzt764	5	40	highest	high	JJS
work_dnaoa4trybfmvfskexkidzt764	5	41	recorded	record	VBN
work_dnaoa4trybfmvfskexkidzt764	5	42	for	for	IN
work_dnaoa4trybfmvfskexkidzt764	5	43	a	a	DT
work_dnaoa4trybfmvfskexkidzt764	5	44	surviving	survive	VBG
work_dnaoa4trybfmvfskexkidzt764	5	45	infant	infant	NN
work_dnaoa4trybfmvfskexkidzt764	5	46	.	.	.
work_dnaoa4trybfmvfskexkidzt764	6	1	Clinical	clinical	JJ
work_dnaoa4trybfmvfskexkidzt764	6	2	record	record	NN
work_dnaoa4trybfmvfskexkidzt764	6	3	A	a	DT
work_dnaoa4trybfmvfskexkidzt764	6	4	24-year	24-year	CD
work_dnaoa4trybfmvfskexkidzt764	6	5	-	-	HYPH
work_dnaoa4trybfmvfskexkidzt764	6	6	old	old	JJ
work_dnaoa4trybfmvfskexkidzt764	6	7	pregnant	pregnant	JJ
work_dnaoa4trybfmvfskexkidzt764	6	8	woman	woman	NN
work_dnaoa4trybfmvfskexkidzt764	6	9	,	,	,
work_dnaoa4trybfmvfskexkidzt764	6	10	who	who	WP
work_dnaoa4trybfmvfskexkidzt764	6	11	had	have	VBD
work_dnaoa4trybfmvfskexkidzt764	6	12	recently	recently	RB
work_dnaoa4trybfmvfskexkidzt764	6	13	emigrated	emigrate	VBN
work_dnaoa4trybfmvfskexkidzt764	6	14	from	from	IN
work_dnaoa4trybfmvfskexkidzt764	6	15	India	India	NNP
work_dnaoa4trybfmvfskexkidzt764	6	16	,	,	,
work_dnaoa4trybfmvfskexkidzt764	6	17	was	be	VBD
work_dnaoa4trybfmvfskexkidzt764	6	18	found	find	VBN
work_dnaoa4trybfmvfskexkidzt764	6	19	to	to	TO
work_dnaoa4trybfmvfskexkidzt764	6	20	have	have	VB
work_dnaoa4trybfmvfskexkidzt764	6	21	a	a	DT
work_dnaoa4trybfmvfskexkidzt764	6	22	haemoglobin	haemoglobin	NN
work_dnaoa4trybfmvfskexkidzt764	6	23	level	level	NN
work_dnaoa4trybfmvfskexkidzt764	6	24	of	of	IN
work_dnaoa4trybfmvfskexkidzt764	6	25	70	70	CD
work_dnaoa4trybfmvfskexkidzt764	6	26	g	g	NN
work_dnaoa4trybfmvfskexkidzt764	6	27	/	/	SYM
work_dnaoa4trybfmvfskexkidzt764	6	28	L	l	NN
work_dnaoa4trybfmvfskexkidzt764	6	29	at	at	IN
work_dnaoa4trybfmvfskexkidzt764	6	30	24	24	CD
work_dnaoa4trybfmvfskexkidzt764	6	31	weeks	week	NNS
work_dnaoa4trybfmvfskexkidzt764	6	32	’	’	POS
work_dnaoa4trybfmvfskexkidzt764	6	33	gestation	gestation	NN
work_dnaoa4trybfmvfskexkidzt764	6	34	.	.	.
work_dnaoa4trybfmvfskexkidzt764	7	1	At	at	IN
work_dnaoa4trybfmvfskexkidzt764	7	2	that	that	DT
work_dnaoa4trybfmvfskexkidzt764	7	3	time	time	NN
work_dnaoa4trybfmvfskexkidzt764	7	4	it	-PRON-	PRP
work_dnaoa4trybfmvfskexkidzt764	7	5	was	be	VBD
work_dnaoa4trybfmvfskexkidzt764	7	6	noted	note	VBN
work_dnaoa4trybfmvfskexkidzt764	7	7	that	that	IN
work_dnaoa4trybfmvfskexkidzt764	7	8	she	-PRON-	PRP
work_dnaoa4trybfmvfskexkidzt764	7	9	was	be	VBD
work_dnaoa4trybfmvfskexkidzt764	7	10	a	a	DT
work_dnaoa4trybfmvfskexkidzt764	7	11	vegan	vegan	NN
work_dnaoa4trybfmvfskexkidzt764	7	12	and	and	CC
work_dnaoa4trybfmvfskexkidzt764	7	13	had	have	VBD
work_dnaoa4trybfmvfskexkidzt764	7	14	a	a	DT
work_dnaoa4trybfmvfskexkidzt764	7	15	normal	normal	JJ
work_dnaoa4trybfmvfskexkidzt764	7	16	blood	blood	NN
work_dnaoa4trybfmvfskexkidzt764	7	17	film	film	NN
work_dnaoa4trybfmvfskexkidzt764	7	18	and	and	CC
work_dnaoa4trybfmvfskexkidzt764	7	19	iron	iron	NN
work_dnaoa4trybfmvfskexkidzt764	7	20	studies	study	NNS
work_dnaoa4trybfmvfskexkidzt764	7	21	.	.	.
work_dnaoa4trybfmvfskexkidzt764	8	1	At	at	IN
work_dnaoa4trybfmvfskexkidzt764	8	2	30	30	CD
work_dnaoa4trybfmvfskexkidzt764	8	3	weeks	week	NNS
work_dnaoa4trybfmvfskexkidzt764	8	4	’	’	POS
work_dnaoa4trybfmvfskexkidzt764	8	5	gestation	gestation	NN
work_dnaoa4trybfmvfskexkidzt764	8	6	,	,	,
work_dnaoa4trybfmvfskexkidzt764	8	7	she	-PRON-	PRP
work_dnaoa4trybfmvfskexkidzt764	8	8	presented	present	VBD
work_dnaoa4trybfmvfskexkidzt764	8	9	with	with	IN
work_dnaoa4trybfmvfskexkidzt764	8	10	abdominal	abdominal	JJ
work_dnaoa4trybfmvfskexkidzt764	8	11	pain	pain	NN
work_dnaoa4trybfmvfskexkidzt764	8	12	and	and	CC
work_dnaoa4trybfmvfskexkidzt764	8	13	a	a	DT
work_dnaoa4trybfmvfskexkidzt764	8	14	progressive	progressive	JJ
work_dnaoa4trybfmvfskexkidzt764	8	15	confusional	confusional	JJ
work_dnaoa4trybfmvfskexkidzt764	8	16	state	state	NN
work_dnaoa4trybfmvfskexkidzt764	8	17	culminating	culminate	VBG
work_dnaoa4trybfmvfskexkidzt764	8	18	in	in	IN
work_dnaoa4trybfmvfskexkidzt764	8	19	seizures	seizure	NNS
work_dnaoa4trybfmvfskexkidzt764	8	20	.	.	.
work_dnaoa4trybfmvfskexkidzt764	9	1	The	the	DT
work_dnaoa4trybfmvfskexkidzt764	9	2	blood	blood	NN
work_dnaoa4trybfmvfskexkidzt764	9	3	film	film	NN
work_dnaoa4trybfmvfskexkidzt764	9	4	now	now	RB
work_dnaoa4trybfmvfskexkidzt764	9	5	showed	show	VBD
work_dnaoa4trybfmvfskexkidzt764	9	6	basophilic	basophilic	JJ
work_dnaoa4trybfmvfskexkidzt764	9	7	stippling	stippling	NN
work_dnaoa4trybfmvfskexkidzt764	9	8	,	,	,
work_dnaoa4trybfmvfskexkidzt764	9	9	a	a	DT
work_dnaoa4trybfmvfskexkidzt764	9	10	typical	typical	JJ
work_dnaoa4trybfmvfskexkidzt764	9	11	sign	sign	NN
work_dnaoa4trybfmvfskexkidzt764	9	12	of	of	IN
work_dnaoa4trybfmvfskexkidzt764	9	13	lead	lead	NN
work_dnaoa4trybfmvfskexkidzt764	9	14	poisoning	poisoning	NN
work_dnaoa4trybfmvfskexkidzt764	9	15	(	(	-LRB-
work_dnaoa4trybfmvfskexkidzt764	9	16	Box	Box	NNP
work_dnaoa4trybfmvfskexkidzt764	9	17	1	1	CD
work_dnaoa4trybfmvfskexkidzt764	9	18	)	)	-RRB-
work_dnaoa4trybfmvfskexkidzt764	9	19	,	,	,
work_dnaoa4trybfmvfskexkidzt764	9	20	and	and	CC
work_dnaoa4trybfmvfskexkidzt764	9	21	subsequent	subsequent	JJ
work_dnaoa4trybfmvfskexkidzt764	9	22	testing	testing	NN
work_dnaoa4trybfmvfskexkidzt764	9	23	showed	show	VBD
work_dnaoa4trybfmvfskexkidzt764	9	24	she	-PRON-	PRP
work_dnaoa4trybfmvfskexkidzt764	9	25	had	have	VBD
work_dnaoa4trybfmvfskexkidzt764	9	26	a	a	DT
work_dnaoa4trybfmvfskexkidzt764	9	27	blood	blood	NN
work_dnaoa4trybfmvfskexkidzt764	9	28	lead	lead	NN
work_dnaoa4trybfmvfskexkidzt764	9	29	concentration	concentration	NN
work_dnaoa4trybfmvfskexkidzt764	9	30	of	of	IN
work_dnaoa4trybfmvfskexkidzt764	9	31	5.2	5.2	CD
work_dnaoa4trybfmvfskexkidzt764	9	32	�	�	NNP
work_dnaoa4trybfmvfskexkidzt764	9	33	mol	mol	NN
work_dnaoa4trybfmvfskexkidzt764	9	34	/	/	SYM
work_dnaoa4trybfmvfskexkidzt764	9	35	L	l	NN
work_dnaoa4trybfmvfskexkidzt764	9	36	(	(	-LRB-
work_dnaoa4trybfmvfskexkidzt764	9	37	the	the	DT
work_dnaoa4trybfmvfskexkidzt764	9	38	National	National	NNP
work_dnaoa4trybfmvfskexkidzt764	9	39	Health	Health	NNP
work_dnaoa4trybfmvfskexkidzt764	9	40	and	and	CC
work_dnaoa4trybfmvfskexkidzt764	9	41	Medical	Medical	NNP
work_dnaoa4trybfmvfskexkidzt764	9	42	Research	Research	NNP
work_dnaoa4trybfmvfskexkidzt764	9	43	Council	Council	NNP
work_dnaoa4trybfmvfskexkidzt764	9	44	’s	’s	POS
work_dnaoa4trybfmvfskexkidzt764	9	45	public	public	JJ
work_dnaoa4trybfmvfskexkidzt764	9	46	health	health	NN
work_dnaoa4trybfmvfskexkidzt764	9	47	goal	goal	NN
work_dnaoa4trybfmvfskexkidzt764	9	48	is	be	VBZ
work_dnaoa4trybfmvfskexkidzt764	9	49	a	a	DT
work_dnaoa4trybfmvfskexkidzt764	9	50	level	level	NN
work_dnaoa4trybfmvfskexkidzt764	9	51	of	of	IN
work_dnaoa4trybfmvfskexkidzt764	9	52	�	�	NNP
work_dnaoa4trybfmvfskexkidzt764	9	53	0.48	0.48	CD
work_dnaoa4trybfmvfskexkidzt764	9	54	�	�	NNP
work_dnaoa4trybfmvfskexkidzt764	9	55	mol	mol	NN
work_dnaoa4trybfmvfskexkidzt764	9	56	/	/	SYM
work_dnaoa4trybfmvfskexkidzt764	9	57	L).3	L).3	NNP
work_dnaoa4trybfmvfskexkidzt764	9	58	Chelating	Chelating	NNP
work_dnaoa4trybfmvfskexkidzt764	9	59	therapy	therapy	NN
work_dnaoa4trybfmvfskexkidzt764	9	60	was	be	VBD
work_dnaoa4trybfmvfskexkidzt764	9	61	initiated	initiate	VBN
work_dnaoa4trybfmvfskexkidzt764	9	62	with	with	IN
work_dnaoa4trybfmvfskexkidzt764	9	63	intramuscular	intramuscular	NNP
work_dnaoa4trybfmvfskexkidzt764	9	64	dimer-	dimer-	NNP
work_dnaoa4trybfmvfskexkidzt764	9	65	caprol	caprol	NN
work_dnaoa4trybfmvfskexkidzt764	9	66	and	and	CC
work_dnaoa4trybfmvfskexkidzt764	9	67	intravenous	intravenous	JJ
work_dnaoa4trybfmvfskexkidzt764	9	68	calcium	calcium	NN
work_dnaoa4trybfmvfskexkidzt764	9	69	disodium	disodium	NN
work_dnaoa4trybfmvfskexkidzt764	9	70	edetate	edetate	NN
work_dnaoa4trybfmvfskexkidzt764	9	71	(	(	-LRB-
work_dnaoa4trybfmvfskexkidzt764	9	72	CaNa2EDTA	cana2edta	NN
work_dnaoa4trybfmvfskexkidzt764	9	73	)	)	-RRB-
work_dnaoa4trybfmvfskexkidzt764	9	74	.	.	.
work_dnaoa4trybfmvfskexkidzt764	10	1	5	5	CD
work_dnaoa4trybfmvfskexkidzt764	10	2	Thirty	thirty	CD
work_dnaoa4trybfmvfskexkidzt764	10	3	-	-	HYPH
work_dnaoa4trybfmvfskexkidzt764	10	4	six	six	CD
work_dnaoa4trybfmvfskexkidzt764	10	5	hours	hour	NNS
work_dnaoa4trybfmvfskexkidzt764	10	6	later	later	RB
work_dnaoa4trybfmvfskexkidzt764	10	7	the	the	DT
work_dnaoa4trybfmvfskexkidzt764	10	8	woman	woman	NN
work_dnaoa4trybfmvfskexkidzt764	10	9	had	have	VBD
work_dnaoa4trybfmvfskexkidzt764	10	10	an	an	DT
work_dnaoa4trybfmvfskexkidzt764	10	11	antepartum	antepartum	JJ
work_dnaoa4trybfmvfskexkidzt764	10	12	haemorrhage	haemorrhage	NN
work_dnaoa4trybfmvfskexkidzt764	10	13	,	,	,
work_dnaoa4trybfmvfskexkidzt764	10	14	and	and	CC
work_dnaoa4trybfmvfskexkidzt764	10	15	,	,	,
work_dnaoa4trybfmvfskexkidzt764	10	16	after	after	IN
work_dnaoa4trybfmvfskexkidzt764	10	17	induction	induction	NN
work_dnaoa4trybfmvfskexkidzt764	10	18	of	of	IN
work_dnaoa4trybfmvfskexkidzt764	10	19	labour	labour	NNP
work_dnaoa4trybfmvfskexkidzt764	10	20	,	,	,
work_dnaoa4trybfmvfskexkidzt764	10	21	she	-PRON-	PRP
work_dnaoa4trybfmvfskexkidzt764	10	22	gave	give	VBD
work_dnaoa4trybfmvfskexkidzt764	10	23	birth	birth	NN
work_dnaoa4trybfmvfskexkidzt764	10	24	to	to	IN
work_dnaoa4trybfmvfskexkidzt764	10	25	a	a	DT
work_dnaoa4trybfmvfskexkidzt764	10	26	1.6	1.6	CD
work_dnaoa4trybfmvfskexkidzt764	10	27	kg	kg	NNS
work_dnaoa4trybfmvfskexkidzt764	10	28	(	(	-LRB-
work_dnaoa4trybfmvfskexkidzt764	10	29	75th	75th	JJ
work_dnaoa4trybfmvfskexkidzt764	10	30	percentile	percentile	NN
work_dnaoa4trybfmvfskexkidzt764	10	31	)	)	-RRB-
work_dnaoa4trybfmvfskexkidzt764	10	32	female	female	JJ
work_dnaoa4trybfmvfskexkidzt764	10	33	baby	baby	NN
work_dnaoa4trybfmvfskexkidzt764	10	34	by	by	IN
work_dnaoa4trybfmvfskexkidzt764	10	35	vaginal	vaginal	JJ
work_dnaoa4trybfmvfskexkidzt764	10	36	delivery	delivery	NN
work_dnaoa4trybfmvfskexkidzt764	10	37	.	.	.
work_dnaoa4trybfmvfskexkidzt764	11	1	Apgar	Apgar	NNP
work_dnaoa4trybfmvfskexkidzt764	11	2	scores	score	NNS
work_dnaoa4trybfmvfskexkidzt764	11	3	were	be	VBD
work_dnaoa4trybfmvfskexkidzt764	11	4	4	4	CD
work_dnaoa4trybfmvfskexkidzt764	11	5	and	and	CC
work_dnaoa4trybfmvfskexkidzt764	11	6	6	6	CD
work_dnaoa4trybfmvfskexkidzt764	11	7	.	.	.
work_dnaoa4trybfmvfskexkidzt764	12	1	The	the	DT
work_dnaoa4trybfmvfskexkidzt764	12	2	infant	infant	NN
work_dnaoa4trybfmvfskexkidzt764	12	3	was	be	VBD
work_dnaoa4trybfmvfskexkidzt764	12	4	flaccid	flaccid	JJ
work_dnaoa4trybfmvfskexkidzt764	12	5	and	and	CC
work_dnaoa4trybfmvfskexkidzt764	12	6	areflexic	areflexic	JJ
work_dnaoa4trybfmvfskexkidzt764	12	7	and	and	CC
work_dnaoa4trybfmvfskexkidzt764	12	8	did	do	VBD
work_dnaoa4trybfmvfskexkidzt764	12	9	not	not	RB
work_dnaoa4trybfmvfskexkidzt764	12	10	move	move	VB
work_dnaoa4trybfmvfskexkidzt764	12	11	in	in	IN
work_dnaoa4trybfmvfskexkidzt764	12	12	response	response	NN
work_dnaoa4trybfmvfskexkidzt764	12	13	to	to	IN
work_dnaoa4trybfmvfskexkidzt764	12	14	noxious	noxious	JJ
work_dnaoa4trybfmvfskexkidzt764	12	15	stimuli	stimulus	NNS
work_dnaoa4trybfmvfskexkidzt764	12	16	,	,	,
work_dnaoa4trybfmvfskexkidzt764	12	17	although	although	IN
work_dnaoa4trybfmvfskexkidzt764	12	18	spontaneous	spontaneous	JJ
work_dnaoa4trybfmvfskexkidzt764	12	19	ocular	ocular	JJ
work_dnaoa4trybfmvfskexkidzt764	12	20	movements	movement	NNS
work_dnaoa4trybfmvfskexkidzt764	12	21	were	be	VBD
work_dnaoa4trybfmvfskexkidzt764	12	22	present	present	JJ
work_dnaoa4trybfmvfskexkidzt764	12	23	.	.	.
work_dnaoa4trybfmvfskexkidzt764	13	1	As	as	IN
work_dnaoa4trybfmvfskexkidzt764	13	2	she	-PRON-	PRP
work_dnaoa4trybfmvfskexkidzt764	13	3	had	have	VBD
work_dnaoa4trybfmvfskexkidzt764	13	4	emerging	emerge	VBG
work_dnaoa4trybfmvfskexkidzt764	13	5	alveolar	alveolar	JJ
work_dnaoa4trybfmvfskexkidzt764	13	6	hypoventilation	hypoventilation	NN
work_dnaoa4trybfmvfskexkidzt764	13	7	and	and	CC
work_dnaoa4trybfmvfskexkidzt764	13	8	no	no	DT
work_dnaoa4trybfmvfskexkidzt764	13	9	gag	gag	NN
work_dnaoa4trybfmvfskexkidzt764	13	10	reflex	reflex	NN
work_dnaoa4trybfmvfskexkidzt764	13	11	,	,	,
work_dnaoa4trybfmvfskexkidzt764	13	12	she	-PRON-	PRP
work_dnaoa4trybfmvfskexkidzt764	13	13	was	be	VBD
work_dnaoa4trybfmvfskexkidzt764	13	14	intubated	intubate	VBN
work_dnaoa4trybfmvfskexkidzt764	13	15	and	and	CC
work_dnaoa4trybfmvfskexkidzt764	13	16	ventilated	ventilate	VBN
work_dnaoa4trybfmvfskexkidzt764	13	17	.	.	.
work_dnaoa4trybfmvfskexkidzt764	14	1	The	the	DT
work_dnaoa4trybfmvfskexkidzt764	14	2	clinical	clinical	JJ
work_dnaoa4trybfmvfskexkidzt764	14	3	suspicion	suspicion	NN
work_dnaoa4trybfmvfskexkidzt764	14	4	of	of	IN
work_dnaoa4trybfmvfskexkidzt764	14	5	bilateral	bilateral	JJ
work_dnaoa4trybfmvfskexkidzt764	14	6	diaphragmatic	diaphragmatic	JJ
work_dnaoa4trybfmvfskexkidzt764	14	7	palsy	palsy	NNP
work_dnaoa4trybfmvfskexkidzt764	14	8	was	be	VBD
work_dnaoa4trybfmvfskexkidzt764	14	9	later	later	RB
work_dnaoa4trybfmvfskexkidzt764	14	10	confirmed	confirm	VBN
work_dnaoa4trybfmvfskexkidzt764	14	11	by	by	IN
work_dnaoa4trybfmvfskexkidzt764	14	12	fluoroscopy	fluoroscopy	NNP
work_dnaoa4trybfmvfskexkidzt764	14	13	.	.	.
work_dnaoa4trybfmvfskexkidzt764	15	1	Basophilic	basophilic	JJ
work_dnaoa4trybfmvfskexkidzt764	15	2	stippling	stippling	NN
work_dnaoa4trybfmvfskexkidzt764	15	3	was	be	VBD
work_dnaoa4trybfmvfskexkidzt764	15	4	not	not	RB
work_dnaoa4trybfmvfskexkidzt764	15	5	seen	see	VBN
work_dnaoa4trybfmvfskexkidzt764	15	6	on	on	IN
work_dnaoa4trybfmvfskexkidzt764	15	7	the	the	DT
work_dnaoa4trybfmvfskexkidzt764	15	8	infant	infant	NN
work_dnaoa4trybfmvfskexkidzt764	15	9	’s	’s	POS
work_dnaoa4trybfmvfskexkidzt764	15	10	blood	blood	NN
work_dnaoa4trybfmvfskexkidzt764	15	11	films	film	NNS
work_dnaoa4trybfmvfskexkidzt764	15	12	,	,	,
work_dnaoa4trybfmvfskexkidzt764	15	13	although	although	IN
work_dnaoa4trybfmvfskexkidzt764	15	14	Heinz	Heinz	NNP
work_dnaoa4trybfmvfskexkidzt764	15	15	bodies	body	NNS
work_dnaoa4trybfmvfskexkidzt764	15	16	were	be	VBD
work_dnaoa4trybfmvfskexkidzt764	15	17	present	present	JJ
work_dnaoa4trybfmvfskexkidzt764	15	18	.	.	.
work_dnaoa4trybfmvfskexkidzt764	16	1	Lead	lead	VB
work_dnaoa4trybfmvfskexkidzt764	16	2	concentra-	concentra-	XX
work_dnaoa4trybfmvfskexkidzt764	16	3	tion	tion	NN
work_dnaoa4trybfmvfskexkidzt764	16	4	in	in	IN
work_dnaoa4trybfmvfskexkidzt764	16	5	the	the	DT
work_dnaoa4trybfmvfskexkidzt764	16	6	cord	cord	NN
work_dnaoa4trybfmvfskexkidzt764	16	7	blood	blood	NN
work_dnaoa4trybfmvfskexkidzt764	16	8	was	be	VBD
work_dnaoa4trybfmvfskexkidzt764	16	9	7.6	7.6	CD
work_dnaoa4trybfmvfskexkidzt764	16	10	�	�	NNP
work_dnaoa4trybfmvfskexkidzt764	16	11	mol	mol	NN
work_dnaoa4trybfmvfskexkidzt764	16	12	/	/	SYM
work_dnaoa4trybfmvfskexkidzt764	16	13	L	l	NN
work_dnaoa4trybfmvfskexkidzt764	16	14	(	(	-LRB-
work_dnaoa4trybfmvfskexkidzt764	16	15	12	12	CD
work_dnaoa4trybfmvfskexkidzt764	16	16	hours	hour	NNS
work_dnaoa4trybfmvfskexkidzt764	16	17	before	before	IN
work_dnaoa4trybfmvfskexkidzt764	16	18	birth	birth	NN
work_dnaoa4trybfmvfskexkidzt764	16	19	,	,	,
work_dnaoa4trybfmvfskexkidzt764	16	20	maternal	maternal	JJ
work_dnaoa4trybfmvfskexkidzt764	16	21	blood	blood	NN
work_dnaoa4trybfmvfskexkidzt764	16	22	lead	lead	NN
work_dnaoa4trybfmvfskexkidzt764	16	23	concentration	concentration	NN
work_dnaoa4trybfmvfskexkidzt764	16	24	had	have	VBD
work_dnaoa4trybfmvfskexkidzt764	16	25	been	be	VBN
work_dnaoa4trybfmvfskexkidzt764	16	26	2.3	2.3	CD
work_dnaoa4trybfmvfskexkidzt764	16	27	�	�	NNP
work_dnaoa4trybfmvfskexkidzt764	16	28	mol	mol	NN
work_dnaoa4trybfmvfskexkidzt764	16	29	/	/	SYM
work_dnaoa4trybfmvfskexkidzt764	16	30	L	L	NNP
work_dnaoa4trybfmvfskexkidzt764	16	31	)	)	-RRB-
work_dnaoa4trybfmvfskexkidzt764	16	32	.	.	.
work_dnaoa4trybfmvfskexkidzt764	17	1	The	the	DT
work_dnaoa4trybfmvfskexkidzt764	17	2	concentration	concentration	NN
work_dnaoa4trybfmvfskexkidzt764	17	3	of	of	IN
work_dnaoa4trybfmvfskexkidzt764	17	4	erythrocyte	erythrocyte	JJ
work_dnaoa4trybfmvfskexkidzt764	17	5	porphyrins	porphyrin	NNS
work_dnaoa4trybfmvfskexkidzt764	17	6	was	be	VBD
work_dnaoa4trybfmvfskexkidzt764	17	7	20.3	20.3	CD
work_dnaoa4trybfmvfskexkidzt764	17	8	�	�	NNP
work_dnaoa4trybfmvfskexkidzt764	17	9	mol	mol	NN
work_dnaoa4trybfmvfskexkidzt764	17	10	/	/	SYM
work_dnaoa4trybfmvfskexkidzt764	17	11	L	L	NNP
work_dnaoa4trybfmvfskexkidzt764	17	12	(	(	-LRB-
work_dnaoa4trybfmvfskexkidzt764	17	13	normal	normal	JJ
work_dnaoa4trybfmvfskexkidzt764	17	14	range	range	NN
work_dnaoa4trybfmvfskexkidzt764	17	15	,	,	,
work_dnaoa4trybfmvfskexkidzt764	17	16	0.4–1.7	0.4–1.7	CD
work_dnaoa4trybfmvfskexkidzt764	17	17	�	�	NNP
work_dnaoa4trybfmvfskexkidzt764	17	18	mol	mol	NN
work_dnaoa4trybfmvfskexkidzt764	17	19	/	/	SYM
work_dnaoa4trybfmvfskexkidzt764	17	20	L	L	NNP
work_dnaoa4trybfmvfskexkidzt764	17	21	)	)	-RRB-
work_dnaoa4trybfmvfskexkidzt764	17	22	,	,	,
work_dnaoa4trybfmvfskexkidzt764	17	23	and	and	CC
work_dnaoa4trybfmvfskexkidzt764	17	24	radiographs	radiograph	NNS
work_dnaoa4trybfmvfskexkidzt764	17	25	of	of	IN
work_dnaoa4trybfmvfskexkidzt764	17	26	the	the	DT
work_dnaoa4trybfmvfskexkidzt764	17	27	long	long	JJ
work_dnaoa4trybfmvfskexkidzt764	17	28	bones	bone	NNS
work_dnaoa4trybfmvfskexkidzt764	17	29	showed	show	VBD
work_dnaoa4trybfmvfskexkidzt764	17	30	an	an	DT
work_dnaoa4trybfmvfskexkidzt764	17	31	increase	increase	NN
work_dnaoa4trybfmvfskexkidzt764	17	32	in	in	IN
work_dnaoa4trybfmvfskexkidzt764	17	33	the	the	DT
work_dnaoa4trybfmvfskexkidzt764	17	34	bone	bone	NN
work_dnaoa4trybfmvfskexkidzt764	17	35	density	density	NN
work_dnaoa4trybfmvfskexkidzt764	17	36	adjacent	adjacent	JJ
work_dnaoa4trybfmvfskexkidzt764	17	37	to	to	IN
work_dnaoa4trybfmvfskexkidzt764	17	38	the	the	DT
work_dnaoa4trybfmvfskexkidzt764	17	39	metaphyses	metaphyse	NNS
work_dnaoa4trybfmvfskexkidzt764	17	40	(	(	-LRB-
work_dnaoa4trybfmvfskexkidzt764	17	41	both	both	DT
work_dnaoa4trybfmvfskexkidzt764	17	42	signs	sign	NNS
work_dnaoa4trybfmvfskexkidzt764	17	43	of	of	IN
work_dnaoa4trybfmvfskexkidzt764	17	44	lead	lead	JJ
work_dnaoa4trybfmvfskexkidzt764	17	45	poisoning	poisoning	NN
work_dnaoa4trybfmvfskexkidzt764	17	46	)	)	-RRB-
work_dnaoa4trybfmvfskexkidzt764	17	47	.	.	.
work_dnaoa4trybfmvfskexkidzt764	18	1	Within	within	IN
work_dnaoa4trybfmvfskexkidzt764	18	2	24	24	CD
work_dnaoa4trybfmvfskexkidzt764	18	3	hours	hour	NNS
work_dnaoa4trybfmvfskexkidzt764	18	4	of	of	IN
work_dnaoa4trybfmvfskexkidzt764	18	5	birth	birth	NN
work_dnaoa4trybfmvfskexkidzt764	18	6	,	,	,
work_dnaoa4trybfmvfskexkidzt764	18	7	the	the	DT
work_dnaoa4trybfmvfskexkidzt764	18	8	infant	infant	NN
work_dnaoa4trybfmvfskexkidzt764	18	9	was	be	VBD
work_dnaoa4trybfmvfskexkidzt764	18	10	commenced	commence	VBN
work_dnaoa4trybfmvfskexkidzt764	18	11	on	on	IN
work_dnaoa4trybfmvfskexkidzt764	18	12	chelation	chelation	NN
work_dnaoa4trybfmvfskexkidzt764	18	13	therapy	therapy	NN
work_dnaoa4trybfmvfskexkidzt764	18	14	(	(	-LRB-
work_dnaoa4trybfmvfskexkidzt764	18	15	intramuscular	intramuscular	NNP
work_dnaoa4trybfmvfskexkidzt764	18	16	dimercaprol	dimercaprol	NNP
work_dnaoa4trybfmvfskexkidzt764	18	17	4	4	CD
work_dnaoa4trybfmvfskexkidzt764	18	18	mg	mg	NNP
work_dnaoa4trybfmvfskexkidzt764	18	19	/	/	SYM
work_dnaoa4trybfmvfskexkidzt764	18	20	kg	kg	NNP
work_dnaoa4trybfmvfskexkidzt764	18	21	/	/	SYM
work_dnaoa4trybfmvfskexkidzt764	18	22	dose	dose	VBP
work_dnaoa4trybfmvfskexkidzt764	18	23	every	every	DT
work_dnaoa4trybfmvfskexkidzt764	18	24	four	four	CD
work_dnaoa4trybfmvfskexkidzt764	18	25	hours	hour	NNS
work_dnaoa4trybfmvfskexkidzt764	18	26	and	and	CC
work_dnaoa4trybfmvfskexkidzt764	18	27	intravenous	intravenous	JJ
work_dnaoa4trybfmvfskexkidzt764	18	28	CaNa2EDTA	CaNa2EDTA	NNP
work_dnaoa4trybfmvfskexkidzt764	18	29	50	50	CD
work_dnaoa4trybfmvfskexkidzt764	18	30	mg	mg	NNP
work_dnaoa4trybfmvfskexkidzt764	18	31	/	/	SYM
work_dnaoa4trybfmvfskexkidzt764	18	32	kg/	kg/	NNP
work_dnaoa4trybfmvfskexkidzt764	18	33	day	day	NNP
work_dnaoa4trybfmvfskexkidzt764	18	34	,	,	,
work_dnaoa4trybfmvfskexkidzt764	18	35	given	give	VBN
work_dnaoa4trybfmvfskexkidzt764	18	36	after	after	IN
work_dnaoa4trybfmvfskexkidzt764	18	37	the	the	DT
work_dnaoa4trybfmvfskexkidzt764	18	38	second	second	JJ
work_dnaoa4trybfmvfskexkidzt764	18	39	dose	dose	NN
work_dnaoa4trybfmvfskexkidzt764	18	40	of	of	IN
work_dnaoa4trybfmvfskexkidzt764	18	41	dimercaprol	dimercaprol	NN
work_dnaoa4trybfmvfskexkidzt764	18	42	)	)	-RRB-
work_dnaoa4trybfmvfskexkidzt764	18	43	.	.	.
work_dnaoa4trybfmvfskexkidzt764	19	1	The	the	DT
work_dnaoa4trybfmvfskexkidzt764	19	2	blood	blood	NN
work_dnaoa4trybfmvfskexkidzt764	19	3	lead	lead	VBP
work_dnaoa4trybfmvfskexkidzt764	19	4	concentration	concentration	NN
work_dnaoa4trybfmvfskexkidzt764	19	5	initially	initially	RB
work_dnaoa4trybfmvfskexkidzt764	19	6	rose	rise	VBD
work_dnaoa4trybfmvfskexkidzt764	19	7	to	to	IN
work_dnaoa4trybfmvfskexkidzt764	19	8	11.8	11.8	CD
work_dnaoa4trybfmvfskexkidzt764	19	9	�	�	NNP
work_dnaoa4trybfmvfskexkidzt764	19	10	mol	mol	NN
work_dnaoa4trybfmvfskexkidzt764	19	11	/	/	SYM
work_dnaoa4trybfmvfskexkidzt764	19	12	L	l	NN
work_dnaoa4trybfmvfskexkidzt764	19	13	within	within	IN
work_dnaoa4trybfmvfskexkidzt764	19	14	the	the	DT
work_dnaoa4trybfmvfskexkidzt764	19	15	first	first	JJ
work_dnaoa4trybfmvfskexkidzt764	19	16	48	48	CD
work_dnaoa4trybfmvfskexkidzt764	19	17	hours	hour	NNS
work_dnaoa4trybfmvfskexkidzt764	19	18	of	of	IN
work_dnaoa4trybfmvfskexkidzt764	19	19	therapy	therapy	NN
work_dnaoa4trybfmvfskexkidzt764	19	20	,	,	,
work_dnaoa4trybfmvfskexkidzt764	19	21	then	then	RB
work_dnaoa4trybfmvfskexkidzt764	19	22	fell	fall	VBD
work_dnaoa4trybfmvfskexkidzt764	19	23	rapidly	rapidly	RB
work_dnaoa4trybfmvfskexkidzt764	19	24	over	over	IN
work_dnaoa4trybfmvfskexkidzt764	19	25	the	the	DT
work_dnaoa4trybfmvfskexkidzt764	19	26	next	next	JJ
work_dnaoa4trybfmvfskexkidzt764	19	27	few	few	JJ
work_dnaoa4trybfmvfskexkidzt764	19	28	days	day	NNS
work_dnaoa4trybfmvfskexkidzt764	19	29	.	.	.
work_dnaoa4trybfmvfskexkidzt764	20	1	The	the	DT
work_dnaoa4trybfmvfskexkidzt764	20	2	high	high	JJ
work_dnaoa4trybfmvfskexkidzt764	20	3	urinary	urinary	JJ
work_dnaoa4trybfmvfskexkidzt764	20	4	lead	lead	NN
work_dnaoa4trybfmvfskexkidzt764	20	5	concentration	concentration	NN
work_dnaoa4trybfmvfskexkidzt764	20	6	of	of	IN
work_dnaoa4trybfmvfskexkidzt764	20	7	52	52	CD
work_dnaoa4trybfmvfskexkidzt764	20	8	�	�	NNP
work_dnaoa4trybfmvfskexkidzt764	20	9	mol	mol	NN
work_dnaoa4trybfmvfskexkidzt764	20	10	/	/	SYM
work_dnaoa4trybfmvfskexkidzt764	20	11	L	L	NNP
work_dnaoa4trybfmvfskexkidzt764	20	12	on	on	IN
work_dnaoa4trybfmvfskexkidzt764	20	13	Day	Day	NNP
work_dnaoa4trybfmvfskexkidzt764	20	14	3	3	CD
work_dnaoa4trybfmvfskexkidzt764	20	15	was	be	VBD
work_dnaoa4trybfmvfskexkidzt764	20	16	an	an	DT
work_dnaoa4trybfmvfskexkidzt764	20	17	indicator	indicator	NN
work_dnaoa4trybfmvfskexkidzt764	20	18	that	that	WDT
work_dnaoa4trybfmvfskexkidzt764	20	19	lead	lead	NN
work_dnaoa4trybfmvfskexkidzt764	20	20	was	be	VBD
work_dnaoa4trybfmvfskexkidzt764	20	21	being	be	VBG
work_dnaoa4trybfmvfskexkidzt764	20	22	excreted	excrete	VBN
work_dnaoa4trybfmvfskexkidzt764	20	23	.	.	.
work_dnaoa4trybfmvfskexkidzt764	21	1	The	the	DT
work_dnaoa4trybfmvfskexkidzt764	21	2	time	time	NN
work_dnaoa4trybfmvfskexkidzt764	21	3	course	course	NN
work_dnaoa4trybfmvfskexkidzt764	21	4	of	of	IN
work_dnaoa4trybfmvfskexkidzt764	21	5	blood	blood	NN
work_dnaoa4trybfmvfskexkidzt764	21	6	and	and	CC
work_dnaoa4trybfmvfskexkidzt764	21	7	urinary	urinary	JJ
work_dnaoa4trybfmvfskexkidzt764	21	8	lead	lead	NN
work_dnaoa4trybfmvfskexkidzt764	21	9	concentrations	concentration	NNS
work_dnaoa4trybfmvfskexkidzt764	21	10	for	for	IN
work_dnaoa4trybfmvfskexkidzt764	21	11	the	the	DT
work_dnaoa4trybfmvfskexkidzt764	21	12	first	first	JJ
work_dnaoa4trybfmvfskexkidzt764	21	13	14	14	CD
work_dnaoa4trybfmvfskexkidzt764	21	14	weeks	week	NNS
work_dnaoa4trybfmvfskexkidzt764	21	15	post	post	NNP
work_dnaoa4trybfmvfskexkidzt764	21	16	partum	partum	NN
work_dnaoa4trybfmvfskexkidzt764	21	17	is	be	VBZ
work_dnaoa4trybfmvfskexkidzt764	21	18	shown	show	VBN
work_dnaoa4trybfmvfskexkidzt764	21	19	in	in	IN
work_dnaoa4trybfmvfskexkidzt764	21	20	Box	Box	NNP
work_dnaoa4trybfmvfskexkidzt764	21	21	2	2	CD
work_dnaoa4trybfmvfskexkidzt764	21	22	.	.	.
work_dnaoa4trybfmvfskexkidzt764	22	1	On	on	IN
work_dnaoa4trybfmvfskexkidzt764	22	2	Day	Day	NNP
work_dnaoa4trybfmvfskexkidzt764	22	3	7	7	CD
work_dnaoa4trybfmvfskexkidzt764	22	4	,	,	,
work_dnaoa4trybfmvfskexkidzt764	22	5	it	-PRON-	PRP
work_dnaoa4trybfmvfskexkidzt764	22	6	was	be	VBD
work_dnaoa4trybfmvfskexkidzt764	22	7	judged	judge	VBN
work_dnaoa4trybfmvfskexkidzt764	22	8	appropriate	appropriate	JJ
work_dnaoa4trybfmvfskexkidzt764	22	9	to	to	TO
work_dnaoa4trybfmvfskexkidzt764	22	10	cease	cease	VB
work_dnaoa4trybfmvfskexkidzt764	22	11	intravenous	intravenous	JJ
work_dnaoa4trybfmvfskexkidzt764	22	12	chelating	chelating	NN
work_dnaoa4trybfmvfskexkidzt764	22	13	ther-	ther-	NN
work_dnaoa4trybfmvfskexkidzt764	22	14	apy	apy	NNP
work_dnaoa4trybfmvfskexkidzt764	22	15	.	.	.
work_dnaoa4trybfmvfskexkidzt764	23	1	Succimer	Succimer	NNP
work_dnaoa4trybfmvfskexkidzt764	23	2	(	(	-LRB-
work_dnaoa4trybfmvfskexkidzt764	23	3	an	an	DT
work_dnaoa4trybfmvfskexkidzt764	23	4	oral	oral	JJ
work_dnaoa4trybfmvfskexkidzt764	23	5	chelating	chelate	VBG
work_dnaoa4trybfmvfskexkidzt764	23	6	agent	agent	NN
work_dnaoa4trybfmvfskexkidzt764	23	7	)	)	-RRB-
work_dnaoa4trybfmvfskexkidzt764	23	8	30	30	CD
work_dnaoa4trybfmvfskexkidzt764	23	9	mg	mg	NNP
work_dnaoa4trybfmvfskexkidzt764	23	10	/	/	SYM
work_dnaoa4trybfmvfskexkidzt764	23	11	kg	kg	NNP
work_dnaoa4trybfmvfskexkidzt764	23	12	/	/	SYM
work_dnaoa4trybfmvfskexkidzt764	23	13	day5	day5	NNP
work_dnaoa4trybfmvfskexkidzt764	23	14	was	be	VBD
work_dnaoa4trybfmvfskexkidzt764	23	15	commenced	commence	VBN
work_dnaoa4trybfmvfskexkidzt764	23	16	three	three	CD
work_dnaoa4trybfmvfskexkidzt764	23	17	days	day	NNS
work_dnaoa4trybfmvfskexkidzt764	23	18	later	later	RB
work_dnaoa4trybfmvfskexkidzt764	23	19	.	.	.
work_dnaoa4trybfmvfskexkidzt764	24	1	At	at	IN
work_dnaoa4trybfmvfskexkidzt764	24	2	that	that	DT
work_dnaoa4trybfmvfskexkidzt764	24	3	time	time	NN
work_dnaoa4trybfmvfskexkidzt764	24	4	,	,	,
work_dnaoa4trybfmvfskexkidzt764	24	5	the	the	DT
work_dnaoa4trybfmvfskexkidzt764	24	6	urinary	urinary	JJ
work_dnaoa4trybfmvfskexkidzt764	24	7	lead	lead	NN
work_dnaoa4trybfmvfskexkidzt764	24	8	concentration	concentration	NN
work_dnaoa4trybfmvfskexkidzt764	24	9	had	have	VBD
work_dnaoa4trybfmvfskexkidzt764	24	10	fallen	fall	VBN
work_dnaoa4trybfmvfskexkidzt764	24	11	to	to	IN
work_dnaoa4trybfmvfskexkidzt764	24	12	4.2	4.2	CD
work_dnaoa4trybfmvfskexkidzt764	24	13	�	�	NNP
work_dnaoa4trybfmvfskexkidzt764	24	14	mol	mol	NN
work_dnaoa4trybfmvfskexkidzt764	24	15	/	/	SYM
work_dnaoa4trybfmvfskexkidzt764	24	16	L.	L.	NNP
work_dnaoa4trybfmvfskexkidzt764	25	1	Over	over	IN
work_dnaoa4trybfmvfskexkidzt764	25	2	the	the	DT
work_dnaoa4trybfmvfskexkidzt764	25	3	three	three	CD
work_dnaoa4trybfmvfskexkidzt764	25	4	-	-	HYPH
work_dnaoa4trybfmvfskexkidzt764	25	5	week	week	NN
work_dnaoa4trybfmvfskexkidzt764	25	6	course	course	NN
work_dnaoa4trybfmvfskexkidzt764	25	7	of	of	IN
work_dnaoa4trybfmvfskexkidzt764	25	8	succimer	succimer	NN
work_dnaoa4trybfmvfskexkidzt764	25	9	,	,	,
work_dnaoa4trybfmvfskexkidzt764	25	10	urinary	urinary	NNP
work_dnaoa4trybfmvfskexkidzt764	25	11	lead	lead	NN
work_dnaoa4trybfmvfskexkidzt764	25	12	concentrations	concentration	NNS
work_dnaoa4trybfmvfskexkidzt764	25	13	fell	fall	VBD
work_dnaoa4trybfmvfskexkidzt764	25	14	further	far	RBR
work_dnaoa4trybfmvfskexkidzt764	25	15	,	,	,
work_dnaoa4trybfmvfskexkidzt764	25	16	while	while	IN
work_dnaoa4trybfmvfskexkidzt764	25	17	blood	blood	NN
work_dnaoa4trybfmvfskexkidzt764	25	18	lead	lead	NN
work_dnaoa4trybfmvfskexkidzt764	25	19	concentrations	concentration	NNS
work_dnaoa4trybfmvfskexkidzt764	25	20	remained	remain	VBD
work_dnaoa4trybfmvfskexkidzt764	25	21	relatively	relatively	RB
work_dnaoa4trybfmvfskexkidzt764	25	22	con-	con-	NN
work_dnaoa4trybfmvfskexkidzt764	25	23	stant	stant	JJ
work_dnaoa4trybfmvfskexkidzt764	25	24	.	.	.
work_dnaoa4trybfmvfskexkidzt764	26	1	As	as	IN
work_dnaoa4trybfmvfskexkidzt764	26	2	the	the	DT
work_dnaoa4trybfmvfskexkidzt764	26	3	succimer	succimer	NN
work_dnaoa4trybfmvfskexkidzt764	26	4	appeared	appear	VBD
work_dnaoa4trybfmvfskexkidzt764	26	5	to	to	TO
work_dnaoa4trybfmvfskexkidzt764	26	6	be	be	VB
work_dnaoa4trybfmvfskexkidzt764	26	7	having	have	VBG
work_dnaoa4trybfmvfskexkidzt764	26	8	little	little	JJ
work_dnaoa4trybfmvfskexkidzt764	26	9	effect	effect	NN
work_dnaoa4trybfmvfskexkidzt764	26	10	,	,	,
work_dnaoa4trybfmvfskexkidzt764	26	11	it	-PRON-	PRP
work_dnaoa4trybfmvfskexkidzt764	26	12	was	be	VBD
work_dnaoa4trybfmvfskexkidzt764	26	13	discontinued	discontinue	VBN
work_dnaoa4trybfmvfskexkidzt764	26	14	on	on	IN
work_dnaoa4trybfmvfskexkidzt764	26	15	Day	Day	NNP
work_dnaoa4trybfmvfskexkidzt764	26	16	31	31	CD
work_dnaoa4trybfmvfskexkidzt764	26	17	,	,	,
work_dnaoa4trybfmvfskexkidzt764	26	18	and	and	CC
work_dnaoa4trybfmvfskexkidzt764	26	19	intravenous	intravenous	JJ
work_dnaoa4trybfmvfskexkidzt764	26	20	CaNa2EDTA	cana2edta	NN
work_dnaoa4trybfmvfskexkidzt764	26	21	was	be	VBD
work_dnaoa4trybfmvfskexkidzt764	26	22	recommenced	recommence	VBN
work_dnaoa4trybfmvfskexkidzt764	26	23	48	48	CD
work_dnaoa4trybfmvfskexkidzt764	26	24	hours	hour	NNS
work_dnaoa4trybfmvfskexkidzt764	26	25	later	later	RB
work_dnaoa4trybfmvfskexkidzt764	26	26	.	.	.
work_dnaoa4trybfmvfskexkidzt764	27	1	A	a	DT
work_dnaoa4trybfmvfskexkidzt764	27	2	rise	rise	NN
work_dnaoa4trybfmvfskexkidzt764	27	3	in	in	IN
work_dnaoa4trybfmvfskexkidzt764	27	4	urinary	urinary	JJ
work_dnaoa4trybfmvfskexkidzt764	27	5	lead	lead	NNP
work_dnaoa4trybfmvfskexkidzt764	27	6	excretion	excretion	NN
work_dnaoa4trybfmvfskexkidzt764	27	7	was	be	VBD
work_dnaoa4trybfmvfskexkidzt764	27	8	observed	observe	VBN
work_dnaoa4trybfmvfskexkidzt764	27	9	after	after	IN
work_dnaoa4trybfmvfskexkidzt764	27	10	this	this	DT
work_dnaoa4trybfmvfskexkidzt764	27	11	course	course	NN
work_dnaoa4trybfmvfskexkidzt764	27	12	and	and	CC
work_dnaoa4trybfmvfskexkidzt764	27	13	subsequent	subsequent	JJ
work_dnaoa4trybfmvfskexkidzt764	27	14	courses	course	NNS
work_dnaoa4trybfmvfskexkidzt764	27	15	of	of	IN
work_dnaoa4trybfmvfskexkidzt764	27	16	parenteral	parenteral	JJ
work_dnaoa4trybfmvfskexkidzt764	27	17	therapy	therapy	NN
work_dnaoa4trybfmvfskexkidzt764	27	18	.	.	.
work_dnaoa4trybfmvfskexkidzt764	28	1	By	by	IN
work_dnaoa4trybfmvfskexkidzt764	28	2	Day	Day	NNP
work_dnaoa4trybfmvfskexkidzt764	28	3	42	42	CD
work_dnaoa4trybfmvfskexkidzt764	28	4	,	,	,
work_dnaoa4trybfmvfskexkidzt764	28	5	facial	facial	JJ
work_dnaoa4trybfmvfskexkidzt764	28	6	,	,	,
work_dnaoa4trybfmvfskexkidzt764	28	7	bulbar	bulbar	NN
work_dnaoa4trybfmvfskexkidzt764	28	8	,	,	,
work_dnaoa4trybfmvfskexkidzt764	28	9	proximal	proximal	JJ
work_dnaoa4trybfmvfskexkidzt764	28	10	-	-	HYPH
work_dnaoa4trybfmvfskexkidzt764	28	11	limb	limb	NN
work_dnaoa4trybfmvfskexkidzt764	28	12	and	and	CC
work_dnaoa4trybfmvfskexkidzt764	28	13	diaphrag-	diaphrag-	NN
work_dnaoa4trybfmvfskexkidzt764	28	14	matic	matic	JJ
work_dnaoa4trybfmvfskexkidzt764	28	15	muscle	muscle	NN
work_dnaoa4trybfmvfskexkidzt764	28	16	activity	activity	NN
work_dnaoa4trybfmvfskexkidzt764	28	17	had	have	VBD
work_dnaoa4trybfmvfskexkidzt764	28	18	improved	improve	VBN
work_dnaoa4trybfmvfskexkidzt764	28	19	sufficiently	sufficiently	RB
work_dnaoa4trybfmvfskexkidzt764	28	20	to	to	TO
work_dnaoa4trybfmvfskexkidzt764	28	21	allow	allow	VB
work_dnaoa4trybfmvfskexkidzt764	28	22	successful	successful	JJ
work_dnaoa4trybfmvfskexkidzt764	28	23	extubation	extubation	NN
work_dnaoa4trybfmvfskexkidzt764	28	24	.	.	.
work_dnaoa4trybfmvfskexkidzt764	29	1	By	by	IN
work_dnaoa4trybfmvfskexkidzt764	29	2	Day	Day	NNP
work_dnaoa4trybfmvfskexkidzt764	29	3	53	53	CD
work_dnaoa4trybfmvfskexkidzt764	29	4	,	,	,
work_dnaoa4trybfmvfskexkidzt764	29	5	the	the	DT
work_dnaoa4trybfmvfskexkidzt764	29	6	blood	blood	NN
work_dnaoa4trybfmvfskexkidzt764	29	7	lead	lead	NN
work_dnaoa4trybfmvfskexkidzt764	29	8	concentra-	concentra-	XX
work_dnaoa4trybfmvfskexkidzt764	29	9	tion	tion	NN
work_dnaoa4trybfmvfskexkidzt764	29	10	appeared	appear	VBD
work_dnaoa4trybfmvfskexkidzt764	29	11	to	to	TO
work_dnaoa4trybfmvfskexkidzt764	29	12	have	have	VB
work_dnaoa4trybfmvfskexkidzt764	29	13	fallen	fall	VBN
work_dnaoa4trybfmvfskexkidzt764	29	14	to	to	IN
work_dnaoa4trybfmvfskexkidzt764	29	15	a	a	DT
work_dnaoa4trybfmvfskexkidzt764	29	16	satisfactory	satisfactory	JJ
work_dnaoa4trybfmvfskexkidzt764	29	17	level	level	NN
work_dnaoa4trybfmvfskexkidzt764	29	18	,	,	,
work_dnaoa4trybfmvfskexkidzt764	29	19	and	and	CC
work_dnaoa4trybfmvfskexkidzt764	29	20	an	an	DT
work_dnaoa4trybfmvfskexkidzt764	29	21	attempt	attempt	NN
work_dnaoa4trybfmvfskexkidzt764	29	22	at	at	IN
work_dnaoa4trybfmvfskexkidzt764	29	23	maintenance	maintenance	NN
work_dnaoa4trybfmvfskexkidzt764	29	24	therapy	therapy	NN
work_dnaoa4trybfmvfskexkidzt764	29	25	using	use	VBG
work_dnaoa4trybfmvfskexkidzt764	29	26	oral	oral	JJ
work_dnaoa4trybfmvfskexkidzt764	29	27	succimer	succimer	NN
work_dnaoa4trybfmvfskexkidzt764	29	28	at	at	IN
work_dnaoa4trybfmvfskexkidzt764	29	29	the	the	DT
work_dnaoa4trybfmvfskexkidzt764	29	30	higher	high	JJR
work_dnaoa4trybfmvfskexkidzt764	29	31	dose	dose	NN
work_dnaoa4trybfmvfskexkidzt764	29	32	of	of	IN
work_dnaoa4trybfmvfskexkidzt764	29	33	60	60	CD
work_dnaoa4trybfmvfskexkidzt764	29	34	mg	mg	NNP
work_dnaoa4trybfmvfskexkidzt764	29	35	/	/	SYM
work_dnaoa4trybfmvfskexkidzt764	29	36	kg	kg	NNP
work_dnaoa4trybfmvfskexkidzt764	29	37	/	/	SYM
work_dnaoa4trybfmvfskexkidzt764	29	38	day	day	NN
work_dnaoa4trybfmvfskexkidzt764	29	39	was	be	VBD
work_dnaoa4trybfmvfskexkidzt764	29	40	commenced.6,7	commenced.6,7	.
work_dnaoa4trybfmvfskexkidzt764	29	41	However	however	RB
work_dnaoa4trybfmvfskexkidzt764	29	42	,	,	,
work_dnaoa4trybfmvfskexkidzt764	29	43	Severe	severe	JJ
work_dnaoa4trybfmvfskexkidzt764	29	44	congenital	congenital	JJ
work_dnaoa4trybfmvfskexkidzt764	29	45	lead	lead	NN
work_dnaoa4trybfmvfskexkidzt764	29	46	poisoning	poisoning	NN
work_dnaoa4trybfmvfskexkidzt764	29	47	in	in	IN
work_dnaoa4trybfmvfskexkidzt764	29	48	a	a	DT
work_dnaoa4trybfmvfskexkidzt764	29	49	preterm	preterm	JJ
work_dnaoa4trybfmvfskexkidzt764	29	50	infant	infant	NN
work_dnaoa4trybfmvfskexkidzt764	29	51	due	due	IN
work_dnaoa4trybfmvfskexkidzt764	29	52	to	to	IN
work_dnaoa4trybfmvfskexkidzt764	29	53	a	a	DT
work_dnaoa4trybfmvfskexkidzt764	29	54	herbal	herbal	JJ
work_dnaoa4trybfmvfskexkidzt764	29	55	remedy	remedy	NN
work_dnaoa4trybfmvfskexkidzt764	29	56	Paul	Paul	NNP
work_dnaoa4trybfmvfskexkidzt764	29	57	A	A	NNP
work_dnaoa4trybfmvfskexkidzt764	29	58	Tait	Tait	NNP
work_dnaoa4trybfmvfskexkidzt764	29	59	,	,	,
work_dnaoa4trybfmvfskexkidzt764	29	60	Amish	amish	JJ
work_dnaoa4trybfmvfskexkidzt764	29	61	Vora	Vora	NNP
work_dnaoa4trybfmvfskexkidzt764	29	62	,	,	,
work_dnaoa4trybfmvfskexkidzt764	29	63	Simon	Simon	NNP
work_dnaoa4trybfmvfskexkidzt764	29	64	James	James	NNP
work_dnaoa4trybfmvfskexkidzt764	29	65	,	,	,
work_dnaoa4trybfmvfskexkidzt764	29	66	D	D	NNP
work_dnaoa4trybfmvfskexkidzt764	29	67	James	James	NNP
work_dnaoa4trybfmvfskexkidzt764	29	68	Fitzgerald	Fitzgerald	NNP
work_dnaoa4trybfmvfskexkidzt764	29	69	and	and	CC
work_dnaoa4trybfmvfskexkidzt764	29	70	Beverly	Beverly	NNP
work_dnaoa4trybfmvfskexkidzt764	29	71	A	A	NNP
work_dnaoa4trybfmvfskexkidzt764	29	72	Pester	Pester	NNP
work_dnaoa4trybfmvfskexkidzt764	29	73	Pharmacy	Pharmacy	NNP
work_dnaoa4trybfmvfskexkidzt764	29	74	Department	Department	NNP
work_dnaoa4trybfmvfskexkidzt764	29	75	,	,	,
work_dnaoa4trybfmvfskexkidzt764	29	76	Women	Women	NNP
work_dnaoa4trybfmvfskexkidzt764	29	77	’s	’s	POS
work_dnaoa4trybfmvfskexkidzt764	29	78	and	and	CC
work_dnaoa4trybfmvfskexkidzt764	29	79	Children	Children	NNP
work_dnaoa4trybfmvfskexkidzt764	29	80	’s	’s	POS
work_dnaoa4trybfmvfskexkidzt764	29	81	Hospital	Hospital	NNP
work_dnaoa4trybfmvfskexkidzt764	29	82	,	,	,
work_dnaoa4trybfmvfskexkidzt764	29	83	North	North	NNP
work_dnaoa4trybfmvfskexkidzt764	29	84	Adelaide	Adelaide	NNP
work_dnaoa4trybfmvfskexkidzt764	29	85	,	,	,
work_dnaoa4trybfmvfskexkidzt764	29	86	SA	SA	NNP
work_dnaoa4trybfmvfskexkidzt764	29	87	.	.	.
work_dnaoa4trybfmvfskexkidzt764	30	1	Paul	Paul	NNP
work_dnaoa4trybfmvfskexkidzt764	30	2	A	A	NNP
work_dnaoa4trybfmvfskexkidzt764	30	3	Tait	Tait	NNP
work_dnaoa4trybfmvfskexkidzt764	30	4	,	,	,
work_dnaoa4trybfmvfskexkidzt764	30	5	BPharm	BPharm	NNP
work_dnaoa4trybfmvfskexkidzt764	30	6	,	,	,
work_dnaoa4trybfmvfskexkidzt764	30	7	Clinical	Clinical	NNP
work_dnaoa4trybfmvfskexkidzt764	30	8	Pharmacist	Pharmacist	NNP
work_dnaoa4trybfmvfskexkidzt764	30	9	and	and	CC
work_dnaoa4trybfmvfskexkidzt764	30	10	Lecturer	Lecturer	NNP
work_dnaoa4trybfmvfskexkidzt764	30	11	.	.	.
work_dnaoa4trybfmvfskexkidzt764	31	1	Neonatal	Neonatal	NNP
work_dnaoa4trybfmvfskexkidzt764	31	2	Unit	Unit	NNP
work_dnaoa4trybfmvfskexkidzt764	31	3	,	,	,
work_dnaoa4trybfmvfskexkidzt764	31	4	Flinders	Flinders	NNP
work_dnaoa4trybfmvfskexkidzt764	31	5	Medical	Medical	NNP
work_dnaoa4trybfmvfskexkidzt764	31	6	Centre	Centre	NNP
work_dnaoa4trybfmvfskexkidzt764	31	7	,	,	,
work_dnaoa4trybfmvfskexkidzt764	31	8	Bedford	Bedford	NNP
work_dnaoa4trybfmvfskexkidzt764	31	9	Park	Park	NNP
work_dnaoa4trybfmvfskexkidzt764	31	10	,	,	,
work_dnaoa4trybfmvfskexkidzt764	31	11	SA	SA	NNP
work_dnaoa4trybfmvfskexkidzt764	31	12	.	.	.
work_dnaoa4trybfmvfskexkidzt764	32	1	Amish	Amish	NNP
work_dnaoa4trybfmvfskexkidzt764	32	2	Vora	Vora	NNP
work_dnaoa4trybfmvfskexkidzt764	32	3	,	,	,
work_dnaoa4trybfmvfskexkidzt764	32	4	MB	MB	NNP
work_dnaoa4trybfmvfskexkidzt764	32	5	BS	BS	NNP
work_dnaoa4trybfmvfskexkidzt764	32	6	,	,	,
work_dnaoa4trybfmvfskexkidzt764	32	7	Neonatal	Neonatal	NNP
work_dnaoa4trybfmvfskexkidzt764	32	8	Registrar	Registrar	NNP
work_dnaoa4trybfmvfskexkidzt764	32	9	;	;	:
work_dnaoa4trybfmvfskexkidzt764	32	10	Simon	Simon	NNP
work_dnaoa4trybfmvfskexkidzt764	32	11	James	James	NNP
work_dnaoa4trybfmvfskexkidzt764	32	12	,	,	,
work_dnaoa4trybfmvfskexkidzt764	32	13	FRACP	FRACP	NNP
work_dnaoa4trybfmvfskexkidzt764	32	14	,	,	,
work_dnaoa4trybfmvfskexkidzt764	32	15	Paediatrician	Paediatrician	NNP
work_dnaoa4trybfmvfskexkidzt764	32	16	.	.	.
work_dnaoa4trybfmvfskexkidzt764	33	1	Environmental	Environmental	NNP
work_dnaoa4trybfmvfskexkidzt764	33	2	Health	Health	NNP
work_dnaoa4trybfmvfskexkidzt764	33	3	Branch	Branch	NNP
work_dnaoa4trybfmvfskexkidzt764	33	4	,	,	,
work_dnaoa4trybfmvfskexkidzt764	33	5	Department	Department	NNP
work_dnaoa4trybfmvfskexkidzt764	33	6	of	of	IN
work_dnaoa4trybfmvfskexkidzt764	33	7	Human	Human	NNP
work_dnaoa4trybfmvfskexkidzt764	33	8	Services	Services	NNPS
work_dnaoa4trybfmvfskexkidzt764	33	9	,	,	,
work_dnaoa4trybfmvfskexkidzt764	33	10	Adelaide	Adelaide	NNP
work_dnaoa4trybfmvfskexkidzt764	33	11	,	,	,
work_dnaoa4trybfmvfskexkidzt764	33	12	SA	SA	NNP
work_dnaoa4trybfmvfskexkidzt764	33	13	.	.	.
work_dnaoa4trybfmvfskexkidzt764	34	1	D	D	NNP
work_dnaoa4trybfmvfskexkidzt764	34	2	James	James	NNP
work_dnaoa4trybfmvfskexkidzt764	34	3	Fitzgerald	Fitzgerald	NNP
work_dnaoa4trybfmvfskexkidzt764	34	4	,	,	,
work_dnaoa4trybfmvfskexkidzt764	34	5	PhD	phd	NN
work_dnaoa4trybfmvfskexkidzt764	34	6	,	,	,
work_dnaoa4trybfmvfskexkidzt764	34	7	Principal	Principal	NNP
work_dnaoa4trybfmvfskexkidzt764	34	8	Toxicologist	Toxicologist	NNP
work_dnaoa4trybfmvfskexkidzt764	34	9	;	;	:
work_dnaoa4trybfmvfskexkidzt764	34	10	Beverly	Beverly	NNP
work_dnaoa4trybfmvfskexkidzt764	34	11	A	A	NNP
work_dnaoa4trybfmvfskexkidzt764	34	12	Pester	Pester	NNP
work_dnaoa4trybfmvfskexkidzt764	34	13	,	,	,
work_dnaoa4trybfmvfskexkidzt764	34	14	BA	BA	NNP
work_dnaoa4trybfmvfskexkidzt764	34	15	MA	MA	NNP
work_dnaoa4trybfmvfskexkidzt764	34	16	,	,	,
work_dnaoa4trybfmvfskexkidzt764	34	17	Scientific	Scientific	NNP
work_dnaoa4trybfmvfskexkidzt764	34	18	Officer	Officer	NNP
work_dnaoa4trybfmvfskexkidzt764	34	19	.	.	.
work_dnaoa4trybfmvfskexkidzt764	35	1	Reprints	reprint	NNS
work_dnaoa4trybfmvfskexkidzt764	35	2	will	will	MD
work_dnaoa4trybfmvfskexkidzt764	35	3	not	not	RB
work_dnaoa4trybfmvfskexkidzt764	35	4	be	be	VB
work_dnaoa4trybfmvfskexkidzt764	35	5	available	available	JJ
work_dnaoa4trybfmvfskexkidzt764	35	6	from	from	IN
work_dnaoa4trybfmvfskexkidzt764	35	7	the	the	DT
work_dnaoa4trybfmvfskexkidzt764	35	8	authors	author	NNS
work_dnaoa4trybfmvfskexkidzt764	35	9	.	.	.
work_dnaoa4trybfmvfskexkidzt764	36	1	Correspondence	correspondence	NN
work_dnaoa4trybfmvfskexkidzt764	36	2	:	:	:
work_dnaoa4trybfmvfskexkidzt764	36	3	Dr	Dr	NNP
work_dnaoa4trybfmvfskexkidzt764	36	4	D	D	NNP
work_dnaoa4trybfmvfskexkidzt764	36	5	James	James	NNP
work_dnaoa4trybfmvfskexkidzt764	36	6	Fitzgerald	Fitzgerald	NNP
work_dnaoa4trybfmvfskexkidzt764	36	7	,	,	,
work_dnaoa4trybfmvfskexkidzt764	36	8	Environmental	Environmental	NNP
work_dnaoa4trybfmvfskexkidzt764	36	9	Health	Health	NNP
work_dnaoa4trybfmvfskexkidzt764	36	10	Branch	Branch	NNP
work_dnaoa4trybfmvfskexkidzt764	36	11	,	,	,
work_dnaoa4trybfmvfskexkidzt764	36	12	Department	Department	NNP
work_dnaoa4trybfmvfskexkidzt764	36	13	of	of	IN
work_dnaoa4trybfmvfskexkidzt764	36	14	Human	Human	NNP
work_dnaoa4trybfmvfskexkidzt764	36	15	Services	Services	NNPS
work_dnaoa4trybfmvfskexkidzt764	36	16	,	,	,
work_dnaoa4trybfmvfskexkidzt764	36	17	PO	PO	NNP
work_dnaoa4trybfmvfskexkidzt764	36	18	Box	Box	NNP
work_dnaoa4trybfmvfskexkidzt764	36	19	6	6	CD
work_dnaoa4trybfmvfskexkidzt764	36	20	,	,	,
work_dnaoa4trybfmvfskexkidzt764	36	21	Rundle	Rundle	NNP
work_dnaoa4trybfmvfskexkidzt764	36	22	Mall	Mall	NNP
work_dnaoa4trybfmvfskexkidzt764	36	23	,	,	,
work_dnaoa4trybfmvfskexkidzt764	36	24	Adelaide	Adelaide	NNP
work_dnaoa4trybfmvfskexkidzt764	36	25	,	,	,
work_dnaoa4trybfmvfskexkidzt764	36	26	SA	SA	NNP
work_dnaoa4trybfmvfskexkidzt764	36	27	5000	5000	CD
work_dnaoa4trybfmvfskexkidzt764	36	28	.	.	.
work_dnaoa4trybfmvfskexkidzt764	36	29	jim.fitzgerald@dhs.sa.gov.au	jim.fitzgerald@dhs.sa.gov.au	NNP
work_dnaoa4trybfmvfskexkidzt764	36	30	NOTABLE	NOTABLE	NNP
work_dnaoa4trybfmvfskexkidzt764	36	31	CASES	cases	NN
work_dnaoa4trybfmvfskexkidzt764	36	32	194	194	CD
work_dnaoa4trybfmvfskexkidzt764	36	33	MJA	MJA	NNP
work_dnaoa4trybfmvfskexkidzt764	36	34	Vol	Vol	NNP
work_dnaoa4trybfmvfskexkidzt764	36	35	177	177	CD
work_dnaoa4trybfmvfskexkidzt764	36	36	19	19	CD
work_dnaoa4trybfmvfskexkidzt764	36	37	August	August	NNP
work_dnaoa4trybfmvfskexkidzt764	36	38	2002	2002	CD
work_dnaoa4trybfmvfskexkidzt764	36	39	NOTABLE	notable	NN
work_dnaoa4trybfmvfskexkidzt764	36	40	CASES	cases	VB
work_dnaoa4trybfmvfskexkidzt764	36	41	the	the	DT
work_dnaoa4trybfmvfskexkidzt764	36	42	blood	blood	NN
work_dnaoa4trybfmvfskexkidzt764	36	43	lead	lead	NN
work_dnaoa4trybfmvfskexkidzt764	36	44	concentration	concentration	NN
work_dnaoa4trybfmvfskexkidzt764	36	45	increased	increase	VBD
work_dnaoa4trybfmvfskexkidzt764	36	46	during	during	IN
work_dnaoa4trybfmvfskexkidzt764	36	47	the	the	DT
work_dnaoa4trybfmvfskexkidzt764	36	48	second	second	JJ
work_dnaoa4trybfmvfskexkidzt764	36	49	course	course	NN
work_dnaoa4trybfmvfskexkidzt764	36	50	of	of	IN
work_dnaoa4trybfmvfskexkidzt764	36	51	succimer	succimer	NN
work_dnaoa4trybfmvfskexkidzt764	36	52	,	,	,
work_dnaoa4trybfmvfskexkidzt764	36	53	with	with	IN
work_dnaoa4trybfmvfskexkidzt764	36	54	a	a	DT
work_dnaoa4trybfmvfskexkidzt764	36	55	corresponding	corresponding	JJ
work_dnaoa4trybfmvfskexkidzt764	36	56	decrease	decrease	NN
work_dnaoa4trybfmvfskexkidzt764	36	57	in	in	IN
work_dnaoa4trybfmvfskexkidzt764	36	58	the	the	DT
work_dnaoa4trybfmvfskexkidzt764	36	59	urinary	urinary	JJ
work_dnaoa4trybfmvfskexkidzt764	36	60	lead	lead	NN
work_dnaoa4trybfmvfskexkidzt764	36	61	concentration	concentration	NN
work_dnaoa4trybfmvfskexkidzt764	36	62	.	.	.
work_dnaoa4trybfmvfskexkidzt764	37	1	Intravenous	intravenous	JJ
work_dnaoa4trybfmvfskexkidzt764	37	2	CaNa2EDTA	CaNa2EDTA	NNP
work_dnaoa4trybfmvfskexkidzt764	37	3	was	be	VBD
work_dnaoa4trybfmvfskexkidzt764	37	4	recommenced	recommence	VBN
work_dnaoa4trybfmvfskexkidzt764	37	5	.	.	.
work_dnaoa4trybfmvfskexkidzt764	38	1	When	when	WRB
work_dnaoa4trybfmvfskexkidzt764	38	2	chelation	chelation	NN
work_dnaoa4trybfmvfskexkidzt764	38	3	therapy	therapy	NN
work_dnaoa4trybfmvfskexkidzt764	38	4	was	be	VBD
work_dnaoa4trybfmvfskexkidzt764	38	5	subsequently	subsequently	RB
work_dnaoa4trybfmvfskexkidzt764	38	6	discontinued	discontinue	VBN
work_dnaoa4trybfmvfskexkidzt764	38	7	for	for	IN
work_dnaoa4trybfmvfskexkidzt764	38	8	two	two	CD
work_dnaoa4trybfmvfskexkidzt764	38	9	weeks	week	NNS
work_dnaoa4trybfmvfskexkidzt764	38	10	,	,	,
work_dnaoa4trybfmvfskexkidzt764	38	11	the	the	DT
work_dnaoa4trybfmvfskexkidzt764	38	12	blood	blood	NN
work_dnaoa4trybfmvfskexkidzt764	38	13	lead	lead	VBP
work_dnaoa4trybfmvfskexkidzt764	38	14	concentration	concentration	NN
work_dnaoa4trybfmvfskexkidzt764	38	15	again	again	RB
work_dnaoa4trybfmvfskexkidzt764	38	16	rose	rise	VBD
work_dnaoa4trybfmvfskexkidzt764	38	17	,	,	,
work_dnaoa4trybfmvfskexkidzt764	38	18	and	and	CC
work_dnaoa4trybfmvfskexkidzt764	38	19	a	a	DT
work_dnaoa4trybfmvfskexkidzt764	38	20	fifth	fifth	JJ
work_dnaoa4trybfmvfskexkidzt764	38	21	course	course	NN
work_dnaoa4trybfmvfskexkidzt764	38	22	of	of	IN
work_dnaoa4trybfmvfskexkidzt764	38	23	CaNa2EDTA	cana2edta	NN
work_dnaoa4trybfmvfskexkidzt764	38	24	was	be	VBD
work_dnaoa4trybfmvfskexkidzt764	38	25	initiated	initiate	VBN
work_dnaoa4trybfmvfskexkidzt764	38	26	.	.	.
work_dnaoa4trybfmvfskexkidzt764	39	1	Progress	progress	NN
work_dnaoa4trybfmvfskexkidzt764	39	2	of	of	IN
work_dnaoa4trybfmvfskexkidzt764	39	3	infant	infant	NN
work_dnaoa4trybfmvfskexkidzt764	39	4	after	after	IN
work_dnaoa4trybfmvfskexkidzt764	39	5	first	first	JJ
work_dnaoa4trybfmvfskexkidzt764	39	6	14	14	CD
work_dnaoa4trybfmvfskexkidzt764	39	7	weeks	week	NNS
work_dnaoa4trybfmvfskexkidzt764	39	8	.	.	.
work_dnaoa4trybfmvfskexkidzt764	40	1	By	by	IN
work_dnaoa4trybfmvfskexkidzt764	40	2	three	three	CD
work_dnaoa4trybfmvfskexkidzt764	40	3	months	month	NNS
work_dnaoa4trybfmvfskexkidzt764	40	4	’	'	''
work_dnaoa4trybfmvfskexkidzt764	40	5	corrected	correct	VBN
work_dnaoa4trybfmvfskexkidzt764	40	6	age	age	NN
work_dnaoa4trybfmvfskexkidzt764	40	7	(	(	-LRB-
work_dnaoa4trybfmvfskexkidzt764	40	8	ie	ie	FW
work_dnaoa4trybfmvfskexkidzt764	40	9	,	,	,
work_dnaoa4trybfmvfskexkidzt764	40	10	about	about	IN
work_dnaoa4trybfmvfskexkidzt764	40	11	5½	5½	CD
work_dnaoa4trybfmvfskexkidzt764	40	12	months	month	NNS
work_dnaoa4trybfmvfskexkidzt764	40	13	after	after	IN
work_dnaoa4trybfmvfskexkidzt764	40	14	birth	birth	NN
work_dnaoa4trybfmvfskexkidzt764	40	15	)	)	-RRB-
work_dnaoa4trybfmvfskexkidzt764	40	16	the	the	DT
work_dnaoa4trybfmvfskexkidzt764	40	17	infant	infant	NN
work_dnaoa4trybfmvfskexkidzt764	40	18	was	be	VBD
work_dnaoa4trybfmvfskexkidzt764	40	19	able	able	JJ
work_dnaoa4trybfmvfskexkidzt764	40	20	to	to	TO
work_dnaoa4trybfmvfskexkidzt764	40	21	fully	fully	RB
work_dnaoa4trybfmvfskexkidzt764	40	22	feed	feed	VB
work_dnaoa4trybfmvfskexkidzt764	40	23	by	by	IN
work_dnaoa4trybfmvfskexkidzt764	40	24	sucking	suck	VBG
work_dnaoa4trybfmvfskexkidzt764	40	25	,	,	,
work_dnaoa4trybfmvfskexkidzt764	40	26	although	although	IN
work_dnaoa4trybfmvfskexkidzt764	40	27	there	there	EX
work_dnaoa4trybfmvfskexkidzt764	40	28	was	be	VBD
work_dnaoa4trybfmvfskexkidzt764	40	29	significant	significant	JJ
work_dnaoa4trybfmvfskexkidzt764	40	30	gastroesophageal	gastroesophageal	NN
work_dnaoa4trybfmvfskexkidzt764	40	31	reflux	reflux	NN
work_dnaoa4trybfmvfskexkidzt764	40	32	.	.	.
work_dnaoa4trybfmvfskexkidzt764	41	1	Her	-PRON-	PRP$
work_dnaoa4trybfmvfskexkidzt764	41	2	peripheral	peripheral	JJ
work_dnaoa4trybfmvfskexkidzt764	41	3	weakness	weakness	NN
work_dnaoa4trybfmvfskexkidzt764	41	4	had	have	VBD
work_dnaoa4trybfmvfskexkidzt764	41	5	almost	almost	RB
work_dnaoa4trybfmvfskexkidzt764	41	6	resolved	resolve	VBN
work_dnaoa4trybfmvfskexkidzt764	41	7	,	,	,
work_dnaoa4trybfmvfskexkidzt764	41	8	but	but	CC
work_dnaoa4trybfmvfskexkidzt764	41	9	bilateral	bilateral	JJ
work_dnaoa4trybfmvfskexkidzt764	41	10	wrist	wrist	NN
work_dnaoa4trybfmvfskexkidzt764	41	11	drop	drop	NN
work_dnaoa4trybfmvfskexkidzt764	41	12	and	and	CC
work_dnaoa4trybfmvfskexkidzt764	41	13	poor	poor	JJ
work_dnaoa4trybfmvfskexkidzt764	41	14	head	head	NN
work_dnaoa4trybfmvfskexkidzt764	41	15	control	control	NN
work_dnaoa4trybfmvfskexkidzt764	41	16	persisted	persist	VBD
work_dnaoa4trybfmvfskexkidzt764	41	17	.	.	.
work_dnaoa4trybfmvfskexkidzt764	42	1	Blood	blood	NN
work_dnaoa4trybfmvfskexkidzt764	42	2	lead	lead	NN
work_dnaoa4trybfmvfskexkidzt764	42	3	concentration	concentration	NN
work_dnaoa4trybfmvfskexkidzt764	42	4	had	have	VBD
work_dnaoa4trybfmvfskexkidzt764	42	5	fallen	fall	VBN
work_dnaoa4trybfmvfskexkidzt764	42	6	to	to	IN
work_dnaoa4trybfmvfskexkidzt764	42	7	1.8	1.8	CD
work_dnaoa4trybfmvfskexkidzt764	42	8	�	�	NNP
work_dnaoa4trybfmvfskexkidzt764	42	9	mol	mol	NN
work_dnaoa4trybfmvfskexkidzt764	42	10	/	/	SYM
work_dnaoa4trybfmvfskexkidzt764	42	11	L.	L.	NNP
work_dnaoa4trybfmvfskexkidzt764	43	1	It	-PRON-	PRP
work_dnaoa4trybfmvfskexkidzt764	43	2	was	be	VBD
work_dnaoa4trybfmvfskexkidzt764	43	3	decided	decide	VBN
work_dnaoa4trybfmvfskexkidzt764	43	4	to	to	TO
work_dnaoa4trybfmvfskexkidzt764	43	5	reintroduce	reintroduce	VB
work_dnaoa4trybfmvfskexkidzt764	43	6	oral	oral	JJ
work_dnaoa4trybfmvfskexkidzt764	43	7	succimer	succimer	NN
work_dnaoa4trybfmvfskexkidzt764	43	8	at	at	IN
work_dnaoa4trybfmvfskexkidzt764	43	9	60	60	CD
work_dnaoa4trybfmvfskexkidzt764	43	10	mg	mg	NNP
work_dnaoa4trybfmvfskexkidzt764	43	11	/	/	SYM
work_dnaoa4trybfmvfskexkidzt764	43	12	kg	kg	NN
work_dnaoa4trybfmvfskexkidzt764	43	13	/	/	SYM
work_dnaoa4trybfmvfskexkidzt764	43	14	day	day	NN
work_dnaoa4trybfmvfskexkidzt764	43	15	.	.	.
work_dnaoa4trybfmvfskexkidzt764	44	1	This	this	DT
work_dnaoa4trybfmvfskexkidzt764	44	2	appeared	appear	VBD
work_dnaoa4trybfmvfskexkidzt764	44	3	to	to	TO
work_dnaoa4trybfmvfskexkidzt764	44	4	be	be	VB
work_dnaoa4trybfmvfskexkidzt764	44	5	effective	effective	JJ
work_dnaoa4trybfmvfskexkidzt764	44	6	,	,	,
work_dnaoa4trybfmvfskexkidzt764	44	7	as	as	IN
work_dnaoa4trybfmvfskexkidzt764	44	8	the	the	DT
work_dnaoa4trybfmvfskexkidzt764	44	9	lead	lead	NN
work_dnaoa4trybfmvfskexkidzt764	44	10	levels	level	NNS
work_dnaoa4trybfmvfskexkidzt764	44	11	not	not	RB
work_dnaoa4trybfmvfskexkidzt764	44	12	only	only	RB
work_dnaoa4trybfmvfskexkidzt764	44	13	fell	fall	VBD
work_dnaoa4trybfmvfskexkidzt764	44	14	in	in	IN
work_dnaoa4trybfmvfskexkidzt764	44	15	the	the	DT
work_dnaoa4trybfmvfskexkidzt764	44	16	blood	blood	NN
work_dnaoa4trybfmvfskexkidzt764	44	17	but	but	CC
work_dnaoa4trybfmvfskexkidzt764	44	18	increased	increase	VBD
work_dnaoa4trybfmvfskexkidzt764	44	19	in	in	IN
work_dnaoa4trybfmvfskexkidzt764	44	20	the	the	DT
work_dnaoa4trybfmvfskexkidzt764	44	21	urine	urine	NN
work_dnaoa4trybfmvfskexkidzt764	44	22	.	.	.
work_dnaoa4trybfmvfskexkidzt764	45	1	A	a	DT
work_dnaoa4trybfmvfskexkidzt764	45	2	brainstem	brainstem	NN
work_dnaoa4trybfmvfskexkidzt764	45	3	auditory	auditory	JJ
work_dnaoa4trybfmvfskexkidzt764	45	4	response	response	NN
work_dnaoa4trybfmvfskexkidzt764	45	5	at	at	IN
work_dnaoa4trybfmvfskexkidzt764	45	6	four	four	CD
work_dnaoa4trybfmvfskexkidzt764	45	7	months	month	NNS
work_dnaoa4trybfmvfskexkidzt764	45	8	’	'	''
work_dnaoa4trybfmvfskexkidzt764	45	9	corrected	correct	VBN
work_dnaoa4trybfmvfskexkidzt764	45	10	age	age	NN
work_dnaoa4trybfmvfskexkidzt764	45	11	showed	show	VBD
work_dnaoa4trybfmvfskexkidzt764	45	12	right	right	JJ
work_dnaoa4trybfmvfskexkidzt764	45	13	sensorineural	sensorineural	JJ
work_dnaoa4trybfmvfskexkidzt764	45	14	deafness	deafness	NN
work_dnaoa4trybfmvfskexkidzt764	45	15	.	.	.
work_dnaoa4trybfmvfskexkidzt764	46	1	(	(	-LRB-
work_dnaoa4trybfmvfskexkidzt764	46	2	A	a	DT
work_dnaoa4trybfmvfskexkidzt764	46	3	magnetic	magnetic	JJ
work_dnaoa4trybfmvfskexkidzt764	46	4	reso-	reso-	NN
work_dnaoa4trybfmvfskexkidzt764	46	5	nance	nance	NN
work_dnaoa4trybfmvfskexkidzt764	46	6	image	image	NN
work_dnaoa4trybfmvfskexkidzt764	46	7	of	of	IN
work_dnaoa4trybfmvfskexkidzt764	46	8	the	the	DT
work_dnaoa4trybfmvfskexkidzt764	46	9	brain	brain	NN
work_dnaoa4trybfmvfskexkidzt764	46	10	at	at	IN
work_dnaoa4trybfmvfskexkidzt764	46	11	three	three	CD
work_dnaoa4trybfmvfskexkidzt764	46	12	weeks	week	NNS
work_dnaoa4trybfmvfskexkidzt764	46	13	of	of	IN
work_dnaoa4trybfmvfskexkidzt764	46	14	age	age	NN
work_dnaoa4trybfmvfskexkidzt764	46	15	had	have	VBD
work_dnaoa4trybfmvfskexkidzt764	46	16	been	be	VBN
work_dnaoa4trybfmvfskexkidzt764	46	17	normal	normal	JJ
work_dnaoa4trybfmvfskexkidzt764	46	18	.	.	.
work_dnaoa4trybfmvfskexkidzt764	46	19	)	)	-RRB-
work_dnaoa4trybfmvfskexkidzt764	47	1	Throughout	throughout	IN
work_dnaoa4trybfmvfskexkidzt764	47	2	the	the	DT
work_dnaoa4trybfmvfskexkidzt764	47	3	hospital	hospital	NN
work_dnaoa4trybfmvfskexkidzt764	47	4	stay	stay	VB
work_dnaoa4trybfmvfskexkidzt764	47	5	her	-PRON-	PRP$
work_dnaoa4trybfmvfskexkidzt764	47	6	serum	serum	NNP
work_dnaoa4trybfmvfskexkidzt764	47	7	calcium	calcium	NN
work_dnaoa4trybfmvfskexkidzt764	47	8	,	,	,
work_dnaoa4trybfmvfskexkidzt764	47	9	zinc	zinc	NN
work_dnaoa4trybfmvfskexkidzt764	47	10	,	,	,
work_dnaoa4trybfmvfskexkidzt764	47	11	iron	iron	NN
work_dnaoa4trybfmvfskexkidzt764	47	12	,	,	,
work_dnaoa4trybfmvfskexkidzt764	47	13	renal	renal	JJ
work_dnaoa4trybfmvfskexkidzt764	47	14	and	and	CC
work_dnaoa4trybfmvfskexkidzt764	47	15	liver	liver	JJ
work_dnaoa4trybfmvfskexkidzt764	47	16	function	function	NN
work_dnaoa4trybfmvfskexkidzt764	47	17	tests	test	NNS
work_dnaoa4trybfmvfskexkidzt764	47	18	were	be	VBD
work_dnaoa4trybfmvfskexkidzt764	47	19	normal	normal	JJ
work_dnaoa4trybfmvfskexkidzt764	47	20	.	.	.
work_dnaoa4trybfmvfskexkidzt764	48	1	The	the	DT
work_dnaoa4trybfmvfskexkidzt764	48	2	infant	infant	NN
work_dnaoa4trybfmvfskexkidzt764	48	3	was	be	VBD
work_dnaoa4trybfmvfskexkidzt764	48	4	discharged	discharge	VBN
work_dnaoa4trybfmvfskexkidzt764	48	5	home	home	RB
work_dnaoa4trybfmvfskexkidzt764	48	6	,	,	,
work_dnaoa4trybfmvfskexkidzt764	48	7	on	on	IN
work_dnaoa4trybfmvfskexkidzt764	48	8	succimer	succimer	NN
work_dnaoa4trybfmvfskexkidzt764	48	9	,	,	,
work_dnaoa4trybfmvfskexkidzt764	48	10	at	at	IN
work_dnaoa4trybfmvfskexkidzt764	48	11	five	five	CD
work_dnaoa4trybfmvfskexkidzt764	48	12	months	month	NNS
work_dnaoa4trybfmvfskexkidzt764	48	13	’	'	''
work_dnaoa4trybfmvfskexkidzt764	48	14	corrected	correct	VBN
work_dnaoa4trybfmvfskexkidzt764	48	15	age	age	NN
work_dnaoa4trybfmvfskexkidzt764	48	16	with	with	IN
work_dnaoa4trybfmvfskexkidzt764	48	17	a	a	DT
work_dnaoa4trybfmvfskexkidzt764	48	18	blood	blood	NN
work_dnaoa4trybfmvfskexkidzt764	48	19	lead	lead	NN
work_dnaoa4trybfmvfskexkidzt764	48	20	concentration	concentration	NN
work_dnaoa4trybfmvfskexkidzt764	48	21	of	of	IN
work_dnaoa4trybfmvfskexkidzt764	48	22	0.95	0.95	CD
work_dnaoa4trybfmvfskexkidzt764	48	23	�	�	NNP
work_dnaoa4trybfmvfskexkidzt764	48	24	mol	mol	NNP
work_dnaoa4trybfmvfskexkidzt764	48	25	/	/	SYM
work_dnaoa4trybfmvfskexkidzt764	48	26	L.	L.	NNP
work_dnaoa4trybfmvfskexkidzt764	49	1	A	a	DT
work_dnaoa4trybfmvfskexkidzt764	49	2	neurodevelopmental	neurodevelopmental	JJ
work_dnaoa4trybfmvfskexkidzt764	49	3	examination	examination	NN
work_dnaoa4trybfmvfskexkidzt764	49	4	at	at	IN
work_dnaoa4trybfmvfskexkidzt764	49	5	the	the	DT
work_dnaoa4trybfmvfskexkidzt764	49	6	time	time	NN
work_dnaoa4trybfmvfskexkidzt764	49	7	revealed	reveal	VBD
work_dnaoa4trybfmvfskexkidzt764	49	8	a	a	DT
work_dnaoa4trybfmvfskexkidzt764	49	9	two	two	CD
work_dnaoa4trybfmvfskexkidzt764	49	10	-	-	HYPH
work_dnaoa4trybfmvfskexkidzt764	49	11	month	month	NN
work_dnaoa4trybfmvfskexkidzt764	49	12	delay	delay	NN
work_dnaoa4trybfmvfskexkidzt764	49	13	.	.	.
work_dnaoa4trybfmvfskexkidzt764	50	1	Her	-PRON-	PRP$
work_dnaoa4trybfmvfskexkidzt764	50	2	two	two	CD
work_dnaoa4trybfmvfskexkidzt764	50	3	siblings	sibling	NNS
work_dnaoa4trybfmvfskexkidzt764	50	4	,	,	,
work_dnaoa4trybfmvfskexkidzt764	50	5	aged	age	VBD
work_dnaoa4trybfmvfskexkidzt764	50	6	two	two	CD
work_dnaoa4trybfmvfskexkidzt764	50	7	and	and	CC
work_dnaoa4trybfmvfskexkidzt764	50	8	four	four	CD
work_dnaoa4trybfmvfskexkidzt764	50	9	years	year	NNS
work_dnaoa4trybfmvfskexkidzt764	50	10	,	,	,
work_dnaoa4trybfmvfskexkidzt764	50	11	were	be	VBD
work_dnaoa4trybfmvfskexkidzt764	50	12	found	find	VBN
work_dnaoa4trybfmvfskexkidzt764	50	13	to	to	TO
work_dnaoa4trybfmvfskexkidzt764	50	14	have	have	VB
work_dnaoa4trybfmvfskexkidzt764	50	15	blood	blood	NN
work_dnaoa4trybfmvfskexkidzt764	50	16	lead	lead	NN
work_dnaoa4trybfmvfskexkidzt764	50	17	concentra-	concentra-	JJ
work_dnaoa4trybfmvfskexkidzt764	50	18	tions	tion	NNS
work_dnaoa4trybfmvfskexkidzt764	50	19	of	of	IN
work_dnaoa4trybfmvfskexkidzt764	50	20	0.6	0.6	CD
work_dnaoa4trybfmvfskexkidzt764	50	21	and	and	CC
work_dnaoa4trybfmvfskexkidzt764	50	22	0.3	0.3	CD
work_dnaoa4trybfmvfskexkidzt764	50	23	�	�	NNP
work_dnaoa4trybfmvfskexkidzt764	50	24	mol	mol	NN
work_dnaoa4trybfmvfskexkidzt764	50	25	/	/	SYM
work_dnaoa4trybfmvfskexkidzt764	50	26	L	l	NN
work_dnaoa4trybfmvfskexkidzt764	50	27	,	,	,
work_dnaoa4trybfmvfskexkidzt764	50	28	respectively	respectively	RB
work_dnaoa4trybfmvfskexkidzt764	50	29	.	.	.
work_dnaoa4trybfmvfskexkidzt764	51	1	Lead	lead	NN
work_dnaoa4trybfmvfskexkidzt764	51	2	source	source	NN
work_dnaoa4trybfmvfskexkidzt764	51	3	identification	identification	NN
work_dnaoa4trybfmvfskexkidzt764	51	4	.	.	.
work_dnaoa4trybfmvfskexkidzt764	52	1	An	an	DT
work_dnaoa4trybfmvfskexkidzt764	52	2	environmental	environmental	JJ
work_dnaoa4trybfmvfskexkidzt764	52	3	audit	audit	NN
work_dnaoa4trybfmvfskexkidzt764	52	4	of	of	IN
work_dnaoa4trybfmvfskexkidzt764	52	5	the	the	DT
work_dnaoa4trybfmvfskexkidzt764	52	6	home	home	NN
work_dnaoa4trybfmvfskexkidzt764	52	7	and	and	CC
work_dnaoa4trybfmvfskexkidzt764	52	8	the	the	DT
work_dnaoa4trybfmvfskexkidzt764	52	9	local	local	JJ
work_dnaoa4trybfmvfskexkidzt764	52	10	Sikh	Sikh	NNP
work_dnaoa4trybfmvfskexkidzt764	52	11	community	community	NN
work_dnaoa4trybfmvfskexkidzt764	52	12	kitchen	kitchen	NN
work_dnaoa4trybfmvfskexkidzt764	52	13	revealed	reveal	VBD
work_dnaoa4trybfmvfskexkidzt764	52	14	no	no	DT
work_dnaoa4trybfmvfskexkidzt764	52	15	obvious	obvious	JJ
work_dnaoa4trybfmvfskexkidzt764	52	16	source	source	NN
work_dnaoa4trybfmvfskexkidzt764	52	17	of	of	IN
work_dnaoa4trybfmvfskexkidzt764	52	18	lead	lead	NN
work_dnaoa4trybfmvfskexkidzt764	52	19	.	.	.
work_dnaoa4trybfmvfskexkidzt764	53	1	Interviews	interview	NNS
work_dnaoa4trybfmvfskexkidzt764	53	2	conducted	conduct	VBN
work_dnaoa4trybfmvfskexkidzt764	53	3	with	with	IN
work_dnaoa4trybfmvfskexkidzt764	53	4	the	the	DT
work_dnaoa4trybfmvfskexkidzt764	53	5	mother	mother	NN
work_dnaoa4trybfmvfskexkidzt764	53	6	established	establish	VBN
work_dnaoa4trybfmvfskexkidzt764	53	7	that	that	IN
work_dnaoa4trybfmvfskexkidzt764	53	8	she	-PRON-	PRP
work_dnaoa4trybfmvfskexkidzt764	53	9	had	have	VBD
work_dnaoa4trybfmvfskexkidzt764	53	10	been	be	VBN
work_dnaoa4trybfmvfskexkidzt764	53	11	taking	take	VBG
work_dnaoa4trybfmvfskexkidzt764	53	12	several	several	JJ
work_dnaoa4trybfmvfskexkidzt764	53	13	tablets	tablet	NNS
work_dnaoa4trybfmvfskexkidzt764	53	14	,	,	,
work_dnaoa4trybfmvfskexkidzt764	53	15	prescribed	prescribe	VBN
work_dnaoa4trybfmvfskexkidzt764	53	16	by	by	IN
work_dnaoa4trybfmvfskexkidzt764	53	17	an	an	DT
work_dnaoa4trybfmvfskexkidzt764	53	18	Ayurvedic	Ayurvedic	NNP
work_dnaoa4trybfmvfskexkidzt764	53	19	doctor	doctor	NN
work_dnaoa4trybfmvfskexkidzt764	53	20	in	in	IN
work_dnaoa4trybfmvfskexkidzt764	53	21	India	India	NNP
work_dnaoa4trybfmvfskexkidzt764	53	22	for	for	IN
work_dnaoa4trybfmvfskexkidzt764	53	23	treatment	treatment	NN
work_dnaoa4trybfmvfskexkidzt764	53	24	of	of	IN
work_dnaoa4trybfmvfskexkidzt764	53	25	a	a	DT
work_dnaoa4trybfmvfskexkidzt764	53	26	gastrointestinal	gastrointestinal	JJ
work_dnaoa4trybfmvfskexkidzt764	53	27	complaint	complaint	NN
work_dnaoa4trybfmvfskexkidzt764	53	28	,	,	,
work_dnaoa4trybfmvfskexkidzt764	53	29	periodically	periodically	RB
work_dnaoa4trybfmvfskexkidzt764	53	30	over	over	IN
work_dnaoa4trybfmvfskexkidzt764	53	31	the	the	DT
work_dnaoa4trybfmvfskexkidzt764	53	32	course	course	NN
work_dnaoa4trybfmvfskexkidzt764	53	33	of	of	IN
work_dnaoa4trybfmvfskexkidzt764	53	34	the	the	DT
work_dnaoa4trybfmvfskexkidzt764	53	35	past	past	JJ
work_dnaoa4trybfmvfskexkidzt764	53	36	nine	nine	CD
work_dnaoa4trybfmvfskexkidzt764	53	37	years	year	NNS
work_dnaoa4trybfmvfskexkidzt764	53	38	.	.	.
work_dnaoa4trybfmvfskexkidzt764	54	1	Analytical	analytical	JJ
work_dnaoa4trybfmvfskexkidzt764	54	2	results	result	NNS
work_dnaoa4trybfmvfskexkidzt764	54	3	for	for	IN
work_dnaoa4trybfmvfskexkidzt764	54	4	the	the	DT
work_dnaoa4trybfmvfskexkidzt764	54	5	various	various	JJ
work_dnaoa4trybfmvfskexkidzt764	54	6	tablets	tablet	NNS
work_dnaoa4trybfmvfskexkidzt764	54	7	are	be	VBP
work_dnaoa4trybfmvfskexkidzt764	54	8	presented	present	VBN
work_dnaoa4trybfmvfskexkidzt764	54	9	in	in	IN
work_dnaoa4trybfmvfskexkidzt764	54	10	Box	Box	NNP
work_dnaoa4trybfmvfskexkidzt764	54	11	3	3	CD
work_dnaoa4trybfmvfskexkidzt764	54	12	,	,	,
work_dnaoa4trybfmvfskexkidzt764	54	13	the	the	DT
work_dnaoa4trybfmvfskexkidzt764	54	14	most	most	RBS
work_dnaoa4trybfmvfskexkidzt764	54	15	notable	notable	JJ
work_dnaoa4trybfmvfskexkidzt764	54	16	being	be	VBG
work_dnaoa4trybfmvfskexkidzt764	54	17	the	the	DT
work_dnaoa4trybfmvfskexkidzt764	54	18	high	high	JJ
work_dnaoa4trybfmvfskexkidzt764	54	19	lead	lead	NN
work_dnaoa4trybfmvfskexkidzt764	54	20	content	content	NN
work_dnaoa4trybfmvfskexkidzt764	54	21	of	of	IN
work_dnaoa4trybfmvfskexkidzt764	54	22	two	two	CD
work_dnaoa4trybfmvfskexkidzt764	54	23	of	of	IN
work_dnaoa4trybfmvfskexkidzt764	54	24	the	the	DT
work_dnaoa4trybfmvfskexkidzt764	54	25	tablet	tablet	NN
work_dnaoa4trybfmvfskexkidzt764	54	26	types	type	NNS
work_dnaoa4trybfmvfskexkidzt764	54	27	(	(	-LRB-
work_dnaoa4trybfmvfskexkidzt764	54	28	4.5%–8.9	4.5%–8.9	CD
work_dnaoa4trybfmvfskexkidzt764	54	29	%	%	NN
work_dnaoa4trybfmvfskexkidzt764	54	30	lead	lead	NN
work_dnaoa4trybfmvfskexkidzt764	54	31	)	)	-RRB-
work_dnaoa4trybfmvfskexkidzt764	54	32	.	.	.
work_dnaoa4trybfmvfskexkidzt764	55	1	The	the	DT
work_dnaoa4trybfmvfskexkidzt764	55	2	mother	mother	NN
work_dnaoa4trybfmvfskexkidzt764	55	3	’s	’s	POS
work_dnaoa4trybfmvfskexkidzt764	55	4	tablet	tablet	NN
work_dnaoa4trybfmvfskexkidzt764	55	5	use	use	NN
work_dnaoa4trybfmvfskexkidzt764	55	6	in	in	IN
work_dnaoa4trybfmvfskexkidzt764	55	7	the	the	DT
work_dnaoa4trybfmvfskexkidzt764	55	8	nine	nine	CD
work_dnaoa4trybfmvfskexkidzt764	55	9	months	month	NNS
work_dnaoa4trybfmvfskexkidzt764	55	10	before	before	IN
work_dnaoa4trybfmvfskexkidzt764	55	11	the	the	DT
work_dnaoa4trybfmvfskexkidzt764	55	12	child	child	NN
work_dnaoa4trybfmvfskexkidzt764	55	13	’s	’s	POS
work_dnaoa4trybfmvfskexkidzt764	55	14	birth	birth	NN
work_dnaoa4trybfmvfskexkidzt764	55	15	represented	represent	VBD
work_dnaoa4trybfmvfskexkidzt764	55	16	a	a	DT
work_dnaoa4trybfmvfskexkidzt764	55	17	lead	lead	NN
work_dnaoa4trybfmvfskexkidzt764	55	18	intake	intake	NN
work_dnaoa4trybfmvfskexkidzt764	55	19	of	of	IN
work_dnaoa4trybfmvfskexkidzt764	55	20	at	at	RB
work_dnaoa4trybfmvfskexkidzt764	55	21	least	least	JJS
work_dnaoa4trybfmvfskexkidzt764	55	22	50	50	CD
work_dnaoa4trybfmvfskexkidzt764	55	23	times	time	NNS
work_dnaoa4trybfmvfskexkidzt764	55	24	the	the	DT
work_dnaoa4trybfmvfskexkidzt764	55	25	average	average	JJ
work_dnaoa4trybfmvfskexkidzt764	55	26	weekly	weekly	JJ
work_dnaoa4trybfmvfskexkidzt764	55	27	lead	lead	NN
work_dnaoa4trybfmvfskexkidzt764	55	28	intake	intake	NN
work_dnaoa4trybfmvfskexkidzt764	55	29	of	of	IN
work_dnaoa4trybfmvfskexkidzt764	55	30	Western	western	JJ
work_dnaoa4trybfmvfskexkidzt764	55	31	populations.2,8	populations.2,8	NN
work_dnaoa4trybfmvfskexkidzt764	55	32	Correspondence	Correspondence	NNP
work_dnaoa4trybfmvfskexkidzt764	55	33	with	with	IN
work_dnaoa4trybfmvfskexkidzt764	55	34	the	the	DT
work_dnaoa4trybfmvfskexkidzt764	55	35	Ayurvedic	Ayurvedic	NNP
work_dnaoa4trybfmvfskexkidzt764	55	36	doctor	doctor	NN
work_dnaoa4trybfmvfskexkidzt764	55	37	in	in	IN
work_dnaoa4trybfmvfskexkidzt764	55	38	India	India	NNP
work_dnaoa4trybfmvfskexkidzt764	55	39	,	,	,
work_dnaoa4trybfmvfskexkidzt764	55	40	who	who	WP
work_dnaoa4trybfmvfskexkidzt764	55	41	prescribed	prescribe	VBD
work_dnaoa4trybfmvfskexkidzt764	55	42	the	the	DT
work_dnaoa4trybfmvfskexkidzt764	55	43	brown	brown	NN
work_dnaoa4trybfmvfskexkidzt764	55	44	(	(	-LRB-
work_dnaoa4trybfmvfskexkidzt764	55	45	“	"	``
work_dnaoa4trybfmvfskexkidzt764	55	46	HSY-15	HSY-15	NNP
work_dnaoa4trybfmvfskexkidzt764	55	47	”	"	''
work_dnaoa4trybfmvfskexkidzt764	55	48	)	)	-RRB-
work_dnaoa4trybfmvfskexkidzt764	55	49	tablets	tablet	NNS
work_dnaoa4trybfmvfskexkidzt764	55	50	in	in	IN
work_dnaoa4trybfmvfskexkidzt764	55	51	this	this	DT
work_dnaoa4trybfmvfskexkidzt764	55	52	case	case	NN
work_dnaoa4trybfmvfskexkidzt764	55	53	,	,	,
work_dnaoa4trybfmvfskexkidzt764	55	54	has	have	VBZ
work_dnaoa4trybfmvfskexkidzt764	55	55	not	not	RB
work_dnaoa4trybfmvfskexkidzt764	55	56	yet	yet	RB
work_dnaoa4trybfmvfskexkidzt764	55	57	provided	provide	VBN
work_dnaoa4trybfmvfskexkidzt764	55	58	any	any	DT
work_dnaoa4trybfmvfskexkidzt764	55	59	clues	clue	NNS
work_dnaoa4trybfmvfskexkidzt764	55	60	as	as	IN
work_dnaoa4trybfmvfskexkidzt764	55	61	to	to	IN
work_dnaoa4trybfmvfskexkidzt764	55	62	the	the	DT
work_dnaoa4trybfmvfskexkidzt764	55	63	origin	origin	NN
work_dnaoa4trybfmvfskexkidzt764	55	64	of	of	IN
work_dnaoa4trybfmvfskexkidzt764	55	65	the	the	DT
work_dnaoa4trybfmvfskexkidzt764	55	66	lead	lead	NN
work_dnaoa4trybfmvfskexkidzt764	55	67	in	in	IN
work_dnaoa4trybfmvfskexkidzt764	55	68	these	these	DT
work_dnaoa4trybfmvfskexkidzt764	55	69	tablets	tablet	NNS
work_dnaoa4trybfmvfskexkidzt764	55	70	.	.	.
work_dnaoa4trybfmvfskexkidzt764	56	1	Discussion	Discussion	NNP
work_dnaoa4trybfmvfskexkidzt764	56	2	Clinical	Clinical	NNP
work_dnaoa4trybfmvfskexkidzt764	56	3	considerations	consideration	NNS
work_dnaoa4trybfmvfskexkidzt764	56	4	The	the	DT
work_dnaoa4trybfmvfskexkidzt764	56	5	diagnosis	diagnosis	NN
work_dnaoa4trybfmvfskexkidzt764	56	6	of	of	IN
work_dnaoa4trybfmvfskexkidzt764	56	7	intrauterine	intrauterine	NN
work_dnaoa4trybfmvfskexkidzt764	56	8	lead	lead	NN
work_dnaoa4trybfmvfskexkidzt764	56	9	intoxication	intoxication	NN
work_dnaoa4trybfmvfskexkidzt764	56	10	was	be	VBD
work_dnaoa4trybfmvfskexkidzt764	56	11	made	make	VBN
work_dnaoa4trybfmvfskexkidzt764	56	12	on	on	IN
work_dnaoa4trybfmvfskexkidzt764	56	13	the	the	DT
work_dnaoa4trybfmvfskexkidzt764	56	14	basis	basis	NN
work_dnaoa4trybfmvfskexkidzt764	56	15	of	of	IN
work_dnaoa4trybfmvfskexkidzt764	56	16	a	a	DT
work_dnaoa4trybfmvfskexkidzt764	56	17	maternal	maternal	JJ
work_dnaoa4trybfmvfskexkidzt764	56	18	encephalopathy	encephalopathy	NN
work_dnaoa4trybfmvfskexkidzt764	56	19	with	with	IN
work_dnaoa4trybfmvfskexkidzt764	56	20	a	a	DT
work_dnaoa4trybfmvfskexkidzt764	56	21	high	high	JJ
work_dnaoa4trybfmvfskexkidzt764	56	22	blood	blood	NN
work_dnaoa4trybfmvfskexkidzt764	56	23	lead	lead	NN
work_dnaoa4trybfmvfskexkidzt764	56	24	concentration	concentration	NN
work_dnaoa4trybfmvfskexkidzt764	56	25	,	,	,
work_dnaoa4trybfmvfskexkidzt764	56	26	maternal	maternal	JJ
work_dnaoa4trybfmvfskexkidzt764	56	27	anaemia	anaemia	NN
work_dnaoa4trybfmvfskexkidzt764	56	28	with	with	IN
work_dnaoa4trybfmvfskexkidzt764	56	29	basophilic	basophilic	JJ
work_dnaoa4trybfmvfskexkidzt764	56	30	stip-	stip-	NNS
work_dnaoa4trybfmvfskexkidzt764	56	31	pling	pling	NN
work_dnaoa4trybfmvfskexkidzt764	56	32	,	,	,
work_dnaoa4trybfmvfskexkidzt764	56	33	and	and	CC
work_dnaoa4trybfmvfskexkidzt764	56	34	a	a	DT
work_dnaoa4trybfmvfskexkidzt764	56	35	high	high	JJ
work_dnaoa4trybfmvfskexkidzt764	56	36	cord	cord	NN
work_dnaoa4trybfmvfskexkidzt764	56	37	-	-	HYPH
work_dnaoa4trybfmvfskexkidzt764	56	38	blood	blood	NN
work_dnaoa4trybfmvfskexkidzt764	56	39	lead	lead	NN
work_dnaoa4trybfmvfskexkidzt764	56	40	concentration	concentration	NN
work_dnaoa4trybfmvfskexkidzt764	56	41	.	.	.
work_dnaoa4trybfmvfskexkidzt764	57	1	Infant	infant	NN
work_dnaoa4trybfmvfskexkidzt764	57	2	blood	blood	NN
work_dnaoa4trybfmvfskexkidzt764	57	3	lead	lead	NN
work_dnaoa4trybfmvfskexkidzt764	57	4	levels	level	NNS
work_dnaoa4trybfmvfskexkidzt764	57	5	of	of	IN
work_dnaoa4trybfmvfskexkidzt764	57	6	a	a	DT
work_dnaoa4trybfmvfskexkidzt764	57	7	third	third	NN
work_dnaoa4trybfmvfskexkidzt764	57	8	to	to	IN
work_dnaoa4trybfmvfskexkidzt764	57	9	a	a	DT
work_dnaoa4trybfmvfskexkidzt764	57	10	half	half	NN
work_dnaoa4trybfmvfskexkidzt764	57	11	the	the	DT
work_dnaoa4trybfmvfskexkidzt764	57	12	peak	peak	NN
work_dnaoa4trybfmvfskexkidzt764	57	13	level	level	NN
work_dnaoa4trybfmvfskexkidzt764	57	14	reported	report	VBN
work_dnaoa4trybfmvfskexkidzt764	57	15	here	here	RB
work_dnaoa4trybfmvfskexkidzt764	57	16	are	be	VBP
work_dnaoa4trybfmvfskexkidzt764	57	17	usually	usually	RB
work_dnaoa4trybfmvfskexkidzt764	57	18	associated	associate	VBN
work_dnaoa4trybfmvfskexkidzt764	57	19	with	with	IN
work_dnaoa4trybfmvfskexkidzt764	57	20	severe	severe	JJ
work_dnaoa4trybfmvfskexkidzt764	57	21	cerebral	cerebral	JJ
work_dnaoa4trybfmvfskexkidzt764	57	22	oedema	oedema	NNP
work_dnaoa4trybfmvfskexkidzt764	57	23	and	and	CC
work_dnaoa4trybfmvfskexkidzt764	57	24	death.2	death.2	JJR
work_dnaoa4trybfmvfskexkidzt764	57	25	In	in	IN
work_dnaoa4trybfmvfskexkidzt764	57	26	this	this	DT
work_dnaoa4trybfmvfskexkidzt764	57	27	instance	instance	NN
work_dnaoa4trybfmvfskexkidzt764	57	28	,	,	,
work_dnaoa4trybfmvfskexkidzt764	57	29	the	the	DT
work_dnaoa4trybfmvfskexkidzt764	57	30	infant	infant	NN
work_dnaoa4trybfmvfskexkidzt764	57	31	was	be	VBD
work_dnaoa4trybfmvfskexkidzt764	57	32	encephalopathic	encephalopathic	JJ
work_dnaoa4trybfmvfskexkidzt764	57	33	and	and	CC
work_dnaoa4trybfmvfskexkidzt764	57	34	profoundly	profoundly	RB
work_dnaoa4trybfmvfskexkidzt764	57	35	weak	weak	JJ
work_dnaoa4trybfmvfskexkidzt764	57	36	and	and	CC
work_dnaoa4trybfmvfskexkidzt764	57	37	had	have	VBD
work_dnaoa4trybfmvfskexkidzt764	57	38	diaphragmatic	diaphragmatic	JJ
work_dnaoa4trybfmvfskexkidzt764	57	39	palsy	palsy	NN
work_dnaoa4trybfmvfskexkidzt764	57	40	at	at	IN
work_dnaoa4trybfmvfskexkidzt764	57	41	birth	birth	NN
work_dnaoa4trybfmvfskexkidzt764	57	42	.	.	.
work_dnaoa4trybfmvfskexkidzt764	58	1	The	the	DT
work_dnaoa4trybfmvfskexkidzt764	58	2	limb	limb	NN
work_dnaoa4trybfmvfskexkidzt764	58	3	weakness	weakness	NN
work_dnaoa4trybfmvfskexkidzt764	58	4	clinically	clinically	RB
work_dnaoa4trybfmvfskexkidzt764	58	5	appeared	appear	VBD
work_dnaoa4trybfmvfskexkidzt764	58	6	to	to	TO
work_dnaoa4trybfmvfskexkidzt764	58	7	be	be	VB
work_dnaoa4trybfmvfskexkidzt764	58	8	predominantly	predominantly	RB
work_dnaoa4trybfmvfskexkidzt764	58	9	neuropathic	neuropathic	JJ
work_dnaoa4trybfmvfskexkidzt764	58	10	.	.	.
work_dnaoa4trybfmvfskexkidzt764	59	1	Several	several	JJ
work_dnaoa4trybfmvfskexkidzt764	59	2	electrophysiological	electrophysiological	JJ
work_dnaoa4trybfmvfskexkidzt764	59	3	attempts	attempt	NNS
work_dnaoa4trybfmvfskexkidzt764	59	4	to	to	TO
work_dnaoa4trybfmvfskexkidzt764	59	5	clarify	clarify	VB
work_dnaoa4trybfmvfskexkidzt764	59	6	2	2	CD
work_dnaoa4trybfmvfskexkidzt764	59	7	:	:	:
work_dnaoa4trybfmvfskexkidzt764	59	8	Infant	infant	NN
work_dnaoa4trybfmvfskexkidzt764	59	9	blood	blood	NN
work_dnaoa4trybfmvfskexkidzt764	59	10	and	and	CC
work_dnaoa4trybfmvfskexkidzt764	59	11	urinary	urinary	JJ
work_dnaoa4trybfmvfskexkidzt764	59	12	lead	lead	NN
work_dnaoa4trybfmvfskexkidzt764	59	13	concentrations	concentration	NNS
work_dnaoa4trybfmvfskexkidzt764	59	14	from	from	IN
work_dnaoa4trybfmvfskexkidzt764	59	15	birth	birth	NN
work_dnaoa4trybfmvfskexkidzt764	59	16	to	to	IN
work_dnaoa4trybfmvfskexkidzt764	59	17	14	14	CD
work_dnaoa4trybfmvfskexkidzt764	59	18	weeks	week	NNS
work_dnaoa4trybfmvfskexkidzt764	59	19	of	of	IN
work_dnaoa4trybfmvfskexkidzt764	59	20	age	age	NN
work_dnaoa4trybfmvfskexkidzt764	59	21	*	*	NFP
work_dnaoa4trybfmvfskexkidzt764	59	22	*	*	NFP
work_dnaoa4trybfmvfskexkidzt764	59	23	Horizontal	horizontal	JJ
work_dnaoa4trybfmvfskexkidzt764	59	24	lines	line	NNS
work_dnaoa4trybfmvfskexkidzt764	59	25	across	across	IN
work_dnaoa4trybfmvfskexkidzt764	59	26	top	top	NN
work_dnaoa4trybfmvfskexkidzt764	59	27	of	of	IN
work_dnaoa4trybfmvfskexkidzt764	59	28	graph	graph	NN
work_dnaoa4trybfmvfskexkidzt764	59	29	indicate	indicate	VBP
work_dnaoa4trybfmvfskexkidzt764	59	30	periods	period	NNS
work_dnaoa4trybfmvfskexkidzt764	59	31	of	of	IN
work_dnaoa4trybfmvfskexkidzt764	59	32	parenteral	parenteral	JJ
work_dnaoa4trybfmvfskexkidzt764	59	33	therapy	therapy	NN
work_dnaoa4trybfmvfskexkidzt764	59	34	with	with	IN
work_dnaoa4trybfmvfskexkidzt764	59	35	calcium	calcium	NN
work_dnaoa4trybfmvfskexkidzt764	59	36	disodium	disodium	NN
work_dnaoa4trybfmvfskexkidzt764	59	37	edetate	edetate	NN
work_dnaoa4trybfmvfskexkidzt764	59	38	and	and	CC
work_dnaoa4trybfmvfskexkidzt764	59	39	oral	oral	JJ
work_dnaoa4trybfmvfskexkidzt764	59	40	succimer	succimer	NN
work_dnaoa4trybfmvfskexkidzt764	59	41	.	.	.
work_dnaoa4trybfmvfskexkidzt764	60	1	Dotted	dotted	JJ
work_dnaoa4trybfmvfskexkidzt764	60	2	horizontal	horizontal	JJ
work_dnaoa4trybfmvfskexkidzt764	60	3	line	line	NN
work_dnaoa4trybfmvfskexkidzt764	60	4	shows	show	VBZ
work_dnaoa4trybfmvfskexkidzt764	60	5	National	National	NNP
work_dnaoa4trybfmvfskexkidzt764	60	6	Health	Health	NNP
work_dnaoa4trybfmvfskexkidzt764	60	7	and	and	CC
work_dnaoa4trybfmvfskexkidzt764	60	8	Medical	Medical	NNP
work_dnaoa4trybfmvfskexkidzt764	60	9	Research	Research	NNP
work_dnaoa4trybfmvfskexkidzt764	60	10	Council	Council	NNP
work_dnaoa4trybfmvfskexkidzt764	60	11	public	public	JJ
work_dnaoa4trybfmvfskexkidzt764	60	12	health	health	NN
work_dnaoa4trybfmvfskexkidzt764	60	13	goal	goal	NN
work_dnaoa4trybfmvfskexkidzt764	60	14	for	for	IN
work_dnaoa4trybfmvfskexkidzt764	60	15	maximum	maximum	JJ
work_dnaoa4trybfmvfskexkidzt764	60	16	lead	lead	JJ
work_dnaoa4trybfmvfskexkidzt764	60	17	concentration	concentration	NN
work_dnaoa4trybfmvfskexkidzt764	60	18	in	in	IN
work_dnaoa4trybfmvfskexkidzt764	60	19	blood	blood	NN
work_dnaoa4trybfmvfskexkidzt764	60	20	(	(	-LRB-
work_dnaoa4trybfmvfskexkidzt764	60	21	0.48	0.48	CD
work_dnaoa4trybfmvfskexkidzt764	60	22	�	�	NNP
work_dnaoa4trybfmvfskexkidzt764	60	23	mol	mol	NN
work_dnaoa4trybfmvfskexkidzt764	60	24	/	/	SYM
work_dnaoa4trybfmvfskexkidzt764	60	25	L	L	NNP
work_dnaoa4trybfmvfskexkidzt764	60	26	)	)	-RRB-
work_dnaoa4trybfmvfskexkidzt764	60	27	.	.	.
work_dnaoa4trybfmvfskexkidzt764	61	1	0	0	NFP
work_dnaoa4trybfmvfskexkidzt764	61	2	2	2	CD
work_dnaoa4trybfmvfskexkidzt764	61	3	4	4	CD
work_dnaoa4trybfmvfskexkidzt764	61	4	6	6	CD
work_dnaoa4trybfmvfskexkidzt764	61	5	8	8	CD
work_dnaoa4trybfmvfskexkidzt764	61	6	10	10	CD
work_dnaoa4trybfmvfskexkidzt764	61	7	12	12	CD
work_dnaoa4trybfmvfskexkidzt764	61	8	14	14	CD
work_dnaoa4trybfmvfskexkidzt764	61	9	988470564228140	988470564228140	CD
work_dnaoa4trybfmvfskexkidzt764	61	10	0	0	CD
work_dnaoa4trybfmvfskexkidzt764	61	11	10	10	CD
work_dnaoa4trybfmvfskexkidzt764	61	12	20	20	CD
work_dnaoa4trybfmvfskexkidzt764	61	13	30	30	CD
work_dnaoa4trybfmvfskexkidzt764	61	14	40	40	CD
work_dnaoa4trybfmvfskexkidzt764	61	15	50	50	CD
work_dnaoa4trybfmvfskexkidzt764	61	16	60	60	CD
work_dnaoa4trybfmvfskexkidzt764	61	17	B	b	NN
work_dnaoa4trybfmvfskexkidzt764	61	18	lo	lo	IN
work_dnaoa4trybfmvfskexkidzt764	61	19	o	o	NN
work_dnaoa4trybfmvfskexkidzt764	61	20	d	d	NNP
work_dnaoa4trybfmvfskexkidzt764	61	21	le	le	NNP
work_dnaoa4trybfmvfskexkidzt764	61	22	a	a	DT
work_dnaoa4trybfmvfskexkidzt764	61	23	d	d	NN
work_dnaoa4trybfmvfskexkidzt764	61	24	c	c	NNP
work_dnaoa4trybfmvfskexkidzt764	61	25	o	o	NN
work_dnaoa4trybfmvfskexkidzt764	61	26	n	n	NNP
work_dnaoa4trybfmvfskexkidzt764	61	27	ce	ce	CC
work_dnaoa4trybfmvfskexkidzt764	61	28	n	n	XX
work_dnaoa4trybfmvfskexkidzt764	61	29	tr	tr	IN
work_dnaoa4trybfmvfskexkidzt764	61	30	a	a	DT
work_dnaoa4trybfmvfskexkidzt764	61	31	tio	tio	NN
work_dnaoa4trybfmvfskexkidzt764	61	32	n	n	NN
work_dnaoa4trybfmvfskexkidzt764	61	33	(	(	-LRB-
work_dnaoa4trybfmvfskexkidzt764	61	34	�	�	NNP
work_dnaoa4trybfmvfskexkidzt764	61	35	m	m	NNP
work_dnaoa4trybfmvfskexkidzt764	61	36	o	o	NNP
work_dnaoa4trybfmvfskexkidzt764	61	37	l	l	NN
work_dnaoa4trybfmvfskexkidzt764	61	38	/	/	SYM
work_dnaoa4trybfmvfskexkidzt764	61	39	L	l	NN
work_dnaoa4trybfmvfskexkidzt764	61	40	)	)	-RRB-
work_dnaoa4trybfmvfskexkidzt764	61	41	U	u	NN
work_dnaoa4trybfmvfskexkidzt764	61	42	rin	rin	VBP
work_dnaoa4trybfmvfskexkidzt764	61	43	a	a	DT
work_dnaoa4trybfmvfskexkidzt764	61	44	ry	ry	NN
work_dnaoa4trybfmvfskexkidzt764	61	45	le	le	NNP
work_dnaoa4trybfmvfskexkidzt764	61	46	a	a	DT
work_dnaoa4trybfmvfskexkidzt764	61	47	d	d	NN
work_dnaoa4trybfmvfskexkidzt764	61	48	co	co	NN
work_dnaoa4trybfmvfskexkidzt764	61	49	n	n	CC
work_dnaoa4trybfmvfskexkidzt764	61	50	ce	ce	CC
work_dnaoa4trybfmvfskexkidzt764	61	51	n	n	CC
work_dnaoa4trybfmvfskexkidzt764	61	52	tra	tra	NN
work_dnaoa4trybfmvfskexkidzt764	61	53	tio	tio	NNP
work_dnaoa4trybfmvfskexkidzt764	61	54	n	n	NN
work_dnaoa4trybfmvfskexkidzt764	61	55	(	(	-LRB-
work_dnaoa4trybfmvfskexkidzt764	61	56	�	�	NNP
work_dnaoa4trybfmvfskexkidzt764	61	57	m	m	NNP
work_dnaoa4trybfmvfskexkidzt764	61	58	o	o	NNP
work_dnaoa4trybfmvfskexkidzt764	61	59	l	l	NN
work_dnaoa4trybfmvfskexkidzt764	61	60	/	/	SYM
work_dnaoa4trybfmvfskexkidzt764	61	61	L	l	NN
work_dnaoa4trybfmvfskexkidzt764	61	62	)	)	-RRB-
work_dnaoa4trybfmvfskexkidzt764	61	63	Postnatal	postnatal	JJ
work_dnaoa4trybfmvfskexkidzt764	61	64	age	age	NN
work_dnaoa4trybfmvfskexkidzt764	61	65	(	(	-LRB-
work_dnaoa4trybfmvfskexkidzt764	61	66	days	day	NNS
work_dnaoa4trybfmvfskexkidzt764	61	67	)	)	-RRB-
work_dnaoa4trybfmvfskexkidzt764	61	68	Parenteral	parenteral	JJ
work_dnaoa4trybfmvfskexkidzt764	61	69	therapy	therapy	NN
work_dnaoa4trybfmvfskexkidzt764	61	70	Oral	oral	JJ
work_dnaoa4trybfmvfskexkidzt764	61	71	succimer	succimer	NN
work_dnaoa4trybfmvfskexkidzt764	61	72	Blood	blood	NN
work_dnaoa4trybfmvfskexkidzt764	61	73	lead	lead	NN
work_dnaoa4trybfmvfskexkidzt764	61	74	concentration	concentration	NN
work_dnaoa4trybfmvfskexkidzt764	61	75	Urinary	Urinary	NNP
work_dnaoa4trybfmvfskexkidzt764	61	76	lead	lead	VB
work_dnaoa4trybfmvfskexkidzt764	61	77	concentration	concentration	NN
work_dnaoa4trybfmvfskexkidzt764	61	78	NHMRC	NHMRC	NNP
work_dnaoa4trybfmvfskexkidzt764	61	79	goal	goal	NN
work_dnaoa4trybfmvfskexkidzt764	61	80	3	3	CD
work_dnaoa4trybfmvfskexkidzt764	61	81	:	:	:
work_dnaoa4trybfmvfskexkidzt764	61	82	Metal	metal	NN
work_dnaoa4trybfmvfskexkidzt764	61	83	analysis	analysis	NN
work_dnaoa4trybfmvfskexkidzt764	61	84	of	of	IN
work_dnaoa4trybfmvfskexkidzt764	61	85	tablets	tablet	NNS
work_dnaoa4trybfmvfskexkidzt764	61	86	used	use	VBN
work_dnaoa4trybfmvfskexkidzt764	61	87	by	by	IN
work_dnaoa4trybfmvfskexkidzt764	61	88	the	the	DT
work_dnaoa4trybfmvfskexkidzt764	61	89	patient	patient	NN
work_dnaoa4trybfmvfskexkidzt764	61	90	*	*	NFP
work_dnaoa4trybfmvfskexkidzt764	61	91	Tablet	Tablet	NNP
work_dnaoa4trybfmvfskexkidzt764	61	92	colour	colour	NN
work_dnaoa4trybfmvfskexkidzt764	61	93	Lead	lead	NN
work_dnaoa4trybfmvfskexkidzt764	61	94	per	per	IN
work_dnaoa4trybfmvfskexkidzt764	61	95	tablet	tablet	NN
work_dnaoa4trybfmvfskexkidzt764	61	96	(	(	-LRB-
work_dnaoa4trybfmvfskexkidzt764	61	97	mg	mg	NNP
work_dnaoa4trybfmvfskexkidzt764	61	98	)	)	-RRB-
work_dnaoa4trybfmvfskexkidzt764	61	99	(	(	-LRB-
work_dnaoa4trybfmvfskexkidzt764	61	100	%	%	NN
work_dnaoa4trybfmvfskexkidzt764	61	101	)	)	-RRB-
work_dnaoa4trybfmvfskexkidzt764	61	102	Mercury	Mercury	NNP
work_dnaoa4trybfmvfskexkidzt764	61	103	per	per	IN
work_dnaoa4trybfmvfskexkidzt764	61	104	tablet	tablet	NN
work_dnaoa4trybfmvfskexkidzt764	61	105	(	(	-LRB-
work_dnaoa4trybfmvfskexkidzt764	61	106	�	�	NNP
work_dnaoa4trybfmvfskexkidzt764	61	107	g	g	NNP
work_dnaoa4trybfmvfskexkidzt764	61	108	)	)	-RRB-
work_dnaoa4trybfmvfskexkidzt764	61	109	(	(	-LRB-
work_dnaoa4trybfmvfskexkidzt764	61	110	%	%	NN
work_dnaoa4trybfmvfskexkidzt764	61	111	)	)	-RRB-
work_dnaoa4trybfmvfskexkidzt764	61	112	Brown	Brown	NNP
work_dnaoa4trybfmvfskexkidzt764	61	113	(	(	-LRB-
work_dnaoa4trybfmvfskexkidzt764	61	114	“	"	``
work_dnaoa4trybfmvfskexkidzt764	61	115	HSY-15	HSY-15	NNS
work_dnaoa4trybfmvfskexkidzt764	61	116	”	"	''
work_dnaoa4trybfmvfskexkidzt764	61	117	)	)	-RRB-
work_dnaoa4trybfmvfskexkidzt764	61	118	45	45	CD
work_dnaoa4trybfmvfskexkidzt764	61	119	(	(	-LRB-
work_dnaoa4trybfmvfskexkidzt764	61	120	8.9	8.9	CD
work_dnaoa4trybfmvfskexkidzt764	61	121	%	%	NN
work_dnaoa4trybfmvfskexkidzt764	61	122	)	)	-RRB-
work_dnaoa4trybfmvfskexkidzt764	61	123	15	15	CD
work_dnaoa4trybfmvfskexkidzt764	61	124	(	(	-LRB-
work_dnaoa4trybfmvfskexkidzt764	61	125	0.003	0.003	CD
work_dnaoa4trybfmvfskexkidzt764	61	126	%	%	NN
work_dnaoa4trybfmvfskexkidzt764	61	127	)	)	-RRB-
work_dnaoa4trybfmvfskexkidzt764	61	128	Red	Red	NNP
work_dnaoa4trybfmvfskexkidzt764	61	129	23	23	CD
work_dnaoa4trybfmvfskexkidzt764	61	130	(	(	-LRB-
work_dnaoa4trybfmvfskexkidzt764	61	131	4.5	4.5	CD
work_dnaoa4trybfmvfskexkidzt764	61	132	%	%	NN
work_dnaoa4trybfmvfskexkidzt764	61	133	)	)	-RRB-
work_dnaoa4trybfmvfskexkidzt764	61	134	NA	NA	NNP
work_dnaoa4trybfmvfskexkidzt764	61	135	Pink	pink	NN
work_dnaoa4trybfmvfskexkidzt764	61	136	1	1	CD
work_dnaoa4trybfmvfskexkidzt764	61	137	(	(	-LRB-
work_dnaoa4trybfmvfskexkidzt764	61	138	0.2	0.2	CD
work_dnaoa4trybfmvfskexkidzt764	61	139	%	%	NN
work_dnaoa4trybfmvfskexkidzt764	61	140	)	)	-RRB-
work_dnaoa4trybfmvfskexkidzt764	61	141	400	400	CD
work_dnaoa4trybfmvfskexkidzt764	61	142	(	(	-LRB-
work_dnaoa4trybfmvfskexkidzt764	61	143	0.08	0.08	CD
work_dnaoa4trybfmvfskexkidzt764	61	144	%	%	NN
work_dnaoa4trybfmvfskexkidzt764	61	145	)	)	-RRB-
work_dnaoa4trybfmvfskexkidzt764	61	146	Green	Green	NNP
work_dnaoa4trybfmvfskexkidzt764	61	147	2	2	CD
work_dnaoa4trybfmvfskexkidzt764	61	148	(	(	-LRB-
work_dnaoa4trybfmvfskexkidzt764	61	149	0.003	0.003	CD
work_dnaoa4trybfmvfskexkidzt764	61	150	%	%	NN
work_dnaoa4trybfmvfskexkidzt764	61	151	)	)	-RRB-
work_dnaoa4trybfmvfskexkidzt764	61	152	10	10	CD
work_dnaoa4trybfmvfskexkidzt764	61	153	(	(	-LRB-
work_dnaoa4trybfmvfskexkidzt764	61	154	0.002	0.002	CD
work_dnaoa4trybfmvfskexkidzt764	61	155	%	%	NN
work_dnaoa4trybfmvfskexkidzt764	61	156	)	)	-RRB-
work_dnaoa4trybfmvfskexkidzt764	61	157	*	*	NFP
work_dnaoa4trybfmvfskexkidzt764	61	158	Analysis	analysis	NN
work_dnaoa4trybfmvfskexkidzt764	61	159	by	by	IN
work_dnaoa4trybfmvfskexkidzt764	61	160	IMVS	IMVS	NNP
work_dnaoa4trybfmvfskexkidzt764	61	161	Laboratories	Laboratories	NNPS
work_dnaoa4trybfmvfskexkidzt764	61	162	,	,	,
work_dnaoa4trybfmvfskexkidzt764	61	163	Adelaide	Adelaide	NNP
work_dnaoa4trybfmvfskexkidzt764	61	164	.	.	.
work_dnaoa4trybfmvfskexkidzt764	62	1	NA	NA	NNP
work_dnaoa4trybfmvfskexkidzt764	62	2	=	=	SYM
work_dnaoa4trybfmvfskexkidzt764	62	3	not	not	RB
work_dnaoa4trybfmvfskexkidzt764	62	4	analysed	analyse	VBN
work_dnaoa4trybfmvfskexkidzt764	62	5	.	.	.
work_dnaoa4trybfmvfskexkidzt764	63	1	1	1	LS
work_dnaoa4trybfmvfskexkidzt764	63	2	:	:	:
work_dnaoa4trybfmvfskexkidzt764	63	3	Mother	mother	NN
work_dnaoa4trybfmvfskexkidzt764	63	4	’s	’s	POS
work_dnaoa4trybfmvfskexkidzt764	63	5	blood	blood	NN
work_dnaoa4trybfmvfskexkidzt764	63	6	film	film	NN
work_dnaoa4trybfmvfskexkidzt764	63	7	just	just	RB
work_dnaoa4trybfmvfskexkidzt764	63	8	before	before	IN
work_dnaoa4trybfmvfskexkidzt764	63	9	parturition	parturition	NN
work_dnaoa4trybfmvfskexkidzt764	63	10	,	,	,
work_dnaoa4trybfmvfskexkidzt764	63	11	showing	show	VBG
work_dnaoa4trybfmvfskexkidzt764	63	12	basophilic	basophilic	JJ
work_dnaoa4trybfmvfskexkidzt764	63	13	stippling	stippling	NN
work_dnaoa4trybfmvfskexkidzt764	63	14	of	of	IN
work_dnaoa4trybfmvfskexkidzt764	63	15	red	red	JJ
work_dnaoa4trybfmvfskexkidzt764	63	16	cells	cell	NNS
work_dnaoa4trybfmvfskexkidzt764	63	17	MJA	MJA	NNP
work_dnaoa4trybfmvfskexkidzt764	63	18	Vol	Vol	NNP
work_dnaoa4trybfmvfskexkidzt764	63	19	177	177	CD
work_dnaoa4trybfmvfskexkidzt764	63	20	19	19	CD
work_dnaoa4trybfmvfskexkidzt764	63	21	August	August	NNP
work_dnaoa4trybfmvfskexkidzt764	63	22	2002	2002	CD
work_dnaoa4trybfmvfskexkidzt764	63	23	195	195	CD
work_dnaoa4trybfmvfskexkidzt764	63	24	NOTABLE	NOTABLE	NNP
work_dnaoa4trybfmvfskexkidzt764	63	25	CASES	cases	VB
work_dnaoa4trybfmvfskexkidzt764	63	26	the	the	DT
work_dnaoa4trybfmvfskexkidzt764	63	27	presence	presence	NN
work_dnaoa4trybfmvfskexkidzt764	63	28	of	of	IN
work_dnaoa4trybfmvfskexkidzt764	63	29	either	either	CC
work_dnaoa4trybfmvfskexkidzt764	63	30	a	a	DT
work_dnaoa4trybfmvfskexkidzt764	63	31	neuropathy	neuropathy	NN
work_dnaoa4trybfmvfskexkidzt764	63	32	or	or	CC
work_dnaoa4trybfmvfskexkidzt764	63	33	a	a	DT
work_dnaoa4trybfmvfskexkidzt764	63	34	myopathy	myopathy	NN
work_dnaoa4trybfmvfskexkidzt764	63	35	failed	fail	VBN
work_dnaoa4trybfmvfskexkidzt764	63	36	owing	owing	NN
work_dnaoa4trybfmvfskexkidzt764	63	37	to	to	IN
work_dnaoa4trybfmvfskexkidzt764	63	38	technical	technical	JJ
work_dnaoa4trybfmvfskexkidzt764	63	39	and	and	CC
work_dnaoa4trybfmvfskexkidzt764	63	40	interpretive	interpretive	JJ
work_dnaoa4trybfmvfskexkidzt764	63	41	difficulties	difficulty	NNS
work_dnaoa4trybfmvfskexkidzt764	63	42	.	.	.
work_dnaoa4trybfmvfskexkidzt764	64	1	Although	although	IN
work_dnaoa4trybfmvfskexkidzt764	64	2	lead	lead	NN
work_dnaoa4trybfmvfskexkidzt764	64	3	-	-	HYPH
work_dnaoa4trybfmvfskexkidzt764	64	4	induced	induce	VBN
work_dnaoa4trybfmvfskexkidzt764	64	5	peripheral	peripheral	JJ
work_dnaoa4trybfmvfskexkidzt764	64	6	neuropathy	neuropathy	NN
work_dnaoa4trybfmvfskexkidzt764	64	7	is	be	VBZ
work_dnaoa4trybfmvfskexkidzt764	64	8	well	well	RB
work_dnaoa4trybfmvfskexkidzt764	64	9	described,9	described,9	NNP
work_dnaoa4trybfmvfskexkidzt764	64	10	dia-	dia-	CC
work_dnaoa4trybfmvfskexkidzt764	64	11	phragmatic	phragmatic	JJ
work_dnaoa4trybfmvfskexkidzt764	64	12	palsy	palsy	NN
work_dnaoa4trybfmvfskexkidzt764	64	13	is	be	VBZ
work_dnaoa4trybfmvfskexkidzt764	64	14	unreported	unreported	JJ
work_dnaoa4trybfmvfskexkidzt764	64	15	.	.	.
work_dnaoa4trybfmvfskexkidzt764	65	1	There	there	EX
work_dnaoa4trybfmvfskexkidzt764	65	2	was	be	VBD
work_dnaoa4trybfmvfskexkidzt764	65	3	no	no	DT
work_dnaoa4trybfmvfskexkidzt764	65	4	evidence	evidence	NN
work_dnaoa4trybfmvfskexkidzt764	65	5	of	of	IN
work_dnaoa4trybfmvfskexkidzt764	65	6	renal	renal	JJ
work_dnaoa4trybfmvfskexkidzt764	65	7	involvement	involvement	NN
work_dnaoa4trybfmvfskexkidzt764	65	8	or	or	CC
work_dnaoa4trybfmvfskexkidzt764	65	9	proteinuria	proteinuria	NN
work_dnaoa4trybfmvfskexkidzt764	65	10	,	,	,
work_dnaoa4trybfmvfskexkidzt764	65	11	possibly	possibly	RB
work_dnaoa4trybfmvfskexkidzt764	65	12	due	due	IN
work_dnaoa4trybfmvfskexkidzt764	65	13	to	to	IN
work_dnaoa4trybfmvfskexkidzt764	65	14	the	the	DT
work_dnaoa4trybfmvfskexkidzt764	65	15	infant	infant	NN
work_dnaoa4trybfmvfskexkidzt764	65	16	’s	’s	POS
work_dnaoa4trybfmvfskexkidzt764	65	17	renal	renal	JJ
work_dnaoa4trybfmvfskexkidzt764	65	18	immaturity	immaturity	NN
work_dnaoa4trybfmvfskexkidzt764	65	19	.	.	.
work_dnaoa4trybfmvfskexkidzt764	66	1	There	there	EX
work_dnaoa4trybfmvfskexkidzt764	66	2	was	be	VBD
work_dnaoa4trybfmvfskexkidzt764	66	3	no	no	DT
work_dnaoa4trybfmvfskexkidzt764	66	4	basophilic	basophilic	JJ
work_dnaoa4trybfmvfskexkidzt764	66	5	stippling	stippling	NN
work_dnaoa4trybfmvfskexkidzt764	66	6	in	in	IN
work_dnaoa4trybfmvfskexkidzt764	66	7	any	any	DT
work_dnaoa4trybfmvfskexkidzt764	66	8	neonatal	neonatal	JJ
work_dnaoa4trybfmvfskexkidzt764	66	9	blood	blood	NN
work_dnaoa4trybfmvfskexkidzt764	66	10	film	film	NN
work_dnaoa4trybfmvfskexkidzt764	66	11	.	.	.
work_dnaoa4trybfmvfskexkidzt764	67	1	This	this	DT
work_dnaoa4trybfmvfskexkidzt764	67	2	relative	relative	JJ
work_dnaoa4trybfmvfskexkidzt764	67	3	paradox	paradox	NN
work_dnaoa4trybfmvfskexkidzt764	67	4	—	—	:
work_dnaoa4trybfmvfskexkidzt764	67	5	the	the	DT
work_dnaoa4trybfmvfskexkidzt764	67	6	absence	absence	NN
work_dnaoa4trybfmvfskexkidzt764	67	7	of	of	IN
work_dnaoa4trybfmvfskexkidzt764	67	8	basophilic	basophilic	NN
work_dnaoa4trybfmvfskexkidzt764	67	9	stippling	stipple	VBG
work_dnaoa4trybfmvfskexkidzt764	67	10	despite	despite	IN
work_dnaoa4trybfmvfskexkidzt764	67	11	lead	lead	JJ
work_dnaoa4trybfmvfskexkidzt764	67	12	intoxication	intoxication	NN
work_dnaoa4trybfmvfskexkidzt764	67	13	—	—	:
work_dnaoa4trybfmvfskexkidzt764	67	14	has	have	VBZ
work_dnaoa4trybfmvfskexkidzt764	67	15	been	be	VBN
work_dnaoa4trybfmvfskexkidzt764	67	16	noted	note	VBN
work_dnaoa4trybfmvfskexkidzt764	67	17	previously.10	previously.10	NNP
work_dnaoa4trybfmvfskexkidzt764	67	18	The	the	DT
work_dnaoa4trybfmvfskexkidzt764	67	19	unilateral	unilateral	JJ
work_dnaoa4trybfmvfskexkidzt764	67	20	sensorineural	sensorineural	JJ
work_dnaoa4trybfmvfskexkidzt764	67	21	deafness	deafness	NN
work_dnaoa4trybfmvfskexkidzt764	67	22	is	be	VBZ
work_dnaoa4trybfmvfskexkidzt764	67	23	likely	likely	JJ
work_dnaoa4trybfmvfskexkidzt764	67	24	to	to	TO
work_dnaoa4trybfmvfskexkidzt764	67	25	be	be	VB
work_dnaoa4trybfmvfskexkidzt764	67	26	due	due	JJ
work_dnaoa4trybfmvfskexkidzt764	67	27	to	to	TO
work_dnaoa4trybfmvfskexkidzt764	67	28	lead	lead	VB
work_dnaoa4trybfmvfskexkidzt764	67	29	toxicity.11	toxicity.11	NNP
work_dnaoa4trybfmvfskexkidzt764	67	30	Previous	previous	JJ
work_dnaoa4trybfmvfskexkidzt764	67	31	reports	report	NNS
work_dnaoa4trybfmvfskexkidzt764	67	32	of	of	IN
work_dnaoa4trybfmvfskexkidzt764	67	33	congenital	congenital	JJ
work_dnaoa4trybfmvfskexkidzt764	67	34	lead	lead	NN
work_dnaoa4trybfmvfskexkidzt764	67	35	intoxication	intoxication	NN
work_dnaoa4trybfmvfskexkidzt764	67	36	indicate	indicate	VBP
work_dnaoa4trybfmvfskexkidzt764	67	37	that	that	IN
work_dnaoa4trybfmvfskexkidzt764	67	38	maternal	maternal	JJ
work_dnaoa4trybfmvfskexkidzt764	67	39	and	and	CC
work_dnaoa4trybfmvfskexkidzt764	67	40	cord	cord	NN
work_dnaoa4trybfmvfskexkidzt764	67	41	blood	blood	NN
work_dnaoa4trybfmvfskexkidzt764	67	42	lead	lead	NN
work_dnaoa4trybfmvfskexkidzt764	67	43	levels	level	NNS
work_dnaoa4trybfmvfskexkidzt764	67	44	correlate.12	correlate.12	NNP
work_dnaoa4trybfmvfskexkidzt764	67	45	The	the	DT
work_dnaoa4trybfmvfskexkidzt764	67	46	marked	marked	JJ
work_dnaoa4trybfmvfskexkidzt764	67	47	discrepancy	discrepancy	NN
work_dnaoa4trybfmvfskexkidzt764	67	48	in	in	IN
work_dnaoa4trybfmvfskexkidzt764	67	49	this	this	DT
work_dnaoa4trybfmvfskexkidzt764	67	50	case	case	NN
work_dnaoa4trybfmvfskexkidzt764	67	51	(	(	-LRB-
work_dnaoa4trybfmvfskexkidzt764	67	52	2.3	2.3	CD
work_dnaoa4trybfmvfskexkidzt764	67	53	�	�	NNP
work_dnaoa4trybfmvfskexkidzt764	67	54	mol	mol	NN
work_dnaoa4trybfmvfskexkidzt764	67	55	/	/	SYM
work_dnaoa4trybfmvfskexkidzt764	67	56	L	L	NNP
work_dnaoa4trybfmvfskexkidzt764	67	57	[	[	-LRB-
work_dnaoa4trybfmvfskexkidzt764	67	58	mother	mother	NN
work_dnaoa4trybfmvfskexkidzt764	67	59	]	]	-RRB-
work_dnaoa4trybfmvfskexkidzt764	67	60	v	v	NNP
work_dnaoa4trybfmvfskexkidzt764	67	61	7.6	7.6	CD
work_dnaoa4trybfmvfskexkidzt764	67	62	�	�	NNP
work_dnaoa4trybfmvfskexkidzt764	67	63	mol	mol	NN
work_dnaoa4trybfmvfskexkidzt764	67	64	/	/	SYM
work_dnaoa4trybfmvfskexkidzt764	67	65	L	L	NNP
work_dnaoa4trybfmvfskexkidzt764	67	66	[	[	-LRB-
work_dnaoa4trybfmvfskexkidzt764	67	67	cord	cord	NN
work_dnaoa4trybfmvfskexkidzt764	67	68	]	]	-RRB-
work_dnaoa4trybfmvfskexkidzt764	67	69	)	)	-RRB-
work_dnaoa4trybfmvfskexkidzt764	67	70	could	could	MD
work_dnaoa4trybfmvfskexkidzt764	67	71	be	be	VB
work_dnaoa4trybfmvfskexkidzt764	67	72	due	due	IN
work_dnaoa4trybfmvfskexkidzt764	67	73	to	to	IN
work_dnaoa4trybfmvfskexkidzt764	67	74	the	the	DT
work_dnaoa4trybfmvfskexkidzt764	67	75	possibility	possibility	NN
work_dnaoa4trybfmvfskexkidzt764	67	76	that	that	IN
work_dnaoa4trybfmvfskexkidzt764	67	77	at	at	IN
work_dnaoa4trybfmvfskexkidzt764	67	78	high	high	JJ
work_dnaoa4trybfmvfskexkidzt764	67	79	maternal	maternal	JJ
work_dnaoa4trybfmvfskexkidzt764	67	80	blood	blood	NN
work_dnaoa4trybfmvfskexkidzt764	67	81	lead	lead	NN
work_dnaoa4trybfmvfskexkidzt764	67	82	concentrations	concentration	NNS
work_dnaoa4trybfmvfskexkidzt764	67	83	the	the	DT
work_dnaoa4trybfmvfskexkidzt764	67	84	lead	lead	NN
work_dnaoa4trybfmvfskexkidzt764	67	85	-	-	HYPH
work_dnaoa4trybfmvfskexkidzt764	67	86	binding	bind	VBG
work_dnaoa4trybfmvfskexkidzt764	67	87	capacity	capacity	NN
work_dnaoa4trybfmvfskexkidzt764	67	88	of	of	IN
work_dnaoa4trybfmvfskexkidzt764	67	89	the	the	DT
work_dnaoa4trybfmvfskexkidzt764	67	90	erythrocytes	erythrocyte	NNS
work_dnaoa4trybfmvfskexkidzt764	67	91	becomes	become	VBZ
work_dnaoa4trybfmvfskexkidzt764	67	92	saturated13	saturated13	FW
work_dnaoa4trybfmvfskexkidzt764	67	93	and	and	CC
work_dnaoa4trybfmvfskexkidzt764	67	94	more	more	JJR
work_dnaoa4trybfmvfskexkidzt764	67	95	lead	lead	NN
work_dnaoa4trybfmvfskexkidzt764	67	96	is	be	VBZ
work_dnaoa4trybfmvfskexkidzt764	67	97	available	available	JJ
work_dnaoa4trybfmvfskexkidzt764	67	98	for	for	IN
work_dnaoa4trybfmvfskexkidzt764	67	99	transfer	transfer	NN
work_dnaoa4trybfmvfskexkidzt764	67	100	to	to	IN
work_dnaoa4trybfmvfskexkidzt764	67	101	the	the	DT
work_dnaoa4trybfmvfskexkidzt764	67	102	fetus	fetus	NN
work_dnaoa4trybfmvfskexkidzt764	67	103	.	.	.
work_dnaoa4trybfmvfskexkidzt764	68	1	Alternatively	alternatively	RB
work_dnaoa4trybfmvfskexkidzt764	68	2	,	,	,
work_dnaoa4trybfmvfskexkidzt764	68	3	the	the	DT
work_dnaoa4trybfmvfskexkidzt764	68	4	discrepancy	discrepancy	NN
work_dnaoa4trybfmvfskexkidzt764	68	5	could	could	MD
work_dnaoa4trybfmvfskexkidzt764	68	6	be	be	VB
work_dnaoa4trybfmvfskexkidzt764	68	7	due	due	IN
work_dnaoa4trybfmvfskexkidzt764	68	8	to	to	IN
work_dnaoa4trybfmvfskexkidzt764	68	9	in	in	IN
work_dnaoa4trybfmvfskexkidzt764	68	10	-	-	HYPH
work_dnaoa4trybfmvfskexkidzt764	68	11	utero	utero	NN
work_dnaoa4trybfmvfskexkidzt764	68	12	mobilisation	mobilisation	NN
work_dnaoa4trybfmvfskexkidzt764	68	13	of	of	IN
work_dnaoa4trybfmvfskexkidzt764	68	14	lead	lead	NN
work_dnaoa4trybfmvfskexkidzt764	68	15	from	from	IN
work_dnaoa4trybfmvfskexkidzt764	68	16	fetal	fetal	JJ
work_dnaoa4trybfmvfskexkidzt764	68	17	tissues	tissue	NNS
work_dnaoa4trybfmvfskexkidzt764	68	18	without	without	IN
work_dnaoa4trybfmvfskexkidzt764	68	19	adequate	adequate	JJ
work_dnaoa4trybfmvfskexkidzt764	68	20	maternal	maternal	JJ
work_dnaoa4trybfmvfskexkidzt764	68	21	clearance	clearance	NN
work_dnaoa4trybfmvfskexkidzt764	68	22	.	.	.
work_dnaoa4trybfmvfskexkidzt764	69	1	This	this	DT
work_dnaoa4trybfmvfskexkidzt764	69	2	latter	latter	JJ
work_dnaoa4trybfmvfskexkidzt764	69	3	consideration	consideration	NN
work_dnaoa4trybfmvfskexkidzt764	69	4	indicates	indicate	VBZ
work_dnaoa4trybfmvfskexkidzt764	69	5	a	a	DT
work_dnaoa4trybfmvfskexkidzt764	69	6	potential	potential	JJ
work_dnaoa4trybfmvfskexkidzt764	69	7	detrimental	detrimental	JJ
work_dnaoa4trybfmvfskexkidzt764	69	8	effect	effect	NN
work_dnaoa4trybfmvfskexkidzt764	69	9	on	on	IN
work_dnaoa4trybfmvfskexkidzt764	69	10	the	the	DT
work_dnaoa4trybfmvfskexkidzt764	69	11	fetus	fetus	NN
work_dnaoa4trybfmvfskexkidzt764	69	12	of	of	IN
work_dnaoa4trybfmvfskexkidzt764	69	13	chelation	chelation	NN
work_dnaoa4trybfmvfskexkidzt764	69	14	therapy	therapy	NN
work_dnaoa4trybfmvfskexkidzt764	69	15	in	in	IN
work_dnaoa4trybfmvfskexkidzt764	69	16	pregnancy	pregnancy	NN
work_dnaoa4trybfmvfskexkidzt764	69	17	.	.	.
work_dnaoa4trybfmvfskexkidzt764	70	1	As	as	IN
work_dnaoa4trybfmvfskexkidzt764	70	2	chelating	chelating	JJ
work_dnaoa4trybfmvfskexkidzt764	70	3	agents	agent	NNS
work_dnaoa4trybfmvfskexkidzt764	70	4	bind	bind	VBP
work_dnaoa4trybfmvfskexkidzt764	70	5	lead	lead	VBP
work_dnaoa4trybfmvfskexkidzt764	70	6	into	into	IN
work_dnaoa4trybfmvfskexkidzt764	70	7	complexes	complex	NNS
work_dnaoa4trybfmvfskexkidzt764	70	8	that	that	WDT
work_dnaoa4trybfmvfskexkidzt764	70	9	are	be	VBP
work_dnaoa4trybfmvfskexkidzt764	70	10	cleared	clear	VBN
work_dnaoa4trybfmvfskexkidzt764	70	11	by	by	IN
work_dnaoa4trybfmvfskexkidzt764	70	12	the	the	DT
work_dnaoa4trybfmvfskexkidzt764	70	13	kidneys	kidney	NNS
work_dnaoa4trybfmvfskexkidzt764	70	14	,	,	,
work_dnaoa4trybfmvfskexkidzt764	70	15	an	an	DT
work_dnaoa4trybfmvfskexkidzt764	70	16	increase	increase	NN
work_dnaoa4trybfmvfskexkidzt764	70	17	in	in	IN
work_dnaoa4trybfmvfskexkidzt764	70	18	urinary	urinary	JJ
work_dnaoa4trybfmvfskexkidzt764	70	19	lead	lead	NN
work_dnaoa4trybfmvfskexkidzt764	70	20	concen-	concen-	NNP
work_dnaoa4trybfmvfskexkidzt764	70	21	tration	tration	NN
work_dnaoa4trybfmvfskexkidzt764	70	22	was	be	VBD
work_dnaoa4trybfmvfskexkidzt764	70	23	expected	expect	VBN
work_dnaoa4trybfmvfskexkidzt764	70	24	after	after	IN
work_dnaoa4trybfmvfskexkidzt764	70	25	administration	administration	NN
work_dnaoa4trybfmvfskexkidzt764	70	26	of	of	IN
work_dnaoa4trybfmvfskexkidzt764	70	27	each	each	DT
work_dnaoa4trybfmvfskexkidzt764	70	28	of	of	IN
work_dnaoa4trybfmvfskexkidzt764	70	29	the	the	DT
work_dnaoa4trybfmvfskexkidzt764	70	30	chelating	chelating	JJ
work_dnaoa4trybfmvfskexkidzt764	70	31	agents	agent	NNS
work_dnaoa4trybfmvfskexkidzt764	70	32	.	.	.
work_dnaoa4trybfmvfskexkidzt764	71	1	This	this	DT
work_dnaoa4trybfmvfskexkidzt764	71	2	phenomenon	phenomenon	NN
work_dnaoa4trybfmvfskexkidzt764	71	3	was	be	VBD
work_dnaoa4trybfmvfskexkidzt764	71	4	consistently	consistently	RB
work_dnaoa4trybfmvfskexkidzt764	71	5	observed	observe	VBN
work_dnaoa4trybfmvfskexkidzt764	71	6	after	after	IN
work_dnaoa4trybfmvfskexkidzt764	71	7	courses	course	NNS
work_dnaoa4trybfmvfskexkidzt764	71	8	of	of	IN
work_dnaoa4trybfmvfskexkidzt764	71	9	dimercaprol	dimercaprol	NN
work_dnaoa4trybfmvfskexkidzt764	71	10	and	and	CC
work_dnaoa4trybfmvfskexkidzt764	71	11	CaNa2EDTA	cana2edta	NN
work_dnaoa4trybfmvfskexkidzt764	71	12	.	.	.
work_dnaoa4trybfmvfskexkidzt764	72	1	However	however	RB
work_dnaoa4trybfmvfskexkidzt764	72	2	,	,	,
work_dnaoa4trybfmvfskexkidzt764	72	3	variable	variable	JJ
work_dnaoa4trybfmvfskexkidzt764	72	4	doses	dose	NNS
work_dnaoa4trybfmvfskexkidzt764	72	5	of	of	IN
work_dnaoa4trybfmvfskexkidzt764	72	6	oral	oral	JJ
work_dnaoa4trybfmvfskexkidzt764	72	7	succimer	succimer	NN
work_dnaoa4trybfmvfskexkidzt764	72	8	during	during	IN
work_dnaoa4trybfmvfskexkidzt764	72	9	the	the	DT
work_dnaoa4trybfmvfskexkidzt764	72	10	preterm	preterm	NNP
work_dnaoa4trybfmvfskexkidzt764	72	11	period	period	NN
work_dnaoa4trybfmvfskexkidzt764	72	12	did	do	VBD
work_dnaoa4trybfmvfskexkidzt764	72	13	not	not	RB
work_dnaoa4trybfmvfskexkidzt764	72	14	lead	lead	VB
work_dnaoa4trybfmvfskexkidzt764	72	15	to	to	IN
work_dnaoa4trybfmvfskexkidzt764	72	16	corresponding	corresponding	JJ
work_dnaoa4trybfmvfskexkidzt764	72	17	increases	increase	NNS
work_dnaoa4trybfmvfskexkidzt764	72	18	in	in	IN
work_dnaoa4trybfmvfskexkidzt764	72	19	urinary	urinary	JJ
work_dnaoa4trybfmvfskexkidzt764	72	20	lead	lead	NN
work_dnaoa4trybfmvfskexkidzt764	72	21	concentration	concentration	NN
work_dnaoa4trybfmvfskexkidzt764	72	22	,	,	,
work_dnaoa4trybfmvfskexkidzt764	72	23	despite	despite	IN
work_dnaoa4trybfmvfskexkidzt764	72	24	raising	raise	VBG
work_dnaoa4trybfmvfskexkidzt764	72	25	the	the	DT
work_dnaoa4trybfmvfskexkidzt764	72	26	dose	dose	NN
work_dnaoa4trybfmvfskexkidzt764	72	27	to	to	IN
work_dnaoa4trybfmvfskexkidzt764	72	28	a	a	DT
work_dnaoa4trybfmvfskexkidzt764	72	29	level	level	NN
work_dnaoa4trybfmvfskexkidzt764	72	30	higher	high	JJR
work_dnaoa4trybfmvfskexkidzt764	72	31	than	than	IN
work_dnaoa4trybfmvfskexkidzt764	72	32	those	those	DT
work_dnaoa4trybfmvfskexkidzt764	72	33	recommended	recommend	VBN
work_dnaoa4trybfmvfskexkidzt764	72	34	in	in	IN
work_dnaoa4trybfmvfskexkidzt764	72	35	the	the	DT
work_dnaoa4trybfmvfskexkidzt764	72	36	literature.5	literature.5	CD
work_dnaoa4trybfmvfskexkidzt764	72	37	-	-	SYM
work_dnaoa4trybfmvfskexkidzt764	72	38	7	7	CD
work_dnaoa4trybfmvfskexkidzt764	72	39	Only	only	RB
work_dnaoa4trybfmvfskexkidzt764	72	40	when	when	WRB
work_dnaoa4trybfmvfskexkidzt764	72	41	oral	oral	JJ
work_dnaoa4trybfmvfskexkidzt764	72	42	succimer	succimer	NN
work_dnaoa4trybfmvfskexkidzt764	72	43	was	be	VBD
work_dnaoa4trybfmvfskexkidzt764	72	44	recommenced	recommence	VBN
work_dnaoa4trybfmvfskexkidzt764	72	45	at	at	IN
work_dnaoa4trybfmvfskexkidzt764	72	46	three	three	CD
work_dnaoa4trybfmvfskexkidzt764	72	47	months	month	NNS
work_dnaoa4trybfmvfskexkidzt764	72	48	’	'	''
work_dnaoa4trybfmvfskexkidzt764	72	49	corrected	correct	VBN
work_dnaoa4trybfmvfskexkidzt764	72	50	age	age	NN
work_dnaoa4trybfmvfskexkidzt764	72	51	did	do	VBD
work_dnaoa4trybfmvfskexkidzt764	72	52	the	the	DT
work_dnaoa4trybfmvfskexkidzt764	72	53	predicted	predict	VBN
work_dnaoa4trybfmvfskexkidzt764	72	54	response	response	NN
work_dnaoa4trybfmvfskexkidzt764	72	55	occur	occur	VB
work_dnaoa4trybfmvfskexkidzt764	72	56	.	.	.
work_dnaoa4trybfmvfskexkidzt764	73	1	This	this	DT
work_dnaoa4trybfmvfskexkidzt764	73	2	apparent	apparent	JJ
work_dnaoa4trybfmvfskexkidzt764	73	3	early	early	JJ
work_dnaoa4trybfmvfskexkidzt764	73	4	ineffectiveness	ineffectiveness	NN
work_dnaoa4trybfmvfskexkidzt764	73	5	of	of	IN
work_dnaoa4trybfmvfskexkidzt764	73	6	succimer	succimer	NN
work_dnaoa4trybfmvfskexkidzt764	73	7	could	could	MD
work_dnaoa4trybfmvfskexkidzt764	73	8	be	be	VB
work_dnaoa4trybfmvfskexkidzt764	73	9	due	due	IN
work_dnaoa4trybfmvfskexkidzt764	73	10	to	to	IN
work_dnaoa4trybfmvfskexkidzt764	73	11	absorptive	absorptive	JJ
work_dnaoa4trybfmvfskexkidzt764	73	12	failure	failure	NN
work_dnaoa4trybfmvfskexkidzt764	73	13	from	from	IN
work_dnaoa4trybfmvfskexkidzt764	73	14	the	the	DT
work_dnaoa4trybfmvfskexkidzt764	73	15	infant	infant	NN
work_dnaoa4trybfmvfskexkidzt764	73	16	’s	’s	POS
work_dnaoa4trybfmvfskexkidzt764	73	17	immature	immature	JJ
work_dnaoa4trybfmvfskexkidzt764	73	18	gut	gut	NN
work_dnaoa4trybfmvfskexkidzt764	73	19	.	.	.
work_dnaoa4trybfmvfskexkidzt764	74	1	Furthermore	furthermore	RB
work_dnaoa4trybfmvfskexkidzt764	74	2	,	,	,
work_dnaoa4trybfmvfskexkidzt764	74	3	succi-	succi-	JJ
work_dnaoa4trybfmvfskexkidzt764	74	4	mer	mer	NNP
work_dnaoa4trybfmvfskexkidzt764	74	5	is	be	VBZ
work_dnaoa4trybfmvfskexkidzt764	74	6	a	a	DT
work_dnaoa4trybfmvfskexkidzt764	74	7	prodrug	prodrug	NN
work_dnaoa4trybfmvfskexkidzt764	74	8	that	that	WDT
work_dnaoa4trybfmvfskexkidzt764	74	9	requires	require	VBZ
work_dnaoa4trybfmvfskexkidzt764	74	10	cysteine	cysteine	NN
work_dnaoa4trybfmvfskexkidzt764	74	11	for	for	IN
work_dnaoa4trybfmvfskexkidzt764	74	12	activation.2	activation.2	NNP
work_dnaoa4trybfmvfskexkidzt764	74	13	It	-PRON-	PRP
work_dnaoa4trybfmvfskexkidzt764	74	14	is	be	VBZ
work_dnaoa4trybfmvfskexkidzt764	74	15	unclear	unclear	JJ
work_dnaoa4trybfmvfskexkidzt764	74	16	whether	whether	IN
work_dnaoa4trybfmvfskexkidzt764	74	17	or	or	CC
work_dnaoa4trybfmvfskexkidzt764	74	18	not	not	RB
work_dnaoa4trybfmvfskexkidzt764	74	19	this	this	DT
work_dnaoa4trybfmvfskexkidzt764	74	20	enzymatic	enzymatic	JJ
work_dnaoa4trybfmvfskexkidzt764	74	21	activation	activation	NN
work_dnaoa4trybfmvfskexkidzt764	74	22	process	process	NN
work_dnaoa4trybfmvfskexkidzt764	74	23	is	be	VBZ
work_dnaoa4trybfmvfskexkidzt764	74	24	mature	mature	JJ
work_dnaoa4trybfmvfskexkidzt764	74	25	in	in	IN
work_dnaoa4trybfmvfskexkidzt764	74	26	the	the	DT
work_dnaoa4trybfmvfskexkidzt764	74	27	premature	premature	JJ
work_dnaoa4trybfmvfskexkidzt764	74	28	infant	infant	NN
work_dnaoa4trybfmvfskexkidzt764	74	29	.	.	.
work_dnaoa4trybfmvfskexkidzt764	75	1	Public	public	JJ
work_dnaoa4trybfmvfskexkidzt764	75	2	health	health	NN
work_dnaoa4trybfmvfskexkidzt764	75	3	considerations	consideration	NNS
work_dnaoa4trybfmvfskexkidzt764	75	4	While	while	IN
work_dnaoa4trybfmvfskexkidzt764	75	5	lead	lead	NN
work_dnaoa4trybfmvfskexkidzt764	75	6	was	be	VBD
work_dnaoa4trybfmvfskexkidzt764	75	7	the	the	DT
work_dnaoa4trybfmvfskexkidzt764	75	8	principal	principal	JJ
work_dnaoa4trybfmvfskexkidzt764	75	9	concern	concern	NN
work_dnaoa4trybfmvfskexkidzt764	75	10	in	in	IN
work_dnaoa4trybfmvfskexkidzt764	75	11	this	this	DT
work_dnaoa4trybfmvfskexkidzt764	75	12	case	case	NN
work_dnaoa4trybfmvfskexkidzt764	75	13	,	,	,
work_dnaoa4trybfmvfskexkidzt764	75	14	mercury	mercury	NNP
work_dnaoa4trybfmvfskexkidzt764	75	15	was	be	VBD
work_dnaoa4trybfmvfskexkidzt764	75	16	also	also	RB
work_dnaoa4trybfmvfskexkidzt764	75	17	detected	detect	VBN
work_dnaoa4trybfmvfskexkidzt764	75	18	in	in	IN
work_dnaoa4trybfmvfskexkidzt764	75	19	some	some	DT
work_dnaoa4trybfmvfskexkidzt764	75	20	of	of	IN
work_dnaoa4trybfmvfskexkidzt764	75	21	the	the	DT
work_dnaoa4trybfmvfskexkidzt764	75	22	tablets	tablet	NNS
work_dnaoa4trybfmvfskexkidzt764	75	23	(	(	-LRB-
work_dnaoa4trybfmvfskexkidzt764	75	24	Box	Box	NNP
work_dnaoa4trybfmvfskexkidzt764	75	25	3	3	CD
work_dnaoa4trybfmvfskexkidzt764	75	26	)	)	-RRB-
work_dnaoa4trybfmvfskexkidzt764	75	27	.	.	.
work_dnaoa4trybfmvfskexkidzt764	76	1	Weekly	weekly	JJ
work_dnaoa4trybfmvfskexkidzt764	76	2	ingestion	ingestion	NN
work_dnaoa4trybfmvfskexkidzt764	76	3	of	of	IN
work_dnaoa4trybfmvfskexkidzt764	76	4	one	one	CD
work_dnaoa4trybfmvfskexkidzt764	76	5	of	of	IN
work_dnaoa4trybfmvfskexkidzt764	76	6	the	the	DT
work_dnaoa4trybfmvfskexkidzt764	76	7	tablets	tablet	NNS
work_dnaoa4trybfmvfskexkidzt764	76	8	containing	contain	VBG
work_dnaoa4trybfmvfskexkidzt764	76	9	400	400	CD
work_dnaoa4trybfmvfskexkidzt764	76	10	�	�	NNP
work_dnaoa4trybfmvfskexkidzt764	76	11	g	g	NN
work_dnaoa4trybfmvfskexkidzt764	76	12	would	would	MD
work_dnaoa4trybfmvfskexkidzt764	76	13	exceed	exceed	VB
work_dnaoa4trybfmvfskexkidzt764	76	14	the	the	DT
work_dnaoa4trybfmvfskexkidzt764	76	15	Australian	australian	JJ
work_dnaoa4trybfmvfskexkidzt764	76	16	average	average	JJ
work_dnaoa4trybfmvfskexkidzt764	76	17	weekly	weekly	JJ
work_dnaoa4trybfmvfskexkidzt764	76	18	mercury	mercury	NN
work_dnaoa4trybfmvfskexkidzt764	76	19	intake	intake	NNP
work_dnaoa4trybfmvfskexkidzt764	76	20	by	by	IN
work_dnaoa4trybfmvfskexkidzt764	76	21	at	at	IN
work_dnaoa4trybfmvfskexkidzt764	76	22	least	least	JJS
work_dnaoa4trybfmvfskexkidzt764	76	23	fourfold.8	fourfold.8	NN
work_dnaoa4trybfmvfskexkidzt764	76	24	Mercury	Mercury	NNP
work_dnaoa4trybfmvfskexkidzt764	76	25	poisoning	poisoning	NN
work_dnaoa4trybfmvfskexkidzt764	76	26	was	be	VBD
work_dnaoa4trybfmvfskexkidzt764	76	27	of	of	IN
work_dnaoa4trybfmvfskexkidzt764	76	28	secondary	secondary	JJ
work_dnaoa4trybfmvfskexkidzt764	76	29	con-	con-	NN
work_dnaoa4trybfmvfskexkidzt764	76	30	cern	cern	NN
work_dnaoa4trybfmvfskexkidzt764	76	31	in	in	IN
work_dnaoa4trybfmvfskexkidzt764	76	32	the	the	DT
work_dnaoa4trybfmvfskexkidzt764	76	33	current	current	JJ
work_dnaoa4trybfmvfskexkidzt764	76	34	circumstance	circumstance	NN
work_dnaoa4trybfmvfskexkidzt764	76	35	,	,	,
work_dnaoa4trybfmvfskexkidzt764	76	36	and	and	CC
work_dnaoa4trybfmvfskexkidzt764	76	37	chelation	chelation	NN
work_dnaoa4trybfmvfskexkidzt764	76	38	therapy	therapy	NN
work_dnaoa4trybfmvfskexkidzt764	76	39	was	be	VBD
work_dnaoa4trybfmvfskexkidzt764	76	40	expected	expect	VBN
work_dnaoa4trybfmvfskexkidzt764	76	41	to	to	TO
work_dnaoa4trybfmvfskexkidzt764	76	42	remove	remove	VB
work_dnaoa4trybfmvfskexkidzt764	76	43	the	the	DT
work_dnaoa4trybfmvfskexkidzt764	76	44	mercury	mercury	NN
work_dnaoa4trybfmvfskexkidzt764	76	45	along	along	IN
work_dnaoa4trybfmvfskexkidzt764	76	46	with	with	IN
work_dnaoa4trybfmvfskexkidzt764	76	47	the	the	DT
work_dnaoa4trybfmvfskexkidzt764	76	48	lead	lead	NN
work_dnaoa4trybfmvfskexkidzt764	76	49	.	.	.
work_dnaoa4trybfmvfskexkidzt764	77	1	This	this	DT
work_dnaoa4trybfmvfskexkidzt764	77	2	does	do	VBZ
work_dnaoa4trybfmvfskexkidzt764	77	3	,	,	,
work_dnaoa4trybfmvfskexkidzt764	77	4	however	however	RB
work_dnaoa4trybfmvfskexkidzt764	77	5	,	,	,
work_dnaoa4trybfmvfskexkidzt764	77	6	illustrate	illustrate	VBP
work_dnaoa4trybfmvfskexkidzt764	77	7	that	that	IN
work_dnaoa4trybfmvfskexkidzt764	77	8	herbal	herbal	JJ
work_dnaoa4trybfmvfskexkidzt764	77	9	medicines	medicine	NNS
work_dnaoa4trybfmvfskexkidzt764	77	10	may	may	MD
work_dnaoa4trybfmvfskexkidzt764	77	11	contain	contain	VB
work_dnaoa4trybfmvfskexkidzt764	77	12	more	more	JJR
work_dnaoa4trybfmvfskexkidzt764	77	13	than	than	IN
work_dnaoa4trybfmvfskexkidzt764	77	14	one	one	CD
work_dnaoa4trybfmvfskexkidzt764	77	15	potentially	potentially	RB
work_dnaoa4trybfmvfskexkidzt764	77	16	toxic	toxic	JJ
work_dnaoa4trybfmvfskexkidzt764	77	17	component	component	NN
work_dnaoa4trybfmvfskexkidzt764	77	18	.	.	.
work_dnaoa4trybfmvfskexkidzt764	78	1	In	in	IN
work_dnaoa4trybfmvfskexkidzt764	78	2	many	many	JJ
work_dnaoa4trybfmvfskexkidzt764	78	3	countries	country	NNS
work_dnaoa4trybfmvfskexkidzt764	78	4	,	,	,
work_dnaoa4trybfmvfskexkidzt764	78	5	including	include	VBG
work_dnaoa4trybfmvfskexkidzt764	78	6	Australia	Australia	NNP
work_dnaoa4trybfmvfskexkidzt764	78	7	,	,	,
work_dnaoa4trybfmvfskexkidzt764	78	8	it	-PRON-	PRP
work_dnaoa4trybfmvfskexkidzt764	78	9	is	be	VBZ
work_dnaoa4trybfmvfskexkidzt764	78	10	legal	legal	JJ
work_dnaoa4trybfmvfskexkidzt764	78	11	to	to	TO
work_dnaoa4trybfmvfskexkidzt764	78	12	import	import	VB
work_dnaoa4trybfmvfskexkidzt764	78	13	herbal	herbal	JJ
work_dnaoa4trybfmvfskexkidzt764	78	14	remedies	remedy	NNS
work_dnaoa4trybfmvfskexkidzt764	78	15	for	for	IN
work_dnaoa4trybfmvfskexkidzt764	78	16	personal	personal	JJ
work_dnaoa4trybfmvfskexkidzt764	78	17	use	use	NN
work_dnaoa4trybfmvfskexkidzt764	78	18	,	,	,
work_dnaoa4trybfmvfskexkidzt764	78	19	although	although	IN
work_dnaoa4trybfmvfskexkidzt764	78	20	some	some	DT
work_dnaoa4trybfmvfskexkidzt764	78	21	restrictions	restriction	NNS
work_dnaoa4trybfmvfskexkidzt764	78	22	apply.14	apply.14	NNP
work_dnaoa4trybfmvfskexkidzt764	78	23	In	in	IN
work_dnaoa4trybfmvfskexkidzt764	78	24	addition	addition	NN
work_dnaoa4trybfmvfskexkidzt764	78	25	,	,	,
work_dnaoa4trybfmvfskexkidzt764	78	26	testing	testing	NN
work_dnaoa4trybfmvfskexkidzt764	78	27	programs	program	NNS
work_dnaoa4trybfmvfskexkidzt764	78	28	for	for	IN
work_dnaoa4trybfmvfskexkidzt764	78	29	con-	con-	NN
work_dnaoa4trybfmvfskexkidzt764	78	30	taminants	taminant	NNS
work_dnaoa4trybfmvfskexkidzt764	78	31	in	in	IN
work_dnaoa4trybfmvfskexkidzt764	78	32	herbal	herbal	JJ
work_dnaoa4trybfmvfskexkidzt764	78	33	remedies	remedy	NNS
work_dnaoa4trybfmvfskexkidzt764	78	34	are	be	VBP
work_dnaoa4trybfmvfskexkidzt764	78	35	virtually	virtually	RB
work_dnaoa4trybfmvfskexkidzt764	78	36	non	non	JJ
work_dnaoa4trybfmvfskexkidzt764	78	37	-	-	JJ
work_dnaoa4trybfmvfskexkidzt764	78	38	existent	existent	NN
work_dnaoa4trybfmvfskexkidzt764	78	39	.	.	.
work_dnaoa4trybfmvfskexkidzt764	79	1	Acute	acute	JJ
work_dnaoa4trybfmvfskexkidzt764	79	2	lead	lead	NN
work_dnaoa4trybfmvfskexkidzt764	79	3	poisoning	poisoning	NN
work_dnaoa4trybfmvfskexkidzt764	79	4	has	have	VBZ
work_dnaoa4trybfmvfskexkidzt764	79	5	been	be	VBN
work_dnaoa4trybfmvfskexkidzt764	79	6	reported	report	VBN
work_dnaoa4trybfmvfskexkidzt764	79	7	from	from	IN
work_dnaoa4trybfmvfskexkidzt764	79	8	traditional	traditional	JJ
work_dnaoa4trybfmvfskexkidzt764	79	9	and	and	CC
work_dnaoa4trybfmvfskexkidzt764	79	10	herbal	herbal	JJ
work_dnaoa4trybfmvfskexkidzt764	79	11	medicines	medicine	NNS
work_dnaoa4trybfmvfskexkidzt764	79	12	and	and	CC
work_dnaoa4trybfmvfskexkidzt764	79	13	cosmetics	cosmetic	NNS
work_dnaoa4trybfmvfskexkidzt764	79	14	obtained	obtain	VBN
work_dnaoa4trybfmvfskexkidzt764	79	15	from	from	IN
work_dnaoa4trybfmvfskexkidzt764	79	16	India,15	India,15	NNP
work_dnaoa4trybfmvfskexkidzt764	79	17	-	-	:
work_dnaoa4trybfmvfskexkidzt764	79	18	17	17	CD
work_dnaoa4trybfmvfskexkidzt764	79	19	the	the	DT
work_dnaoa4trybfmvfskexkidzt764	79	20	Middle	Middle	NNP
work_dnaoa4trybfmvfskexkidzt764	79	21	East,18	East,18	NNP
work_dnaoa4trybfmvfskexkidzt764	79	22	-	-	SYM
work_dnaoa4trybfmvfskexkidzt764	79	23	19	19	CD
work_dnaoa4trybfmvfskexkidzt764	79	24	Mexico20	Mexico20	NNP
work_dnaoa4trybfmvfskexkidzt764	79	25	and	and	CC
work_dnaoa4trybfmvfskexkidzt764	79	26	Asia.20	Asia.20	NNP
work_dnaoa4trybfmvfskexkidzt764	79	27	-	-	HYPH
work_dnaoa4trybfmvfskexkidzt764	79	28	21	21	CD
work_dnaoa4trybfmvfskexkidzt764	79	29	This	this	DT
work_dnaoa4trybfmvfskexkidzt764	79	30	should	should	MD
work_dnaoa4trybfmvfskexkidzt764	79	31	be	be	VB
work_dnaoa4trybfmvfskexkidzt764	79	32	a	a	DT
work_dnaoa4trybfmvfskexkidzt764	79	33	matter	matter	NN
work_dnaoa4trybfmvfskexkidzt764	79	34	of	of	IN
work_dnaoa4trybfmvfskexkidzt764	79	35	grave	grave	JJ
work_dnaoa4trybfmvfskexkidzt764	79	36	concern	concern	NN
work_dnaoa4trybfmvfskexkidzt764	79	37	to	to	IN
work_dnaoa4trybfmvfskexkidzt764	79	38	patients	patient	NNS
work_dnaoa4trybfmvfskexkidzt764	79	39	who	who	WP
work_dnaoa4trybfmvfskexkidzt764	79	40	take	take	VBP
work_dnaoa4trybfmvfskexkidzt764	79	41	such	such	JJ
work_dnaoa4trybfmvfskexkidzt764	79	42	remedies	remedy	NNS
work_dnaoa4trybfmvfskexkidzt764	79	43	,	,	,
work_dnaoa4trybfmvfskexkidzt764	79	44	and	and	CC
work_dnaoa4trybfmvfskexkidzt764	79	45	to	to	IN
work_dnaoa4trybfmvfskexkidzt764	79	46	health	health	NN
work_dnaoa4trybfmvfskexkidzt764	79	47	professionals	professional	NNS
work_dnaoa4trybfmvfskexkidzt764	79	48	and	and	CC
work_dnaoa4trybfmvfskexkidzt764	79	49	health	health	NN
work_dnaoa4trybfmvfskexkidzt764	79	50	authorities	authority	NNS
work_dnaoa4trybfmvfskexkidzt764	79	51	in	in	IN
work_dnaoa4trybfmvfskexkidzt764	79	52	these	these	DT
work_dnaoa4trybfmvfskexkidzt764	79	53	countries	country	NNS
work_dnaoa4trybfmvfskexkidzt764	79	54	and	and	CC
work_dnaoa4trybfmvfskexkidzt764	79	55	in	in	IN
work_dnaoa4trybfmvfskexkidzt764	79	56	Australia	Australia	NNP
work_dnaoa4trybfmvfskexkidzt764	79	57	.	.	.
work_dnaoa4trybfmvfskexkidzt764	80	1	Acknowledgements	acknowledgement	NNS
work_dnaoa4trybfmvfskexkidzt764	80	2	The	the	DT
work_dnaoa4trybfmvfskexkidzt764	80	3	authors	author	NNS
work_dnaoa4trybfmvfskexkidzt764	80	4	gratefully	gratefully	RB
work_dnaoa4trybfmvfskexkidzt764	80	5	acknowledge	acknowledge	VBP
work_dnaoa4trybfmvfskexkidzt764	80	6	Dr	Dr	NNP
work_dnaoa4trybfmvfskexkidzt764	80	7	Stephen	Stephen	NNP
work_dnaoa4trybfmvfskexkidzt764	80	8	Rothenberg	Rothenberg	NNP
work_dnaoa4trybfmvfskexkidzt764	80	9	,	,	,
work_dnaoa4trybfmvfskexkidzt764	80	10	of	of	IN
work_dnaoa4trybfmvfskexkidzt764	80	11	Charles	Charles	NNP
work_dnaoa4trybfmvfskexkidzt764	80	12	Drew	Drew	NNP
work_dnaoa4trybfmvfskexkidzt764	80	13	Univer-	Univer-	NNP
work_dnaoa4trybfmvfskexkidzt764	80	14	sity	sity	NN
work_dnaoa4trybfmvfskexkidzt764	80	15	,	,	,
work_dnaoa4trybfmvfskexkidzt764	80	16	Los	Los	NNP
work_dnaoa4trybfmvfskexkidzt764	80	17	Angeles	Angeles	NNP
work_dnaoa4trybfmvfskexkidzt764	80	18	,	,	,
work_dnaoa4trybfmvfskexkidzt764	80	19	for	for	IN
work_dnaoa4trybfmvfskexkidzt764	80	20	discussion	discussion	NN
work_dnaoa4trybfmvfskexkidzt764	80	21	of	of	IN
work_dnaoa4trybfmvfskexkidzt764	80	22	fetal	fetal	JJ
work_dnaoa4trybfmvfskexkidzt764	80	23	and	and	CC
work_dnaoa4trybfmvfskexkidzt764	80	24	maternal	maternal	JJ
work_dnaoa4trybfmvfskexkidzt764	80	25	blood	blood	NN
work_dnaoa4trybfmvfskexkidzt764	80	26	lead	lead	NN
work_dnaoa4trybfmvfskexkidzt764	80	27	levels	level	NNS
work_dnaoa4trybfmvfskexkidzt764	80	28	;	;	:
work_dnaoa4trybfmvfskexkidzt764	80	29	Mike	Mike	NNP
work_dnaoa4trybfmvfskexkidzt764	80	30	Stevenson	Stevenson	NNP
work_dnaoa4trybfmvfskexkidzt764	80	31	,	,	,
work_dnaoa4trybfmvfskexkidzt764	80	32	of	of	IN
work_dnaoa4trybfmvfskexkidzt764	80	33	Berri	Berri	NNP
work_dnaoa4trybfmvfskexkidzt764	80	34	/	/	SYM
work_dnaoa4trybfmvfskexkidzt764	80	35	Barmera	Barmera	NNP
work_dnaoa4trybfmvfskexkidzt764	80	36	Council	Council	NNP
work_dnaoa4trybfmvfskexkidzt764	80	37	,	,	,
work_dnaoa4trybfmvfskexkidzt764	80	38	for	for	IN
work_dnaoa4trybfmvfskexkidzt764	80	39	the	the	DT
work_dnaoa4trybfmvfskexkidzt764	80	40	environmental	environmental	JJ
work_dnaoa4trybfmvfskexkidzt764	80	41	audit	audit	NN
work_dnaoa4trybfmvfskexkidzt764	80	42	;	;	:
work_dnaoa4trybfmvfskexkidzt764	80	43	Sam	Sam	NNP
work_dnaoa4trybfmvfskexkidzt764	80	44	Mangas	Mangas	NNP
work_dnaoa4trybfmvfskexkidzt764	80	45	,	,	,
work_dnaoa4trybfmvfskexkidzt764	80	46	for	for	IN
work_dnaoa4trybfmvfskexkidzt764	80	47	assistance	assistance	NN
work_dnaoa4trybfmvfskexkidzt764	80	48	with	with	IN
work_dnaoa4trybfmvfskexkidzt764	80	49	the	the	DT
work_dnaoa4trybfmvfskexkidzt764	80	50	source	source	NN
work_dnaoa4trybfmvfskexkidzt764	80	51	investigation	investigation	NN
work_dnaoa4trybfmvfskexkidzt764	80	52	;	;	:
work_dnaoa4trybfmvfskexkidzt764	80	53	and	and	CC
work_dnaoa4trybfmvfskexkidzt764	80	54	Bill	Bill	NNP
work_dnaoa4trybfmvfskexkidzt764	80	55	Dollman	Dollman	NNP
work_dnaoa4trybfmvfskexkidzt764	80	56	and	and	CC
work_dnaoa4trybfmvfskexkidzt764	80	57	Dr	Dr	NNP
work_dnaoa4trybfmvfskexkidzt764	80	58	Brian	Brian	NNP
work_dnaoa4trybfmvfskexkidzt764	80	59	Priestly	Priestly	NNP
work_dnaoa4trybfmvfskexkidzt764	80	60	,	,	,
work_dnaoa4trybfmvfskexkidzt764	80	61	for	for	IN
work_dnaoa4trybfmvfskexkidzt764	80	62	discussions	discussion	NNS
work_dnaoa4trybfmvfskexkidzt764	80	63	on	on	IN
work_dnaoa4trybfmvfskexkidzt764	80	64	the	the	DT
work_dnaoa4trybfmvfskexkidzt764	80	65	regulation	regulation	NN
work_dnaoa4trybfmvfskexkidzt764	80	66	of	of	IN
work_dnaoa4trybfmvfskexkidzt764	80	67	herbal	herbal	JJ
work_dnaoa4trybfmvfskexkidzt764	80	68	remedies	remedy	NNS
work_dnaoa4trybfmvfskexkidzt764	80	69	in	in	IN
work_dnaoa4trybfmvfskexkidzt764	80	70	Australia	Australia	NNP
work_dnaoa4trybfmvfskexkidzt764	80	71	.	.	.
work_dnaoa4trybfmvfskexkidzt764	81	1	Competing	compete	VBG
work_dnaoa4trybfmvfskexkidzt764	81	2	interests	interest	NNS
work_dnaoa4trybfmvfskexkidzt764	81	3	None	none	NN
work_dnaoa4trybfmvfskexkidzt764	81	4	identified	identify	VBD
work_dnaoa4trybfmvfskexkidzt764	81	5	.	.	.
work_dnaoa4trybfmvfskexkidzt764	82	1	References	reference	NNS
work_dnaoa4trybfmvfskexkidzt764	82	2	1	1	CD
work_dnaoa4trybfmvfskexkidzt764	82	3	.	.	.
work_dnaoa4trybfmvfskexkidzt764	83	1	Fuhrman	Fuhrman	NNP
work_dnaoa4trybfmvfskexkidzt764	83	2	BP	BP	NNP
work_dnaoa4trybfmvfskexkidzt764	83	3	.	.	.
work_dnaoa4trybfmvfskexkidzt764	84	1	The	the	DT
work_dnaoa4trybfmvfskexkidzt764	84	2	acutely	acutely	RB
work_dnaoa4trybfmvfskexkidzt764	84	3	ill	ill	JJ
work_dnaoa4trybfmvfskexkidzt764	84	4	child	child	NN
work_dnaoa4trybfmvfskexkidzt764	84	5	.	.	.
work_dnaoa4trybfmvfskexkidzt764	85	1	In	in	IN
work_dnaoa4trybfmvfskexkidzt764	85	2	:	:	:
work_dnaoa4trybfmvfskexkidzt764	85	3	Nelson	Nelson	NNP
work_dnaoa4trybfmvfskexkidzt764	85	4	’s	’s	POS
work_dnaoa4trybfmvfskexkidzt764	85	5	essentials	essential	NNS
work_dnaoa4trybfmvfskexkidzt764	85	6	of	of	IN
work_dnaoa4trybfmvfskexkidzt764	85	7	paediatrics	paediatric	NNS
work_dnaoa4trybfmvfskexkidzt764	85	8	.	.	.
work_dnaoa4trybfmvfskexkidzt764	86	1	2nd	2nd	NNP
work_dnaoa4trybfmvfskexkidzt764	86	2	ed	ed	NNP
work_dnaoa4trybfmvfskexkidzt764	86	3	.	.	.
work_dnaoa4trybfmvfskexkidzt764	87	1	Philadelphia	Philadelphia	NNP
work_dnaoa4trybfmvfskexkidzt764	87	2	:	:	:
work_dnaoa4trybfmvfskexkidzt764	87	3	WB	WB	NNP
work_dnaoa4trybfmvfskexkidzt764	87	4	Saunders	Saunders	NNPS
work_dnaoa4trybfmvfskexkidzt764	87	5	,	,	,
work_dnaoa4trybfmvfskexkidzt764	87	6	1994	1994	CD
work_dnaoa4trybfmvfskexkidzt764	87	7	:	:	:
work_dnaoa4trybfmvfskexkidzt764	87	8	91	91	CD
work_dnaoa4trybfmvfskexkidzt764	87	9	-	-	HYPH
work_dnaoa4trybfmvfskexkidzt764	87	10	122	122	CD
work_dnaoa4trybfmvfskexkidzt764	87	11	.	.	.
work_dnaoa4trybfmvfskexkidzt764	88	1	2	2	LS
work_dnaoa4trybfmvfskexkidzt764	88	2	.	.	.
work_dnaoa4trybfmvfskexkidzt764	89	1	Klaassen	Klaassen	NNP
work_dnaoa4trybfmvfskexkidzt764	89	2	CD	CD	NNP
work_dnaoa4trybfmvfskexkidzt764	89	3	.	.	.
work_dnaoa4trybfmvfskexkidzt764	90	1	Heavy	heavy	JJ
work_dnaoa4trybfmvfskexkidzt764	90	2	metals	metal	NNS
work_dnaoa4trybfmvfskexkidzt764	90	3	and	and	CC
work_dnaoa4trybfmvfskexkidzt764	90	4	heavy	heavy	JJ
work_dnaoa4trybfmvfskexkidzt764	90	5	-	-	HYPH
work_dnaoa4trybfmvfskexkidzt764	90	6	metal	metal	NN
work_dnaoa4trybfmvfskexkidzt764	90	7	antagonists	antagonist	NNS
work_dnaoa4trybfmvfskexkidzt764	90	8	.	.	.
work_dnaoa4trybfmvfskexkidzt764	91	1	In	in	IN
work_dnaoa4trybfmvfskexkidzt764	91	2	:	:	:
work_dnaoa4trybfmvfskexkidzt764	91	3	Goodman	Goodman	NNP
work_dnaoa4trybfmvfskexkidzt764	91	4	and	and	CC
work_dnaoa4trybfmvfskexkidzt764	91	5	Gilman	Gilman	NNP
work_dnaoa4trybfmvfskexkidzt764	91	6	’s	’s	,
work_dnaoa4trybfmvfskexkidzt764	91	7	The	the	DT
work_dnaoa4trybfmvfskexkidzt764	91	8	pharmacological	pharmacological	JJ
work_dnaoa4trybfmvfskexkidzt764	91	9	basis	basis	NN
work_dnaoa4trybfmvfskexkidzt764	91	10	of	of	IN
work_dnaoa4trybfmvfskexkidzt764	91	11	therapeutics	therapeutic	NNS
work_dnaoa4trybfmvfskexkidzt764	91	12	.	.	.
work_dnaoa4trybfmvfskexkidzt764	92	1	10th	10th	JJ
work_dnaoa4trybfmvfskexkidzt764	92	2	ed	ed	NNP
work_dnaoa4trybfmvfskexkidzt764	92	3	.	.	.
work_dnaoa4trybfmvfskexkidzt764	93	1	New	New	NNP
work_dnaoa4trybfmvfskexkidzt764	93	2	York	York	NNP
work_dnaoa4trybfmvfskexkidzt764	93	3	:	:	:
work_dnaoa4trybfmvfskexkidzt764	93	4	McGraw	McGraw	NNP
work_dnaoa4trybfmvfskexkidzt764	93	5	Hill	Hill	NNP
work_dnaoa4trybfmvfskexkidzt764	93	6	,	,	,
work_dnaoa4trybfmvfskexkidzt764	93	7	2001	2001	CD
work_dnaoa4trybfmvfskexkidzt764	93	8	:	:	:
work_dnaoa4trybfmvfskexkidzt764	93	9	1851	1851	CD
work_dnaoa4trybfmvfskexkidzt764	93	10	-	-	SYM
work_dnaoa4trybfmvfskexkidzt764	93	11	1875	1875	CD
work_dnaoa4trybfmvfskexkidzt764	93	12	.	.	.
work_dnaoa4trybfmvfskexkidzt764	94	1	3	3	LS
work_dnaoa4trybfmvfskexkidzt764	94	2	.	.	.
work_dnaoa4trybfmvfskexkidzt764	95	1	Statement	statement	NN
work_dnaoa4trybfmvfskexkidzt764	95	2	issued	issue	VBN
work_dnaoa4trybfmvfskexkidzt764	95	3	by	by	IN
work_dnaoa4trybfmvfskexkidzt764	95	4	115th	115th	JJ
work_dnaoa4trybfmvfskexkidzt764	95	5	session	session	NN
work_dnaoa4trybfmvfskexkidzt764	95	6	of	of	IN
work_dnaoa4trybfmvfskexkidzt764	95	7	the	the	DT
work_dnaoa4trybfmvfskexkidzt764	95	8	National	National	NNP
work_dnaoa4trybfmvfskexkidzt764	95	9	Health	Health	NNP
work_dnaoa4trybfmvfskexkidzt764	95	10	and	and	CC
work_dnaoa4trybfmvfskexkidzt764	95	11	Medical	Medical	NNP
work_dnaoa4trybfmvfskexkidzt764	95	12	Research	Research	NNP
work_dnaoa4trybfmvfskexkidzt764	95	13	Council	Council	NNP
work_dnaoa4trybfmvfskexkidzt764	95	14	,	,	,
work_dnaoa4trybfmvfskexkidzt764	95	15	2	2	CD
work_dnaoa4trybfmvfskexkidzt764	95	16	June	June	NNP
work_dnaoa4trybfmvfskexkidzt764	95	17	1993	1993	CD
work_dnaoa4trybfmvfskexkidzt764	95	18	.	.	.
work_dnaoa4trybfmvfskexkidzt764	96	1	Revision	revision	NN
work_dnaoa4trybfmvfskexkidzt764	96	2	of	of	IN
work_dnaoa4trybfmvfskexkidzt764	96	3	the	the	DT
work_dnaoa4trybfmvfskexkidzt764	96	4	Australian	australian	JJ
work_dnaoa4trybfmvfskexkidzt764	96	5	guidelines	guideline	NNS
work_dnaoa4trybfmvfskexkidzt764	96	6	for	for	IN
work_dnaoa4trybfmvfskexkidzt764	96	7	lead	lead	NN
work_dnaoa4trybfmvfskexkidzt764	96	8	in	in	IN
work_dnaoa4trybfmvfskexkidzt764	96	9	blood	blood	NN
work_dnaoa4trybfmvfskexkidzt764	96	10	and	and	CC
work_dnaoa4trybfmvfskexkidzt764	96	11	lead	lead	NN
work_dnaoa4trybfmvfskexkidzt764	96	12	in	in	IN
work_dnaoa4trybfmvfskexkidzt764	96	13	ambient	ambient	JJ
work_dnaoa4trybfmvfskexkidzt764	96	14	air	air	NN
work_dnaoa4trybfmvfskexkidzt764	96	15	.	.	.
work_dnaoa4trybfmvfskexkidzt764	97	1	Available	available	JJ
work_dnaoa4trybfmvfskexkidzt764	97	2	at	at	IN
work_dnaoa4trybfmvfskexkidzt764	97	3	:	:	:
work_dnaoa4trybfmvfskexkidzt764	97	4	<	<	XX
work_dnaoa4trybfmvfskexkidzt764	97	5	http://www.health.gov.au/nhmrc/publications/	http://www.health.gov.au/nhmrc/publications/	NNP
work_dnaoa4trybfmvfskexkidzt764	97	6	pdf/115th.pdf	pdf/115th.pdf	NNP
work_dnaoa4trybfmvfskexkidzt764	97	7	>	>	XX
work_dnaoa4trybfmvfskexkidzt764	97	8	,	,	,
work_dnaoa4trybfmvfskexkidzt764	97	9	pp	pp	NNP
work_dnaoa4trybfmvfskexkidzt764	97	10	15	15	CD
work_dnaoa4trybfmvfskexkidzt764	97	11	-	-	SYM
work_dnaoa4trybfmvfskexkidzt764	97	12	20	20	CD
work_dnaoa4trybfmvfskexkidzt764	97	13	.	.	.
work_dnaoa4trybfmvfskexkidzt764	98	1	Accessed	access	VBN
work_dnaoa4trybfmvfskexkidzt764	98	2	4	4	CD
work_dnaoa4trybfmvfskexkidzt764	98	3	July	July	NNP
work_dnaoa4trybfmvfskexkidzt764	98	4	2002	2002	CD
work_dnaoa4trybfmvfskexkidzt764	98	5	.	.	.
work_dnaoa4trybfmvfskexkidzt764	99	1	4	4	LS
work_dnaoa4trybfmvfskexkidzt764	99	2	.	.	.
work_dnaoa4trybfmvfskexkidzt764	100	1	Parfitt	Parfitt	NNP
work_dnaoa4trybfmvfskexkidzt764	100	2	K	K	NNP
work_dnaoa4trybfmvfskexkidzt764	100	3	,	,	,
work_dnaoa4trybfmvfskexkidzt764	100	4	editor	editor	NN
work_dnaoa4trybfmvfskexkidzt764	100	5	.	.	.
work_dnaoa4trybfmvfskexkidzt764	101	1	Martindale	Martindale	NNP
work_dnaoa4trybfmvfskexkidzt764	101	2	:	:	:
work_dnaoa4trybfmvfskexkidzt764	101	3	the	the	DT
work_dnaoa4trybfmvfskexkidzt764	101	4	complete	complete	JJ
work_dnaoa4trybfmvfskexkidzt764	101	5	drug	drug	NN
work_dnaoa4trybfmvfskexkidzt764	101	6	reference	reference	NN
work_dnaoa4trybfmvfskexkidzt764	101	7	.	.	.
work_dnaoa4trybfmvfskexkidzt764	102	1	32nd	32nd	NNP
work_dnaoa4trybfmvfskexkidzt764	102	2	ed	ed	NNP
work_dnaoa4trybfmvfskexkidzt764	102	3	.	.	.
work_dnaoa4trybfmvfskexkidzt764	103	1	London	London	NNP
work_dnaoa4trybfmvfskexkidzt764	103	2	:	:	:
work_dnaoa4trybfmvfskexkidzt764	103	3	Pharmaceutical	Pharmaceutical	NNP
work_dnaoa4trybfmvfskexkidzt764	103	4	Press	Press	NNP
work_dnaoa4trybfmvfskexkidzt764	103	5	,	,	,
work_dnaoa4trybfmvfskexkidzt764	103	6	1999	1999	CD
work_dnaoa4trybfmvfskexkidzt764	103	7	.	.	.
work_dnaoa4trybfmvfskexkidzt764	104	1	5	5	CD
work_dnaoa4trybfmvfskexkidzt764	104	2	.	.	.
work_dnaoa4trybfmvfskexkidzt764	105	1	Treatment	treatment	NN
work_dnaoa4trybfmvfskexkidzt764	105	2	guidelines	guideline	NNS
work_dnaoa4trybfmvfskexkidzt764	105	3	for	for	IN
work_dnaoa4trybfmvfskexkidzt764	105	4	lead	lead	JJ
work_dnaoa4trybfmvfskexkidzt764	105	5	exposure	exposure	NN
work_dnaoa4trybfmvfskexkidzt764	105	6	in	in	IN
work_dnaoa4trybfmvfskexkidzt764	105	7	children	child	NNS
work_dnaoa4trybfmvfskexkidzt764	105	8	(	(	-LRB-
work_dnaoa4trybfmvfskexkidzt764	105	9	RE9529	RE9529	NNP
work_dnaoa4trybfmvfskexkidzt764	105	10	)	)	-RRB-
work_dnaoa4trybfmvfskexkidzt764	105	11	.	.	.
work_dnaoa4trybfmvfskexkidzt764	106	1	American	American	NNP
work_dnaoa4trybfmvfskexkidzt764	106	2	Academy	Academy	NNP
work_dnaoa4trybfmvfskexkidzt764	106	3	of	of	IN
work_dnaoa4trybfmvfskexkidzt764	106	4	Pediatrics	Pediatrics	NNP
work_dnaoa4trybfmvfskexkidzt764	106	5	Committee	Committee	NNP
work_dnaoa4trybfmvfskexkidzt764	106	6	on	on	IN
work_dnaoa4trybfmvfskexkidzt764	106	7	Drugs	Drugs	NNPS
work_dnaoa4trybfmvfskexkidzt764	106	8	.	.	.
work_dnaoa4trybfmvfskexkidzt764	107	1	Pediatrics	pediatric	NNS
work_dnaoa4trybfmvfskexkidzt764	107	2	1995	1995	CD
work_dnaoa4trybfmvfskexkidzt764	107	3	;	;	:
work_dnaoa4trybfmvfskexkidzt764	107	4	96	96	CD
work_dnaoa4trybfmvfskexkidzt764	107	5	:	:	:
work_dnaoa4trybfmvfskexkidzt764	107	6	155	155	CD
work_dnaoa4trybfmvfskexkidzt764	107	7	-	-	SYM
work_dnaoa4trybfmvfskexkidzt764	107	8	160	160	CD
work_dnaoa4trybfmvfskexkidzt764	107	9	.	.	.
work_dnaoa4trybfmvfskexkidzt764	108	1	6	6	CD
work_dnaoa4trybfmvfskexkidzt764	108	2	.	.	.
work_dnaoa4trybfmvfskexkidzt764	109	1	Graziano	Graziano	NNP
work_dnaoa4trybfmvfskexkidzt764	109	2	JH	JH	NNP
work_dnaoa4trybfmvfskexkidzt764	109	3	,	,	,
work_dnaoa4trybfmvfskexkidzt764	109	4	Lolacono	Lolacono	NNP
work_dnaoa4trybfmvfskexkidzt764	109	5	NJ	NJ	NNP
work_dnaoa4trybfmvfskexkidzt764	109	6	,	,	,
work_dnaoa4trybfmvfskexkidzt764	109	7	Meyer	Meyer	NNP
work_dnaoa4trybfmvfskexkidzt764	109	8	P.	P.	NNP
work_dnaoa4trybfmvfskexkidzt764	109	9	Dose	Dose	NNP
work_dnaoa4trybfmvfskexkidzt764	109	10	-	-	HYPH
work_dnaoa4trybfmvfskexkidzt764	109	11	response	response	NN
work_dnaoa4trybfmvfskexkidzt764	109	12	study	study	NN
work_dnaoa4trybfmvfskexkidzt764	109	13	of	of	IN
work_dnaoa4trybfmvfskexkidzt764	109	14	oral	oral	JJ
work_dnaoa4trybfmvfskexkidzt764	109	15	2,3-	2,3-	CD
work_dnaoa4trybfmvfskexkidzt764	109	16	dimercaptosuccinic	dimercaptosuccinic	JJ
work_dnaoa4trybfmvfskexkidzt764	109	17	acid	acid	NN
work_dnaoa4trybfmvfskexkidzt764	109	18	in	in	IN
work_dnaoa4trybfmvfskexkidzt764	109	19	children	child	NNS
work_dnaoa4trybfmvfskexkidzt764	109	20	with	with	IN
work_dnaoa4trybfmvfskexkidzt764	109	21	elevated	elevated	JJ
work_dnaoa4trybfmvfskexkidzt764	109	22	blood	blood	NN
work_dnaoa4trybfmvfskexkidzt764	109	23	lead	lead	NN
work_dnaoa4trybfmvfskexkidzt764	109	24	concentrations	concentration	NNS
work_dnaoa4trybfmvfskexkidzt764	109	25	.	.	.
work_dnaoa4trybfmvfskexkidzt764	110	1	J	J	NNP
work_dnaoa4trybfmvfskexkidzt764	110	2	Pediatr	Pediatr	NNP
work_dnaoa4trybfmvfskexkidzt764	110	3	1988	1988	CD
work_dnaoa4trybfmvfskexkidzt764	110	4	;	;	:
work_dnaoa4trybfmvfskexkidzt764	110	5	113	113	CD
work_dnaoa4trybfmvfskexkidzt764	110	6	:	:	:
work_dnaoa4trybfmvfskexkidzt764	110	7	751	751	CD
work_dnaoa4trybfmvfskexkidzt764	110	8	-	-	SYM
work_dnaoa4trybfmvfskexkidzt764	110	9	757	757	CD
work_dnaoa4trybfmvfskexkidzt764	110	10	.	.	.
work_dnaoa4trybfmvfskexkidzt764	111	1	7	7	LS
work_dnaoa4trybfmvfskexkidzt764	111	2	.	.	.
work_dnaoa4trybfmvfskexkidzt764	112	1	Graziano	Graziano	NNP
work_dnaoa4trybfmvfskexkidzt764	112	2	JH	JH	NNP
work_dnaoa4trybfmvfskexkidzt764	112	3	,	,	,
work_dnaoa4trybfmvfskexkidzt764	112	4	Lolacono	Lolacono	NNP
work_dnaoa4trybfmvfskexkidzt764	112	5	NJ	NJ	NNP
work_dnaoa4trybfmvfskexkidzt764	112	6	,	,	,
work_dnaoa4trybfmvfskexkidzt764	112	7	Moulton	Moulton	NNP
work_dnaoa4trybfmvfskexkidzt764	112	8	T	T	NNP
work_dnaoa4trybfmvfskexkidzt764	112	9	,	,	,
work_dnaoa4trybfmvfskexkidzt764	112	10	et	et	NNP
work_dnaoa4trybfmvfskexkidzt764	112	11	al	al	NNP
work_dnaoa4trybfmvfskexkidzt764	112	12	.	.	.
work_dnaoa4trybfmvfskexkidzt764	113	1	Controlled	control	VBN
work_dnaoa4trybfmvfskexkidzt764	113	2	study	study	NN
work_dnaoa4trybfmvfskexkidzt764	113	3	of	of	IN
work_dnaoa4trybfmvfskexkidzt764	113	4	2,3-dimercapto-	2,3-dimercapto-	CD
work_dnaoa4trybfmvfskexkidzt764	113	5	succinic	succinic	JJ
work_dnaoa4trybfmvfskexkidzt764	113	6	acid	acid	NN
work_dnaoa4trybfmvfskexkidzt764	113	7	for	for	IN
work_dnaoa4trybfmvfskexkidzt764	113	8	management	management	NN
work_dnaoa4trybfmvfskexkidzt764	113	9	of	of	IN
work_dnaoa4trybfmvfskexkidzt764	113	10	childhood	childhood	NN
work_dnaoa4trybfmvfskexkidzt764	113	11	lead	lead	NN
work_dnaoa4trybfmvfskexkidzt764	113	12	intoxication	intoxication	NN
work_dnaoa4trybfmvfskexkidzt764	113	13	.	.	.
work_dnaoa4trybfmvfskexkidzt764	114	1	J	J	NNP
work_dnaoa4trybfmvfskexkidzt764	114	2	Pediatr	Pediatr	NNP
work_dnaoa4trybfmvfskexkidzt764	114	3	1992	1992	CD
work_dnaoa4trybfmvfskexkidzt764	114	4	;	;	:
work_dnaoa4trybfmvfskexkidzt764	114	5	120	120	CD
work_dnaoa4trybfmvfskexkidzt764	114	6	:	:	SYM
work_dnaoa4trybfmvfskexkidzt764	114	7	133	133	CD
work_dnaoa4trybfmvfskexkidzt764	114	8	-	-	SYM
work_dnaoa4trybfmvfskexkidzt764	114	9	139	139	CD
work_dnaoa4trybfmvfskexkidzt764	114	10	.	.	.
work_dnaoa4trybfmvfskexkidzt764	115	1	8	8	LS
work_dnaoa4trybfmvfskexkidzt764	115	2	.	.	.
work_dnaoa4trybfmvfskexkidzt764	116	1	19th	19th	JJ
work_dnaoa4trybfmvfskexkidzt764	116	2	Australian	Australian	NNP
work_dnaoa4trybfmvfskexkidzt764	116	3	Total	Total	NNP
work_dnaoa4trybfmvfskexkidzt764	116	4	Diet	Diet	NNP
work_dnaoa4trybfmvfskexkidzt764	116	5	Survey	Survey	NNP
work_dnaoa4trybfmvfskexkidzt764	116	6	.	.	.
work_dnaoa4trybfmvfskexkidzt764	117	1	A	a	DT
work_dnaoa4trybfmvfskexkidzt764	117	2	total	total	JJ
work_dnaoa4trybfmvfskexkidzt764	117	3	diet	diet	NN
work_dnaoa4trybfmvfskexkidzt764	117	4	survey	survey	NN
work_dnaoa4trybfmvfskexkidzt764	117	5	of	of	IN
work_dnaoa4trybfmvfskexkidzt764	117	6	pesticide	pesticide	NN
work_dnaoa4trybfmvfskexkidzt764	117	7	residues	residue	NNS
work_dnaoa4trybfmvfskexkidzt764	117	8	and	and	CC
work_dnaoa4trybfmvfskexkidzt764	117	9	contaminants	contaminant	NNS
work_dnaoa4trybfmvfskexkidzt764	117	10	.	.	.
work_dnaoa4trybfmvfskexkidzt764	118	1	Canberra	Canberra	NNP
work_dnaoa4trybfmvfskexkidzt764	118	2	:	:	:
work_dnaoa4trybfmvfskexkidzt764	118	3	Australian	Australian	NNP
work_dnaoa4trybfmvfskexkidzt764	118	4	New	New	NNP
work_dnaoa4trybfmvfskexkidzt764	118	5	Zealand	Zealand	NNP
work_dnaoa4trybfmvfskexkidzt764	118	6	Food	Food	NNP
work_dnaoa4trybfmvfskexkidzt764	118	7	Authority	Authority	NNP
work_dnaoa4trybfmvfskexkidzt764	118	8	,	,	,
work_dnaoa4trybfmvfskexkidzt764	118	9	2001	2001	CD
work_dnaoa4trybfmvfskexkidzt764	118	10	.	.	.
work_dnaoa4trybfmvfskexkidzt764	119	1	9	9	CD
work_dnaoa4trybfmvfskexkidzt764	119	2	.	.	.
work_dnaoa4trybfmvfskexkidzt764	120	1	Howard	Howard	NNP
work_dnaoa4trybfmvfskexkidzt764	120	2	H.	H.	NNP
work_dnaoa4trybfmvfskexkidzt764	120	3	Heavy	Heavy	NNP
work_dnaoa4trybfmvfskexkidzt764	120	4	metal	metal	NN
work_dnaoa4trybfmvfskexkidzt764	120	5	poisoning	poisoning	NN
work_dnaoa4trybfmvfskexkidzt764	120	6	.	.	.
work_dnaoa4trybfmvfskexkidzt764	121	1	In	in	IN
work_dnaoa4trybfmvfskexkidzt764	121	2	:	:	:
work_dnaoa4trybfmvfskexkidzt764	121	3	Harrison	Harrison	NNP
work_dnaoa4trybfmvfskexkidzt764	121	4	’s	’s	POS
work_dnaoa4trybfmvfskexkidzt764	121	5	principles	principle	NNS
work_dnaoa4trybfmvfskexkidzt764	121	6	of	of	IN
work_dnaoa4trybfmvfskexkidzt764	121	7	internal	internal	JJ
work_dnaoa4trybfmvfskexkidzt764	121	8	medicine	medicine	NN
work_dnaoa4trybfmvfskexkidzt764	121	9	.	.	.
work_dnaoa4trybfmvfskexkidzt764	122	1	14th	14th	JJ
work_dnaoa4trybfmvfskexkidzt764	122	2	ed	ed	NNP
work_dnaoa4trybfmvfskexkidzt764	122	3	.	.	.
work_dnaoa4trybfmvfskexkidzt764	123	1	New	New	NNP
work_dnaoa4trybfmvfskexkidzt764	123	2	York	York	NNP
work_dnaoa4trybfmvfskexkidzt764	123	3	:	:	:
work_dnaoa4trybfmvfskexkidzt764	123	4	McGraw	McGraw	NNP
work_dnaoa4trybfmvfskexkidzt764	123	5	-	-	HYPH
work_dnaoa4trybfmvfskexkidzt764	123	6	Hill	Hill	NNP
work_dnaoa4trybfmvfskexkidzt764	123	7	;	;	:
work_dnaoa4trybfmvfskexkidzt764	123	8	1998	1998	CD
work_dnaoa4trybfmvfskexkidzt764	123	9	:	:	:
work_dnaoa4trybfmvfskexkidzt764	123	10	2564	2564	CD
work_dnaoa4trybfmvfskexkidzt764	123	11	-	-	SYM
work_dnaoa4trybfmvfskexkidzt764	123	12	2569	2569	CD
work_dnaoa4trybfmvfskexkidzt764	123	13	.	.	.
work_dnaoa4trybfmvfskexkidzt764	124	1	10	10	CD
work_dnaoa4trybfmvfskexkidzt764	124	2	.	.	.
work_dnaoa4trybfmvfskexkidzt764	125	1	Timpo	Timpo	VBN
work_dnaoa4trybfmvfskexkidzt764	125	2	AE	AE	NNP
work_dnaoa4trybfmvfskexkidzt764	125	3	,	,	,
work_dnaoa4trybfmvfskexkidzt764	125	4	Amin	Amin	NNP
work_dnaoa4trybfmvfskexkidzt764	125	5	JS	JS	NNP
work_dnaoa4trybfmvfskexkidzt764	125	6	,	,	,
work_dnaoa4trybfmvfskexkidzt764	125	7	Casalino	Casalino	NNP
work_dnaoa4trybfmvfskexkidzt764	125	8	MB	MB	NNP
work_dnaoa4trybfmvfskexkidzt764	125	9	,	,	,
work_dnaoa4trybfmvfskexkidzt764	125	10	Yuceoglu	Yuceoglu	NNP
work_dnaoa4trybfmvfskexkidzt764	125	11	AM	am	VBP
work_dnaoa4trybfmvfskexkidzt764	125	12	.	.	.
work_dnaoa4trybfmvfskexkidzt764	126	1	Congenital	congenital	JJ
work_dnaoa4trybfmvfskexkidzt764	126	2	lead	lead	NN
work_dnaoa4trybfmvfskexkidzt764	126	3	intoxication	intoxication	NN
work_dnaoa4trybfmvfskexkidzt764	126	4	.	.	.
work_dnaoa4trybfmvfskexkidzt764	127	1	J	J	NNP
work_dnaoa4trybfmvfskexkidzt764	127	2	Pediatr	Pediatr	NNP
work_dnaoa4trybfmvfskexkidzt764	127	3	1979	1979	CD
work_dnaoa4trybfmvfskexkidzt764	127	4	;	;	:
work_dnaoa4trybfmvfskexkidzt764	127	5	94	94	CD
work_dnaoa4trybfmvfskexkidzt764	127	6	:	:	:
work_dnaoa4trybfmvfskexkidzt764	127	7	765	765	CD
work_dnaoa4trybfmvfskexkidzt764	127	8	-	-	SYM
work_dnaoa4trybfmvfskexkidzt764	127	9	767	767	CD
work_dnaoa4trybfmvfskexkidzt764	127	10	.	.	.
work_dnaoa4trybfmvfskexkidzt764	128	1	11	11	CD
work_dnaoa4trybfmvfskexkidzt764	128	2	.	.	.
work_dnaoa4trybfmvfskexkidzt764	129	1	Knecht	Knecht	NNP
work_dnaoa4trybfmvfskexkidzt764	129	2	CD	CD	NNP
work_dnaoa4trybfmvfskexkidzt764	129	3	,	,	,
work_dnaoa4trybfmvfskexkidzt764	129	4	Crabtree	Crabtree	NNP
work_dnaoa4trybfmvfskexkidzt764	129	5	J	J	NNP
work_dnaoa4trybfmvfskexkidzt764	129	6	,	,	,
work_dnaoa4trybfmvfskexkidzt764	129	7	Katherman	Katherman	NNP
work_dnaoa4trybfmvfskexkidzt764	129	8	A.	a.	NN
work_dnaoa4trybfmvfskexkidzt764	130	1	Clinical	clinical	JJ
work_dnaoa4trybfmvfskexkidzt764	130	2	,	,	,
work_dnaoa4trybfmvfskexkidzt764	130	3	clinicopathologic	clinicopathologic	NN
work_dnaoa4trybfmvfskexkidzt764	130	4	,	,	,
work_dnaoa4trybfmvfskexkidzt764	130	5	and	and	CC
work_dnaoa4trybfmvfskexkidzt764	130	6	electroen-	electroen-	XX
work_dnaoa4trybfmvfskexkidzt764	130	7	cephalographic	cephalographic	JJ
work_dnaoa4trybfmvfskexkidzt764	130	8	features	feature	NNS
work_dnaoa4trybfmvfskexkidzt764	130	9	of	of	IN
work_dnaoa4trybfmvfskexkidzt764	130	10	lead	lead	NN
work_dnaoa4trybfmvfskexkidzt764	130	11	poisoning	poisoning	NN
work_dnaoa4trybfmvfskexkidzt764	130	12	in	in	IN
work_dnaoa4trybfmvfskexkidzt764	130	13	dogs	dog	NNS
work_dnaoa4trybfmvfskexkidzt764	130	14	.	.	.
work_dnaoa4trybfmvfskexkidzt764	131	1	J	J	NNP
work_dnaoa4trybfmvfskexkidzt764	131	2	Am	Am	NNP
work_dnaoa4trybfmvfskexkidzt764	131	3	Vet	Vet	NNP
work_dnaoa4trybfmvfskexkidzt764	131	4	Med	Med	NNP
work_dnaoa4trybfmvfskexkidzt764	131	5	Assoc	Assoc	NNP
work_dnaoa4trybfmvfskexkidzt764	131	6	1979	1979	CD
work_dnaoa4trybfmvfskexkidzt764	131	7	;	;	:
work_dnaoa4trybfmvfskexkidzt764	131	8	175	175	CD
work_dnaoa4trybfmvfskexkidzt764	131	9	:	:	SYM
work_dnaoa4trybfmvfskexkidzt764	131	10	196	196	CD
work_dnaoa4trybfmvfskexkidzt764	131	11	-	-	SYM
work_dnaoa4trybfmvfskexkidzt764	131	12	201	201	CD
work_dnaoa4trybfmvfskexkidzt764	131	13	.	.	.
work_dnaoa4trybfmvfskexkidzt764	132	1	12	12	CD
work_dnaoa4trybfmvfskexkidzt764	132	2	.	.	.
work_dnaoa4trybfmvfskexkidzt764	133	1	Goyer	Goyer	NNP
work_dnaoa4trybfmvfskexkidzt764	133	2	RA	RA	NNP
work_dnaoa4trybfmvfskexkidzt764	133	3	.	.	.
work_dnaoa4trybfmvfskexkidzt764	134	1	Transplacental	transplacental	JJ
work_dnaoa4trybfmvfskexkidzt764	134	2	transport	transport	NN
work_dnaoa4trybfmvfskexkidzt764	134	3	of	of	IN
work_dnaoa4trybfmvfskexkidzt764	134	4	lead	lead	NN
work_dnaoa4trybfmvfskexkidzt764	134	5	.	.	.
work_dnaoa4trybfmvfskexkidzt764	135	1	Environ	Environ	NNP
work_dnaoa4trybfmvfskexkidzt764	135	2	Health	Health	NNP
work_dnaoa4trybfmvfskexkidzt764	135	3	Perspect	Perspect	NNP
work_dnaoa4trybfmvfskexkidzt764	135	4	1990	1990	CD
work_dnaoa4trybfmvfskexkidzt764	135	5	;	;	:
work_dnaoa4trybfmvfskexkidzt764	135	6	89	89	CD
work_dnaoa4trybfmvfskexkidzt764	135	7	:	:	SYM
work_dnaoa4trybfmvfskexkidzt764	135	8	101	101	CD
work_dnaoa4trybfmvfskexkidzt764	135	9	-	-	SYM
work_dnaoa4trybfmvfskexkidzt764	135	10	105	105	CD
work_dnaoa4trybfmvfskexkidzt764	135	11	.	.	.
work_dnaoa4trybfmvfskexkidzt764	136	1	13	13	CD
work_dnaoa4trybfmvfskexkidzt764	136	2	.	.	.
work_dnaoa4trybfmvfskexkidzt764	137	1	Marcus	Marcus	NNP
work_dnaoa4trybfmvfskexkidzt764	137	2	AH	AH	NNP
work_dnaoa4trybfmvfskexkidzt764	137	3	.	.	.
work_dnaoa4trybfmvfskexkidzt764	138	1	Multicompartment	multicompartment	JJ
work_dnaoa4trybfmvfskexkidzt764	138	2	kinetic	kinetic	JJ
work_dnaoa4trybfmvfskexkidzt764	138	3	model	model	NN
work_dnaoa4trybfmvfskexkidzt764	138	4	for	for	IN
work_dnaoa4trybfmvfskexkidzt764	138	5	lead	lead	NN
work_dnaoa4trybfmvfskexkidzt764	138	6	.	.	.
work_dnaoa4trybfmvfskexkidzt764	139	1	III	iii	CD
work_dnaoa4trybfmvfskexkidzt764	139	2	.	.	.
work_dnaoa4trybfmvfskexkidzt764	140	1	Lead	lead	VB
work_dnaoa4trybfmvfskexkidzt764	140	2	in	in	IN
work_dnaoa4trybfmvfskexkidzt764	140	3	blood	blood	NN
work_dnaoa4trybfmvfskexkidzt764	140	4	plasma	plasma	NN
work_dnaoa4trybfmvfskexkidzt764	140	5	and	and	CC
work_dnaoa4trybfmvfskexkidzt764	140	6	erythrocytes	erythrocyte	NNS
work_dnaoa4trybfmvfskexkidzt764	140	7	.	.	.
work_dnaoa4trybfmvfskexkidzt764	141	1	Environ	Environ	NNP
work_dnaoa4trybfmvfskexkidzt764	141	2	Res	Res	NNP
work_dnaoa4trybfmvfskexkidzt764	141	3	1985	1985	CD
work_dnaoa4trybfmvfskexkidzt764	141	4	;	;	:
work_dnaoa4trybfmvfskexkidzt764	141	5	36	36	CD
work_dnaoa4trybfmvfskexkidzt764	141	6	:	:	:
work_dnaoa4trybfmvfskexkidzt764	141	7	473	473	CD
work_dnaoa4trybfmvfskexkidzt764	141	8	-	-	SYM
work_dnaoa4trybfmvfskexkidzt764	141	9	489	489	CD
work_dnaoa4trybfmvfskexkidzt764	141	10	.	.	.
work_dnaoa4trybfmvfskexkidzt764	142	1	14	14	CD
work_dnaoa4trybfmvfskexkidzt764	142	2	.	.	.
work_dnaoa4trybfmvfskexkidzt764	143	1	Therapeutic	Therapeutic	NNP
work_dnaoa4trybfmvfskexkidzt764	143	2	Goods	Goods	NNPS
work_dnaoa4trybfmvfskexkidzt764	143	3	Administration	Administration	NNP
work_dnaoa4trybfmvfskexkidzt764	143	4	.	.	.
work_dnaoa4trybfmvfskexkidzt764	144	1	Australian	Australian	NNP
work_dnaoa4trybfmvfskexkidzt764	144	2	Department	Department	NNP
work_dnaoa4trybfmvfskexkidzt764	144	3	of	of	IN
work_dnaoa4trybfmvfskexkidzt764	144	4	Health	Health	NNP
work_dnaoa4trybfmvfskexkidzt764	144	5	and	and	CC
work_dnaoa4trybfmvfskexkidzt764	144	6	Age-	Age-	NNP
work_dnaoa4trybfmvfskexkidzt764	144	7	ing	ing	NNP
work_dnaoa4trybfmvfskexkidzt764	144	8	.	.	.
work_dnaoa4trybfmvfskexkidzt764	145	1	2002	2002	CD
work_dnaoa4trybfmvfskexkidzt764	145	2	.	.	.
work_dnaoa4trybfmvfskexkidzt764	146	1	Available	available	JJ
work_dnaoa4trybfmvfskexkidzt764	146	2	at	at	IN
work_dnaoa4trybfmvfskexkidzt764	146	3	:	:	:
work_dnaoa4trybfmvfskexkidzt764	146	4	<	<	XX
work_dnaoa4trybfmvfskexkidzt764	146	5	http://www.health.gov.au/tga/cm/cm.htm	http://www.health.gov.au/tga/cm/cm.htm	PRP$
work_dnaoa4trybfmvfskexkidzt764	146	6	>	>	XX
work_dnaoa4trybfmvfskexkidzt764	146	7	.	.	.
work_dnaoa4trybfmvfskexkidzt764	147	1	Accessed	access	VBN
work_dnaoa4trybfmvfskexkidzt764	147	2	4	4	CD
work_dnaoa4trybfmvfskexkidzt764	147	3	July	July	NNP
work_dnaoa4trybfmvfskexkidzt764	147	4	2002	2002	CD
work_dnaoa4trybfmvfskexkidzt764	147	5	.	.	.
work_dnaoa4trybfmvfskexkidzt764	148	1	15	15	CD
work_dnaoa4trybfmvfskexkidzt764	148	2	.	.	.
work_dnaoa4trybfmvfskexkidzt764	149	1	McElvaine	McElvaine	NNP
work_dnaoa4trybfmvfskexkidzt764	149	2	MD	MD	NNP
work_dnaoa4trybfmvfskexkidzt764	149	3	,	,	,
work_dnaoa4trybfmvfskexkidzt764	149	4	Harder	Harder	NNP
work_dnaoa4trybfmvfskexkidzt764	149	5	EM	EM	NNP
work_dnaoa4trybfmvfskexkidzt764	149	6	,	,	,
work_dnaoa4trybfmvfskexkidzt764	149	7	Johnson	Johnson	NNP
work_dnaoa4trybfmvfskexkidzt764	149	8	L	L	NNP
work_dnaoa4trybfmvfskexkidzt764	149	9	,	,	,
work_dnaoa4trybfmvfskexkidzt764	149	10	et	et	NNP
work_dnaoa4trybfmvfskexkidzt764	149	11	al	al	NNP
work_dnaoa4trybfmvfskexkidzt764	149	12	.	.	.
work_dnaoa4trybfmvfskexkidzt764	150	1	Lead	lead	VB
work_dnaoa4trybfmvfskexkidzt764	150	2	poisoning	poisoning	NN
work_dnaoa4trybfmvfskexkidzt764	150	3	from	from	IN
work_dnaoa4trybfmvfskexkidzt764	150	4	the	the	DT
work_dnaoa4trybfmvfskexkidzt764	150	5	use	use	NN
work_dnaoa4trybfmvfskexkidzt764	150	6	of	of	IN
work_dnaoa4trybfmvfskexkidzt764	150	7	Indian	indian	JJ
work_dnaoa4trybfmvfskexkidzt764	150	8	folk	folk	NN
work_dnaoa4trybfmvfskexkidzt764	150	9	medicines	medicine	NNS
work_dnaoa4trybfmvfskexkidzt764	150	10	.	.	.
work_dnaoa4trybfmvfskexkidzt764	151	1	JAMA	JAMA	NNP
work_dnaoa4trybfmvfskexkidzt764	151	2	1990	1990	CD
work_dnaoa4trybfmvfskexkidzt764	151	3	;	;	:
work_dnaoa4trybfmvfskexkidzt764	151	4	264	264	CD
work_dnaoa4trybfmvfskexkidzt764	151	5	:	:	SYM
work_dnaoa4trybfmvfskexkidzt764	151	6	2212	2212	CD
work_dnaoa4trybfmvfskexkidzt764	151	7	-	-	SYM
work_dnaoa4trybfmvfskexkidzt764	151	8	2213	2213	CD
work_dnaoa4trybfmvfskexkidzt764	151	9	.	.	.
work_dnaoa4trybfmvfskexkidzt764	152	1	16	16	CD
work_dnaoa4trybfmvfskexkidzt764	152	2	.	.	.
work_dnaoa4trybfmvfskexkidzt764	153	1	Dunbabin	Dunbabin	NNP
work_dnaoa4trybfmvfskexkidzt764	153	2	DW	DW	NNP
work_dnaoa4trybfmvfskexkidzt764	153	3	,	,	,
work_dnaoa4trybfmvfskexkidzt764	153	4	Tallis	Tallis	NNP
work_dnaoa4trybfmvfskexkidzt764	153	5	GA	GA	NNP
work_dnaoa4trybfmvfskexkidzt764	153	6	,	,	,
work_dnaoa4trybfmvfskexkidzt764	153	7	Popplewell	Popplewell	NNP
work_dnaoa4trybfmvfskexkidzt764	153	8	PY	PY	NNP
work_dnaoa4trybfmvfskexkidzt764	153	9	,	,	,
work_dnaoa4trybfmvfskexkidzt764	153	10	Lee	Lee	NNP
work_dnaoa4trybfmvfskexkidzt764	153	11	RA	RA	NNP
work_dnaoa4trybfmvfskexkidzt764	153	12	.	.	.
work_dnaoa4trybfmvfskexkidzt764	154	1	Lead	lead	VB
work_dnaoa4trybfmvfskexkidzt764	154	2	poisoning	poisoning	NN
work_dnaoa4trybfmvfskexkidzt764	154	3	from	from	IN
work_dnaoa4trybfmvfskexkidzt764	154	4	Indian	indian	JJ
work_dnaoa4trybfmvfskexkidzt764	154	5	herbal	herbal	JJ
work_dnaoa4trybfmvfskexkidzt764	154	6	medicine	medicine	NN
work_dnaoa4trybfmvfskexkidzt764	154	7	(	(	-LRB-
work_dnaoa4trybfmvfskexkidzt764	154	8	Ayurveda	Ayurveda	NNP
work_dnaoa4trybfmvfskexkidzt764	154	9	)	)	-RRB-
work_dnaoa4trybfmvfskexkidzt764	154	10	.	.	.
work_dnaoa4trybfmvfskexkidzt764	155	1	Med	Med	NNP
work_dnaoa4trybfmvfskexkidzt764	155	2	J	J	NNP
work_dnaoa4trybfmvfskexkidzt764	155	3	Aust	Aust	NNP
work_dnaoa4trybfmvfskexkidzt764	155	4	1992	1992	CD
work_dnaoa4trybfmvfskexkidzt764	155	5	;	;	:
work_dnaoa4trybfmvfskexkidzt764	155	6	157	157	CD
work_dnaoa4trybfmvfskexkidzt764	155	7	:	:	SYM
work_dnaoa4trybfmvfskexkidzt764	155	8	835	835	CD
work_dnaoa4trybfmvfskexkidzt764	155	9	-	-	SYM
work_dnaoa4trybfmvfskexkidzt764	155	10	836	836	CD
work_dnaoa4trybfmvfskexkidzt764	155	11	.	.	.
work_dnaoa4trybfmvfskexkidzt764	156	1	17	17	CD
work_dnaoa4trybfmvfskexkidzt764	156	2	.	.	.
work_dnaoa4trybfmvfskexkidzt764	156	3	van	van	NNP
work_dnaoa4trybfmvfskexkidzt764	156	4	Vonderen	Vonderen	NNP
work_dnaoa4trybfmvfskexkidzt764	156	5	MGA	MGA	NNP
work_dnaoa4trybfmvfskexkidzt764	156	6	,	,	,
work_dnaoa4trybfmvfskexkidzt764	156	7	Klinkenberg	Klinkenberg	NNP
work_dnaoa4trybfmvfskexkidzt764	156	8	-	-	HYPH
work_dnaoa4trybfmvfskexkidzt764	156	9	Knol	Knol	NNP
work_dnaoa4trybfmvfskexkidzt764	156	10	EC	EC	NNP
work_dnaoa4trybfmvfskexkidzt764	156	11	,	,	,
work_dnaoa4trybfmvfskexkidzt764	156	12	Craanen	Craanen	NNP
work_dnaoa4trybfmvfskexkidzt764	156	13	ME	ME	NNP
work_dnaoa4trybfmvfskexkidzt764	156	14	,	,	,
work_dnaoa4trybfmvfskexkidzt764	156	15	et	et	NNP
work_dnaoa4trybfmvfskexkidzt764	156	16	al	al	NNP
work_dnaoa4trybfmvfskexkidzt764	156	17	.	.	.
work_dnaoa4trybfmvfskexkidzt764	157	1	Severe	severe	JJ
work_dnaoa4trybfmvfskexkidzt764	157	2	gastroin-	gastroin-	JJ
work_dnaoa4trybfmvfskexkidzt764	157	3	testinal	testinal	JJ
work_dnaoa4trybfmvfskexkidzt764	157	4	symptoms	symptom	NNS
work_dnaoa4trybfmvfskexkidzt764	157	5	due	due	JJ
work_dnaoa4trybfmvfskexkidzt764	157	6	to	to	TO
work_dnaoa4trybfmvfskexkidzt764	157	7	lead	lead	VB
work_dnaoa4trybfmvfskexkidzt764	157	8	poisoning	poisoning	NN
work_dnaoa4trybfmvfskexkidzt764	157	9	from	from	IN
work_dnaoa4trybfmvfskexkidzt764	157	10	Indian	indian	JJ
work_dnaoa4trybfmvfskexkidzt764	157	11	traditional	traditional	JJ
work_dnaoa4trybfmvfskexkidzt764	157	12	medicine	medicine	NN
work_dnaoa4trybfmvfskexkidzt764	157	13	.	.	.
work_dnaoa4trybfmvfskexkidzt764	158	1	Am	Am	NNP
work_dnaoa4trybfmvfskexkidzt764	158	2	J	J	NNP
work_dnaoa4trybfmvfskexkidzt764	158	3	Gastroenterol	Gastroenterol	NNP
work_dnaoa4trybfmvfskexkidzt764	158	4	2000	2000	CD
work_dnaoa4trybfmvfskexkidzt764	158	5	;	;	:
work_dnaoa4trybfmvfskexkidzt764	158	6	95	95	CD
work_dnaoa4trybfmvfskexkidzt764	158	7	:	:	SYM
work_dnaoa4trybfmvfskexkidzt764	158	8	1591	1591	CD
work_dnaoa4trybfmvfskexkidzt764	158	9	-	-	SYM
work_dnaoa4trybfmvfskexkidzt764	158	10	1592	1592	CD
work_dnaoa4trybfmvfskexkidzt764	158	11	.	.	.
work_dnaoa4trybfmvfskexkidzt764	159	1	18	18	CD
work_dnaoa4trybfmvfskexkidzt764	159	2	.	.	.
work_dnaoa4trybfmvfskexkidzt764	160	1	Shaltout	Shaltout	NNP
work_dnaoa4trybfmvfskexkidzt764	160	2	A	A	NNP
work_dnaoa4trybfmvfskexkidzt764	160	3	,	,	,
work_dnaoa4trybfmvfskexkidzt764	160	4	Yaish	yaish	JJ
work_dnaoa4trybfmvfskexkidzt764	160	5	SA	SA	NNP
work_dnaoa4trybfmvfskexkidzt764	160	6	,	,	,
work_dnaoa4trybfmvfskexkidzt764	160	7	Fernando	Fernando	NNP
work_dnaoa4trybfmvfskexkidzt764	160	8	N.	N.	NNP
work_dnaoa4trybfmvfskexkidzt764	160	9	Lead	Lead	NNP
work_dnaoa4trybfmvfskexkidzt764	160	10	encephalopathy	encephalopathy	NN
work_dnaoa4trybfmvfskexkidzt764	160	11	in	in	IN
work_dnaoa4trybfmvfskexkidzt764	160	12	infants	infant	NNS
work_dnaoa4trybfmvfskexkidzt764	160	13	in	in	IN
work_dnaoa4trybfmvfskexkidzt764	160	14	Kuwait	Kuwait	NNP
work_dnaoa4trybfmvfskexkidzt764	160	15	.	.	.
work_dnaoa4trybfmvfskexkidzt764	161	1	Ann	Ann	NNP
work_dnaoa4trybfmvfskexkidzt764	161	2	Trop	Trop	NNP
work_dnaoa4trybfmvfskexkidzt764	161	3	Paed	Paed	NNP
work_dnaoa4trybfmvfskexkidzt764	161	4	1981	1981	CD
work_dnaoa4trybfmvfskexkidzt764	161	5	;	;	:
work_dnaoa4trybfmvfskexkidzt764	161	6	1	1	CD
work_dnaoa4trybfmvfskexkidzt764	161	7	:	:	:
work_dnaoa4trybfmvfskexkidzt764	161	8	209	209	CD
work_dnaoa4trybfmvfskexkidzt764	161	9	-	-	SYM
work_dnaoa4trybfmvfskexkidzt764	161	10	215	215	CD
work_dnaoa4trybfmvfskexkidzt764	161	11	.	.	.
work_dnaoa4trybfmvfskexkidzt764	162	1	19	19	CD
work_dnaoa4trybfmvfskexkidzt764	162	2	.	.	.
work_dnaoa4trybfmvfskexkidzt764	163	1	Rahman	Rahman	NNP
work_dnaoa4trybfmvfskexkidzt764	163	2	H	H	NNP
work_dnaoa4trybfmvfskexkidzt764	163	3	,	,	,
work_dnaoa4trybfmvfskexkidzt764	163	4	Al	Al	NNP
work_dnaoa4trybfmvfskexkidzt764	163	5	Khayat	Khayat	NNP
work_dnaoa4trybfmvfskexkidzt764	163	6	A	A	NNP
work_dnaoa4trybfmvfskexkidzt764	163	7	,	,	,
work_dnaoa4trybfmvfskexkidzt764	163	8	Menon	Menon	NNP
work_dnaoa4trybfmvfskexkidzt764	163	9	N.	N.	NNP
work_dnaoa4trybfmvfskexkidzt764	163	10	Lead	Lead	NNP
work_dnaoa4trybfmvfskexkidzt764	163	11	poisoning	poisoning	NN
work_dnaoa4trybfmvfskexkidzt764	163	12	in	in	IN
work_dnaoa4trybfmvfskexkidzt764	163	13	infancy	infancy	NN
work_dnaoa4trybfmvfskexkidzt764	163	14	–	–	:
work_dnaoa4trybfmvfskexkidzt764	163	15	unusual	unusual	JJ
work_dnaoa4trybfmvfskexkidzt764	163	16	causes	cause	NNS
work_dnaoa4trybfmvfskexkidzt764	163	17	in	in	IN
work_dnaoa4trybfmvfskexkidzt764	163	18	the	the	DT
work_dnaoa4trybfmvfskexkidzt764	163	19	U.A.E.	U.A.E.	NNP
work_dnaoa4trybfmvfskexkidzt764	164	1	Ann	Ann	NNP
work_dnaoa4trybfmvfskexkidzt764	164	2	Trop	Trop	NNP
work_dnaoa4trybfmvfskexkidzt764	164	3	Paediatr	Paediatr	NNP
work_dnaoa4trybfmvfskexkidzt764	164	4	1986	1986	CD
work_dnaoa4trybfmvfskexkidzt764	164	5	;	;	:
work_dnaoa4trybfmvfskexkidzt764	164	6	6	6	CD
work_dnaoa4trybfmvfskexkidzt764	164	7	:	:	SYM
work_dnaoa4trybfmvfskexkidzt764	164	8	213	213	CD
work_dnaoa4trybfmvfskexkidzt764	164	9	-	-	SYM
work_dnaoa4trybfmvfskexkidzt764	164	10	217	217	CD
work_dnaoa4trybfmvfskexkidzt764	164	11	.	.	.
work_dnaoa4trybfmvfskexkidzt764	165	1	20	20	CD
work_dnaoa4trybfmvfskexkidzt764	165	2	.	.	.
work_dnaoa4trybfmvfskexkidzt764	166	1	Lead	lead	JJ
work_dnaoa4trybfmvfskexkidzt764	166	2	poisoning	poisoning	NN
work_dnaoa4trybfmvfskexkidzt764	166	3	associated	associate	VBN
work_dnaoa4trybfmvfskexkidzt764	166	4	with	with	IN
work_dnaoa4trybfmvfskexkidzt764	166	5	use	use	NN
work_dnaoa4trybfmvfskexkidzt764	166	6	of	of	IN
work_dnaoa4trybfmvfskexkidzt764	166	7	traditional	traditional	JJ
work_dnaoa4trybfmvfskexkidzt764	166	8	ethnic	ethnic	JJ
work_dnaoa4trybfmvfskexkidzt764	166	9	remedies	remedy	NNS
work_dnaoa4trybfmvfskexkidzt764	166	10	—	—	:
work_dnaoa4trybfmvfskexkidzt764	166	11	California	California	NNP
work_dnaoa4trybfmvfskexkidzt764	166	12	,	,	,
work_dnaoa4trybfmvfskexkidzt764	166	13	1991–1992	1991–1992	CD
work_dnaoa4trybfmvfskexkidzt764	166	14	.	.	.
work_dnaoa4trybfmvfskexkidzt764	167	1	MMWR	MMWR	NNP
work_dnaoa4trybfmvfskexkidzt764	167	2	Morb	Morb	NNP
work_dnaoa4trybfmvfskexkidzt764	167	3	Mortal	Mortal	NNP
work_dnaoa4trybfmvfskexkidzt764	167	4	Wkly	Wkly	NNP
work_dnaoa4trybfmvfskexkidzt764	167	5	Rep	Rep	NNP
work_dnaoa4trybfmvfskexkidzt764	167	6	1993	1993	CD
work_dnaoa4trybfmvfskexkidzt764	167	7	;	;	:
work_dnaoa4trybfmvfskexkidzt764	167	8	42	42	CD
work_dnaoa4trybfmvfskexkidzt764	167	9	:	:	:
work_dnaoa4trybfmvfskexkidzt764	167	10	521	521	CD
work_dnaoa4trybfmvfskexkidzt764	167	11	-	-	SYM
work_dnaoa4trybfmvfskexkidzt764	167	12	524	524	CD
work_dnaoa4trybfmvfskexkidzt764	167	13	.	.	.
work_dnaoa4trybfmvfskexkidzt764	168	1	21	21	CD
work_dnaoa4trybfmvfskexkidzt764	168	2	.	.	.
work_dnaoa4trybfmvfskexkidzt764	169	1	Adult	adult	JJ
work_dnaoa4trybfmvfskexkidzt764	169	2	lead	lead	NN
work_dnaoa4trybfmvfskexkidzt764	169	3	poisoning	poisoning	NN
work_dnaoa4trybfmvfskexkidzt764	169	4	from	from	IN
work_dnaoa4trybfmvfskexkidzt764	169	5	an	an	DT
work_dnaoa4trybfmvfskexkidzt764	169	6	Asian	asian	JJ
work_dnaoa4trybfmvfskexkidzt764	169	7	remedy	remedy	NN
work_dnaoa4trybfmvfskexkidzt764	169	8	for	for	IN
work_dnaoa4trybfmvfskexkidzt764	169	9	menstrual	menstrual	JJ
work_dnaoa4trybfmvfskexkidzt764	169	10	cramps	cramp	NNS
work_dnaoa4trybfmvfskexkidzt764	169	11	—	—	:
work_dnaoa4trybfmvfskexkidzt764	169	12	Connecti-	Connecti-	NNP
work_dnaoa4trybfmvfskexkidzt764	169	13	cut	cut	NN
work_dnaoa4trybfmvfskexkidzt764	169	14	,	,	,
work_dnaoa4trybfmvfskexkidzt764	169	15	1997	1997	CD
work_dnaoa4trybfmvfskexkidzt764	169	16	.	.	.
work_dnaoa4trybfmvfskexkidzt764	170	1	MMWR	MMWR	NNP
work_dnaoa4trybfmvfskexkidzt764	170	2	Morb	Morb	NNP
work_dnaoa4trybfmvfskexkidzt764	170	3	Mortal	Mortal	NNP
work_dnaoa4trybfmvfskexkidzt764	170	4	Wkly	Wkly	NNP
work_dnaoa4trybfmvfskexkidzt764	170	5	Rep	Rep	NNP
work_dnaoa4trybfmvfskexkidzt764	170	6	1999	1999	CD
work_dnaoa4trybfmvfskexkidzt764	170	7	;	;	:
work_dnaoa4trybfmvfskexkidzt764	170	8	48	48	CD
work_dnaoa4trybfmvfskexkidzt764	170	9	:	:	:
work_dnaoa4trybfmvfskexkidzt764	170	10	27	27	CD
work_dnaoa4trybfmvfskexkidzt764	170	11	-	-	SYM
work_dnaoa4trybfmvfskexkidzt764	170	12	29	29	CD
work_dnaoa4trybfmvfskexkidzt764	170	13	.	.	.
work_dnaoa4trybfmvfskexkidzt764	171	1	(	(	-LRB-
work_dnaoa4trybfmvfskexkidzt764	171	2	Received	receive	VBN
work_dnaoa4trybfmvfskexkidzt764	171	3	4	4	CD
work_dnaoa4trybfmvfskexkidzt764	171	4	Jan	Jan	NNP
work_dnaoa4trybfmvfskexkidzt764	171	5	2002	2002	CD
work_dnaoa4trybfmvfskexkidzt764	171	6	,	,	,
work_dnaoa4trybfmvfskexkidzt764	171	7	accepted	accept	VBD
work_dnaoa4trybfmvfskexkidzt764	171	8	7	7	CD
work_dnaoa4trybfmvfskexkidzt764	171	9	Jun	Jun	NNP
work_dnaoa4trybfmvfskexkidzt764	171	10	2002	2002	CD
work_dnaoa4trybfmvfskexkidzt764	171	11	)	)	-RRB-
work_dnaoa4trybfmvfskexkidzt764	171	12	❏	❏	NNP